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Hypertension affects one in two adults in the United States and contributes 
to more than 10% of deaths worldwide. The salt sensitivity of blood pressure, a 
clinical phenomenon present in one half of hypertensive patients and one quarter 
of normotensive individuals, predicts the development of hypertension. The 
prevalence of hypertension rises with age, and age-related increases in salt 
sensitivity and sympathetic nervous system activity, which promotes renal sodium 
reabsorption and plays a pathophysiological role in salt sensitivity and 
hypertension, have been documented. Increased mechanistic insight into the 
integrated renal and neural mechanisms influencing sodium homeostasis and 
blood pressure, particularly in aging, could yield valuable information for the 
phenotypically targeted treatment of hypertension.  
 The renal nerves, comprised of the sensory afferent renal nerves (ARN) and 
the efferent renal sympathetic nerves, influence sodium homeostasis and blood 
 
 ix 
pressure. The ARN, which include mechanosensitive and chemosensitive fibers, 
mediate a sympathoinhibitory reno-renal reflex that suppresses renal sympathetic 
nerve activity. The renal sympathetic nerves release norepinephrine, which can 
promote salt-sensitive hypertension in part by activating the sodium chloride 
cotransporter (NCC). 
 In this thesis, Sprague Dawley rats were used as a model of normal aging 
to demonstrate that 1) the ARN are critical to the sympathoinhibitory and natriuretic 
responses to alterations in sodium homeostasis and protect against salt sensitivity 
of blood pressure, 2) the paraventricular nucleus of the hypothalamus may be a 
site of central integration of the mechanosensitive sympathoinhibitory reno-renal 
reflex, 3) norepinephrine promotes NCC activity through an α1-adrenoceptor-gated 
WNK1-OxSR1-dependent signaling pathway, driving salt-sensitive hypertension, 
and 4) impairments in the sympathoinhibitory reno-renal reflex may promote 
sympathoexcitation and NCC-mediated sodium retention, driving salt-sensitive 
hypertension in aging rats. Finally, data from the Genetic Epidemiology of Salt 
Sensitivity study were used to demonstrate that variance in the gene encoding 
Gαi2 proteins, which are upregulated in the paraventricular nucleus during high salt 
intake in salt-resistant animal models and are required for dietary sodium-evoked 
suppression of renal sympathetic outflow, may be a biomarker for the salt 
sensitivity of blood pressure in humans. Together, these findings highlight the 
integrated renal and neural mechanisms contributing to salt sensitivity and age-
related hypertension.  
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CHAPTER ONE: Introduction 
Hypertension 
Hypertension, or high blood pressure, affects approximately one in two 
adults above the age of 18 in the United States (Muntner et al., 2018; Whelton et 
al., 2018). As the strongest risk factor for stroke, myocardial infarction, and chronic 
kidney disease, hypertension contributes to more than 10% of deaths worldwide 
and represents a significant public health issue that is projected to be the leading 
cause of death and disability by the year 2020 (Kannel, 2000; Lifton et al., 2001; 
Danaei et al., 2011; Statistics, 2011; World Health, 2013). Normal blood pressure 
is defined as a systolic blood pressure of less than 120mmHg and diastolic blood 
pressure of less than 80mmHg, and the importance of small increases in blood 
pressure is highlighted by a recent change in United States guidelines that reduced 
the threshold for diagnosis of hypertension from 140mmHg systolic or 90mmHg 
diastolic to 130mmHg systolic or 80mmHg diastolic blood pressure (Whelton et al., 
2018). There is a well-documented benefit of blood pressure reduction on 
hypertension-related morbidity and mortality (Rashid et al., 2003; Group et al., 
2015; Hardy et al., 2015). However, therapeutic control of blood pressure to the 
recommended target of less than 130/80mmHg is achieved in less than one half 
of hypertensive patients (Muntner et al., 2018). 
Effective blood pressure control remains elusive in part because the 
mechanisms that promote hypertension are incompletely understood. 




which no secondary cause of increased blood pressure can be identified 
(Carretero & Oparil, 2000). In these individuals, hypertension represents a 
heterogeneous disease that may be driven by impairments in one or more of the 
physiological systems contributing to blood pressure regulation, which include the 
vascular, neurohumoral, and renal systems (Oparil et al., 2003). Currently, anti-
hypertensive medications targeting each of these systems are prescribed broadly 
and with little regard to individual phenotype, and anti-hypertensive drug 
development has been virtually stagnant for more than a decade (Table 1.1) (Shah 
& Stafford, 2017). There is a critical need for new insight into the mechanistic 
underpinnings of essential hypertension, which will aid in the identification of new 
therapeutic targets and guide the phenotypically targeted use of existing 
interventions.  
Table 1.1. Major anti-hypertensive therapeutics. First line 
therapies recommended for the general population are indicated 




Salt Sensitivity of Blood Pressure 
The salt sensitivity of blood pressure, defined as an exaggerated pressor 
response to increased dietary sodium intake, predicts the development and 
severity of hypertension and increases the risk of its associated adverse clinical 
outcomes (Weinberger et al., 1986; Weinberger, 1996; Morimoto et al., 1997; 
Meneton et al., 2005; Franco & Oparil, 2006; Appel et al., 2011). In salt-resistant 
individuals, dietary sodium-evoked sympathoinhibition facilitates natriuresis and 
maintenance of normotension (Lohmeier et al., 1999; Brooks et al., 2005; Gao et 
al., 2005; Osborn et al., 2008; Johns et al., 2011; Johns, 2014). In contrast, salt 
sensitivity is characterized by a sympathoexcitatory response to dietary sodium 
intake that promotes sodium retention and hypertension (Bayorh et al., 1998; 
Miyajima & Yamada, 1999; Huang et al., 2001; Dobesova et al., 2002; Brooks et 
al., 2005; Yatabe et al., 2010; Stocker et al., 2013; Johns, 2014). While it has been 
estimated that approximately one half of hypertensive individuals and one quarter 
of normotensive individuals exhibit salt sensitivity of blood pressure, clinical tests 
to determine salt sensitivity versus salt resistance are poorly standardized, 
cumbersome, and rarely used (Weinberger et al., 1986). Salt sensitivity is 
particularly relevant given that the average daily sodium intake in the United States 
is roughly 3.5g per day and far exceeds the recommendations of the American 
Heart Association (1.5g/day) and World Health Organization (2g/day) (Appel et al., 
2011; Powles et al., 2013; Mozaffarian et al., 2014). The factors that determine salt 




but likely include impairments in the sympathetic nervous system regulation and 
renal sodium handling.  
 
Overview of Blood Pressure Regulation 
 Blood pressure is determined by cardiac output and total peripheral 
resistance. Cardiac output is a function of heart rate and stroke volume and reflects 
the volume of blood pumped through the heart each minute, while total peripheral 
resistance reflects the resistance to blood flow within the systemic vasculature and 
is influenced primarily by changes in vessel diameter and blood viscosity. These 
factors are in turn modulated by the integrated actions of the cardiovascular, 
neurohumoral, and renal systems (Figure 1.1) (Cowley, 2006).  
Figure 1.1. An overview of blood pressure regulation. Blood pressure is 
determined by the cardiovascular, renal, and neurohumoral mechanisms that 
influence total peripheral resistance and cardiac output. Reproduced from Cowley, 




 The involvement of both the cardiovascular system and the sympathetic 
nervous system in blood pressure regulation is highlighted by baroreceptor 
reflexes that play a dominant role in acute, moment-to-moment blood pressure 
regulation (Cowley et al., 1973). The baroreceptor reflexes are mediated by 
stretch-sensitive arterial mechanoreceptors that are activated by acute alterations 
in blood pressure and in turn influence parasympathetic and sympathetic outflow 
to the heart and vasculature. Momentary decreases in blood pressure are rapidly 
corrected via an increase in sympathetic outflow that promotes vasoconstriction, 
increased cardiac contractility, and increased heart rate as well as a decrease in 
parasympathetic nerve activity that contributes to increased heart rate. In contrast, 
acute increases in blood pressure are corrected via decreases in sympathetic 
outflow and increases in parasympathetic outflow to the heart and vasculature.  
 In addition to a role in the acute reflex modulation of blood pressure, the 
sympathetic nervous system plays a role in long-term blood pressure regulation 
that will be described in greater detail in the Sympathetic Nervous System and 
Blood Pressure Regulation section. In brief, the sympathetic nervous system can 
influence blood pressure directly through the effects of norepinephrine, which 
increases heart rate, promotes vasoconstriction, and drives renal sodium 
reabsorption. Further, norepinephrine released by the renal sympathetic nerves 
can modulate blood pressure indirectly by stimulating the release of renin and 
activating the renin angiotensin aldosterone system. The ultimate effectors of the 




that also stimulates renal sodium reabsorption, sympathetic nervous system 
activity, and vasopressin secretion, and aldosterone, which promotes renal sodium 
reabsorption. Notably, each of these systems influences blood pressure in part by 
altering renal sodium handling, and all anti-hypertensive therapeutics influence 
renal sodium excretion either directly or through indirect effects on the 
cardiovascular system, the sympathetic nervous system, or the renin angiotensin 
aldosterone system (Table 1.1) (Ivy & Bailey, 2014).  
Direct evidence for a role of the kidney in blood pressure regulation was first 
observed during the development of the Goldblatt model of hypertension, in which 
experimentally induced renal ischemia was found to be sufficient to drive an 
increase in blood pressure (Goldblatt et al., 1934). Decades later, the Guytonian 
paradigm, in which the kidneys influence blood pressure via the regulation of 
extracellular fluid volume, provided mechanistic insight into the relationship 
between renal sodium handling and blood pressure regulation (Guyton et al., 
1972). In this paradigm, blood pressure is maintained by a classical pressure-
natriuresis relationship in which an increase in blood pressure drives an increase 
in renal perfusion pressure, promoting natriuresis and an associated diuresis that 
reduces extracellular fluid volume and returns blood pressure to normal. 
Conversely, a decrease in blood pressure results in a decrease in renal perfusion 
pressure, promoting renal sodium reabsorption and an increase in extracellular 
fluid volume that increases blood pressure. According to the Guytonian model of 




are characterized by aberrations in the pressure-natriuresis relationship – 
hypertension by a rightward shift of the pressure-natriuresis curve, and salt 
sensitivity of blood pressure by a reduction in the slope of the curve – which may 
reflect pathological changes in renal excretory function and the neurohumoral 
systems that influence it. 
 
Renal Sodium Handling and Blood Pressure Regulation 
Overview of the Kidney 
The kidneys are critical to the maintenance of fluid and electrolyte balance, 
among other critical physiological functions that include waste excretion and acid-
base homeostasis. Blood enters the kidney through the afferent renal artery, which 
is part of a neurovascular bundle that includes the renal vein and mixed sensory 
afferent and efferent sympathetic renal nerves, and eventually reaches the afferent 
renal arterioles. Each afferent arteriole empties into a glomerular capillary tuft that 
is surrounded by Bowman’s space, or the luminal space within a renal corpuscle 
that serves as the start of a nephron. The close proximity of the capillary and the 
lumen of Bowman’s capsule allows for the filtration of fluid and small solutes from 
the capillaries into the lumen of the nephron, the functional unit of the kidney. The 
normal glomerular filtration rate, or volume of filtrate entering the lumen per unit 
time, is 180 L/day (120mL/min) in an average, healthy adult, indicating that the 
entire 3 liters of plasma in an average adult is filtered into Bowman’s capsule 




each day, and almost all of the filtered water and sodium must be reabsorbed along 
the length of the nephron in order to maintain fluid and electrolyte homeostasis.  
Each human kidney is composed of approximately 1 million nephrons, and 
each nephron consists of a series of segments, including Bowman’s capsule, the 
proximal convoluted tubule, the Loop of Henle, the distal convoluted tubule, and 
the collecting duct, which empties into a calyx of the renal pelvis and then into the 
ureter (Figure 1.2). The movement of water, sodium, and other solutes between 
the lumen of the nephron and the bloodstream varies in each of these sequential 
segments based on the differential expression and activity of luminal and 
basolateral transporters in the epithelial cells that line the nephron, the external 
milieu surrounding the nephron, and the physiological needs of the body. In all 
segments, activity of the basolateral Na+/K+ ATPase creates an electrochemical 




Figure 1.2. Anatomy of the kidney. Adapted from UptoDate (2019). 
 
The Proximal Tubule and the Na+/H+ Exchanger 
 The proximal tubule, situated primarily in the cortex and extending into the 
outer medulla, is the site of reabsorption of approximately two thirds of filtered 
water and sodium. In the early part of the proximal tubule, the renal epithelium 
generates protons in a process that also creates bicarbonate. The luminal Na+/H+ 




the bicarbonate ion moves into the bloodstream. This process is critical to the 
regulation of both sodium homeostasis and acid-base balance. Sodium is also 
reabsorbed with glucose, phosphates, and amino acids in the early proximal 
tubule, and in the late proximal tubule sodium is reabsorbed in a process that 
essentially equates to cotransport with chloride, although the two ions are 
transported via different mechanisms. Throughout the proximal tubule, sodium 
reabsorption drives the proportional reabsorption of water. The bulk reabsorption 
of sodium and water in the proximal tubule is essential to life, and changes in 
proximal tubule sodium reabsorption are often compensated for by opposing 
changes in the distal nephron.  
 
The Loop of Henle and the Na-K-2Cl Cotransporter 
 The loop of Henle, which descends into the inner medulla and then ascends 
through the medulla into the cortex, receives a modified fluid from the proximal 
tubule that is roughly isosmotic compared to plasma. The loop of Henle is 
comprised of a descending limb, a thin ascending limb present only in a subset of 
nephrons, and a thick ascending limb, and is responsible for the reabsorption of 
roughly 25% of filtered sodium and 10% of filtered water. The descending limb of 
the loop of Henle is permeable to water, but not to sodium or chloride, and water 
reabsorption is driven primarily by interstitial osmolality, which increases 
dramatically with depth within the medulla. Selective reabsorption of water creates 




through chloride channels expressed in the water-impermeable thin ascending 
limb. Although the thin ascending limb does not contain sodium transporters, 
sodium reabsorption passively accompanies chloride reabsorption due to leaky 
tight junctions between epithelial cells.  
All nephrons contain a thick ascending limb, which is also impermeable to 
water but contains the Na-K-2Cl cotransporter (NKCC2). The NKCC2 uses the 
sodium gradient created by selective water reabsorption in the descending limb to 
drive the active reabsorption of one sodium and one potassium ion while removing 
two chloride ions from the lumen of the nephron. Luminal potassium channels 
allow the reabsorbed potassium to diffuse back into the nephron such that 
potassium availability is not a limiting factor for sodium reabsorption. This luminal 
recycling of potassium results in an imbalance in overall reabsorption whereby the 
movement of the two chloride ions is matched by only one sodium ion, creating an 
electrical gradient that drives the paracellular reabsorption of other cations – 
including sodium. 
 
The Distal Convoluted Tubule and the Sodium Chloride Cotransporter 
 The distal convoluted tubule, which is contained within the renal cortex, 
receives a modified tubular fluid that is more dilute than plasma due to the net 
reabsorption of more sodium than water in the loop of Henle. The distal convoluted 
tubule is responsible for the reabsorption of approximately 5% of filtered sodium 




cotransporter (NCC) throughout the distal convoluted tubule permits the 
reabsorption of sodium with chloride. In the late distal convoluted tubule, sodium 
is also reabsorbed in part via the epithelial sodium channel (ENaC), which 
generates an electrical gradient driving the paracellular reabsorption of chloride. 
Although a relatively small proportion of filtered sodium is reabsorbed in the distal 
convoluted tubule, the NCC is highly responsive to alterations in sodium and fluid 
homeostasis and therefore plays a critical role in the fine-tuning of renal sodium 
excretion (Gamba, 2009; Moes et al., 2014).  
 
The Collecting Duct and the Epithelial Sodium Channel 
The collecting duct, which extends from the renal cortex through the 
medulla to empty into the renal pelvis, receives a further diluted fluid from the distal 
convoluted tubule. The collecting duct is responsible for the reabsorption of 
approximately 2-5% of filtered sodium and a variable proportion of filtered water 
that depends largely on fluid status and electrolyte balance. Similarly to the late 
distal convoluted tubule, sodium is reabsorbed through the ENaC and chloride 
follows via paracellular diffusion in the collecting duct. Like the NCC, the ENaC 
influences the fine-tuning of renal sodium excretion. The fluid that ultimately exits 
the collecting duct into the renal pelvis is excreted as urine and is not further altered 





The NCC in Health and Disease 
Overview of NCC Regulation 
The activity of the NCC depends on its total protein expression, localization 
to the plasma membrane, and phosphorylation at key threonine and serine 
residues associated with activation. Highlighting the critical homeostatic role of the 
NCC, the abundance, plasma membrane localization, and phosphorylation of the 
NCC decrease during high salt intake and increase during low salt intake 
(Masilamani et al., 2002; Sandberg et al., 2006; Chiga et al., 2008) and similar 
changes are seen in response to alterations in potassium intake (Vallon et al., 
2009; Frindt & Palmer, 2010; Sorensen et al., 2013; Castaneda-Bueno et al., 
2014).  
NCC activity is modulated in part by hormonal influences that include 
aldosterone, angiotensin II, vasopressin, and norepinephrine (Rojas-Vega & 
Gamba, 2016). Aldosterone, administered exogenously or stimulated by a low 
sodium diet or loop diuretic infusion, increases both the expression and 
phosphorylation of the NCC (Kim et al., 1998; Abdallah et al., 2001; Masilamani et 
al., 2002; Chiga et al., 2008; van der Lubbe et al., 2012). Angiotensin II, which 
promotes aldosterone secretion, can regulate NCC activity independently of 
aldosterone by promoting NCC phosphorylation and localization to the plasma 
membrane (Sandberg et al., 2007; San-Cristobal et al., 2009; Zhao et al., 2009; 
van der Lubbe et al., 2011). NCC phosphorylation is also stimulated by 




norepinephrine, the effector of the sympathetic nervous system, increases NCC 
expression and phosphorylation in mice (Mu et al., 2011; Terker et al., 2014), and 
prevents dietary sodium-evoked suppression of NCC activity and expression in 
rats (Walsh et al., 2016). The signaling pathways that mediate the effects of 
norepinephrine and other modulators of the NCC are complex and incompletely 
understood but involve a kinase network that includes with no lysine (WNK) 
kinases, STE20/SPS1-related Proline-Alanine-rich kinase (SPAK), and oxidative 
stress responsive kinase 1 (OxSR1) (Figure 1.3) (Subramanya & Ellison, 2014; 
Hadchouel et al., 2016).  
 
 
Figure 1.3. Model of the NCC regulatory kinase network. The activity of the 
NCC depends on its phosphorylation and localization to the plasma membrane. 
The NCC is phosphorylated and activated directly by SPAK/OxSR1. WNK1 can 
phosphorylate and activate SPAK/OxSR1 and prevent tonic WNK4-mediated 
suppression of NCC translocation to the plasma membrane. Kinase-inactive 
WNK4 prevents the translocation of the NCC to the plasma membrane, while 
stimulated WNK4 phosphorylates SPAK/OxSR1. Kelch-like 3 and cullin 3 
promote degradation of WNK1 and WNK4. Adapted from Subramanya & 





The WNK kinases exist as four isoforms, WNK1-WNK4, of which WNK1, 
WNK3, and WNK4 are expressed in the kidney and have varying effects on the 
NCC as well as NKCC2 and ENaC (Hadchouel et al., 2016). WNK1 is expressed 
ubiquitously in its full length isoform, L-WNK1, and in the distal nephron as both L-
WNK1 and a kidney specific isoform (KS-WNK1) that lacks kinase activity. WNK1 
promotes the phosphorylation and activation of the NCC via a SPAK-dependent 
pathway in which OxSR1 has also been implicated (Anselmo et al., 2006; Chavez-
Canales et al., 2014). KS-WNK1 and a variant of L-WNK1 can also promote NCC 
activity by inhibiting WNK4, which is expressed in the distal nephron as well as 
non-renal tissues and reduces renal NCC expression at the plasma membrane in 
unstimulated conditions by diverting the NCC to lysosomal degradation post-Golgi 
processing (Wilson et al., 2003; Yang et al., 2003; Yang et al., 2005; Subramanya 
et al., 2009; Argaiz et al., 2018). WNK3, present in all segments of the nephron, 
similarly promotes NCC activity by phosphorylating and inhibiting WNK4, blunting 
lysosomal degradation and thereby increasing NCC protein expression. 
Interestingly, while unstimulated WNK4 reduces NCC expression at the plasma 
membrane, WNK4 also has the capacity to promote NCC phosphorylation and 
activation in a SPAK-dependent pathway under conditions that include angiotensin 
II stimulation (San-Cristobal et al., 2009).  
SPAK and OxSR1 are serine/threonine kinases that share a nearly 90% 
homologous kinase domain. WNK1 and WNK4 phosphorylate and activate SPAK 




Thr46, Thr55, and Thr60 in the human NCC (corresponding to Thr44, Thr53, and 
Thr58 in rats and mice) (Moriguchi et al., 2005; Vitari et al., 2005; Richardson et 
al., 2008). SPAK and OxSR1 have also been implicated in the direct 
phosphorylation of Ser73 and indirectly in the phosphorylation of Ser91 in the 
human NCC (Ser71 and Ser89, respectively, in rats and mice) (Richardson et al., 
2008; Yang et al., 2010; Filippi et al., 2011). Phosphorylation at Thr60 appears to 
be particularly important to NCC activation, as a missense mutation that prevents 
phosphorylation at Thr60 also reduces phosphorylation at Thr44 and Thr53 and 
significantly reduces NCC activity (Richardson et al., 2008; Glover et al., 2009). 
Further, phosphorylation at Thr58 in mice (Thr60 in humans) both stabilizes the 
NCC at the plasma membrane and increases its intrinsic activity (Yang et al., 
2013). Demonstrating the relevance of the NCC and its regulatory kinases, 
mutations in SLC12A3, the gene encoding the NCC, and in the genes encoding 
WNK4 and WNK1 underlie hereditary disorders characterized by dysregulated 
renal sodium handling and blood pressure.  
 
The NCC in Monogenic Disorders 
Gitelman’s syndrome, familial hyperkalemic hypertension, and 
pseudohypoaldosteronism type II are monogenic diseases characterized by 
mutations in SLC12A3 and NCC regulatory kinases that ultimately result in altered 
NCC activity. Homozygous loss-of-function mutations in SLC12A3 lead to 




hypokalemia, hypomagnesemia, and metabolic alkalosis are accompanied by 
hypotension (Simon et al., 1996). Interestingly, there is evidence that heterozygous 
loss-of-function mutations, which do not manifest in an overt clinical syndrome, 
may actually provide protection against the development of hypertension (Fava et 
al., 2008; Ji et al., 2008).  
In contrast, mutations in the genes encoding WNK1 and WNK4 (Wilson et 
al., 2001; Vitari et al., 2005; Yang et al., 2007), along with two other regulatory 
proteins that influence the NCC, kelch-like 3 and cullin 3 (see Figure 3) (Boyden 
et al., 2012; Louis-Dit-Picard et al., 2012; Glover et al., 2014), cause familial 
hyperkalemic hypertension, also known as pseudohypoaldosteronism type II. In 
the case of WNK4, disease-related mutations reduce the inhibitory effect of WNK4 
on the NCC and stimulate it to activate SPAK and OxSR1 instead (Yang et al., 
2007). In the case of WNK1, intronic mutations drive its overexpression and may 
thereby drive activation of SPAK/OxSR1-mediated NCC phosphorylation (Wilson 
et al., 2001). Indicating that NCC-mediated sodium reabsorption is a unifying 
mechanism driving familial hyperkalemic hypertension, each disease-associated 
mutation can promote in an increase in NCC activity (Wilson et al., 2001; Boyden 
et al., 2012; Louis-Dit-Picard et al., 2012), and familial hyperkalemic hypertension 





The NCC in Hypertension 
Thiazide diuretics, which compete for the chloride-binding site of the NCC 
and thereby prevent the cotransport of sodium with chloride, serve as a first-line 
therapy for essential hypertension (Hughes, 2004). This suggests a potential 
pathophysiological role for the NCC and its regulatory network in more common, 
non-genetic forms of hypertension, which has not been directly addressed. 
Supporting a role for the NCC in hypertension, the blood pressure response to 
hydrochlorothiazide treatment in hypertensive patients is positively correlated with 
NCC abundance in urinary exosomes, which reflect total expression levels in the 
distal convoluted tubule (Pathare et al., 2017). Building upon a report indicating 
that kidney transplant from normotensive, healthy donors can attenuate resistant 
hypertension in humans, transplant of a kidney from a patient with Gitelman’s 
syndrome due to a known mutation in SLC12A3 rapidly normalized blood pressure 
in a patient with kidney failure secondary to longstanding resistant hypertension 
(Curtis et al., 1983; Stewart et al., 2018) – suggesting that increased NCC activity, 
corrected by a Gitelman’s syndrome transplant with loss-of-function mutations in 
SLC12A3, may have been driving sodium retention and resistant hypertension.  
Angiotensin II has an established role in the regulation of both blood 
pressure and the NCC, and angiotension II receptor blockers are approved anti-
hypertensive therapeutics. Suggesting a role for the NCC in angiotensin II-evoked 
hypertension, disruption of the WNK-SPAK signaling pathway attenuates NCC 




(Cervantes-Perez et al., 2018). The sympathetic nervous system also has an 
established role in the regulation of blood pressure and NCC activity. While 
norepinephrine can influence NCC activity directly and indirectly, via activation of 
the renin angiotensin aldosterone system, several studies have demonstrated that 
the direct influence of the sympathetic nervous system on NCC activity is 
particularly relevant to salt-sensitive hypertension (Mu et al., 2011; Terker et al., 
2014; Walsh et al., 2016; Liu et al., 2017). 
 
The NCC in Salt-Sensitive Hypertension 
Several studies have provided evidence supporting a potential role of the 
NCC in the pathogenesis of salt-sensitive hypertension (Mu et al., 2011; Terker et 
al., 2014; Walsh et al., 2016; Liu et al., 2017). Signaling via β2-adrenoceptors 
results in WNK4 downregulation during chronic infusion of norepinephrine or 
isoproterenol, a non-selective β-agonist, evoking salt-sensitive hypertension 
associated with an increase in NCC total protein expression, phosphorylation at 
Ser71 and Thr53, and activity in mice (Mu et al., 2011). Further, salt-resistant 
Sprague Dawley and Dahl Salt Resistant rats exhibited reduced renal 
norepinephrine turnover, generally reflective of reduced renal sympathetic outflow, 
and enhanced WNK4 expression during high salt intake (Mu et al., 2011). In 
contrast, WNK4 mRNA failed to increase and decreased during high salt intake in 
DOCA-salt rats and Dahl Salt Sensitive rats, respectively, both of which fail to 




hypertension (Mu et al., 2011). Supporting a role for increased NCC activity in the 
salt-sensitive animals, infusion of isoproterenol during high salt intake promoted 
NCC activity and sodium retention in salt-sensitive rats (Mu et al., 2011). Another 
group validated the finding that norepinephrine infusion evokes salt-sensitive 
hypertension in mice but was unable to reproduce the role of WNK4, calling into 
question the link between the β2-WNK4-NCC signaling pathway and salt-sensitive 
hypertension (Uchida et al., 2012). However, in another study that used chronic 
norepinephrine infusion to drive the development of salt-sensitive hypertension in 
mice, an increase in NCC protein expression and phosphorylation at Thr53 was 
observed (Terker et al., 2014). The same group used acute infusions of 
norepinephrine, isoproterenol, and phenylephrine, a specific α1-agonist, to 
investigate NCC regulation in the absence of compensating mechanisms and 
observed that α1- and β-adrenoceptors act synergistically to phosphorylate the 
NCC via a pathway that requires OxSR1 but not SPAK (Terker et al., 2014). 
Although the differential roles of β1- and β2-adrenoceptors were not specifically 
investigated, β1-adreceptors were present in distal convoluted tubule cells at far 
greater density than β2-adrenoceptors, leading the authors to hypothesize that β1-
adrenoceptors may play a more important role in norepinephrine-mediated NCC 
activation (Terker et al., 2014). 
Regardless of the signaling pathways linking norepinephrine with NCC 
activity, the integrated roles of norepinephrine and the NCC in salt-sensitive 




infusion in salt-resistant Sprague Dawley rats evoked salt-sensitive hypertension 
associated with a failure to suppress NCC activity and expression during high salt 
intake (Walsh et al., 2016). Critically, chronic infusion of hydrochlorothiazide 
abolished the salt-sensitive component of norepinephrine-evoked hypertension 
(Walsh et al., 2016). Together, these observations suggest an important role for 
the NCC and for the integrated sympathetic nervous system and renal responses 
to dietary sodium intake in the pathophysiology of salt-sensitive hypertension.  
 
Integrated Renal and Sympathetic Nervous System Regulation of Sodium 
Balance and Blood Pressure 
The sympathetic nervous system influences blood pressure through the 
effects of norepinephrine in the heart, the systemic vasculature, and kidney. 
Norepinephrine acts at α1-, α2-, β1-, and β2-adrenoceptors that are distributed 
differentially throughout the body and produce system-specific effects. In the heart, 
norepinephrine acts primarily at β1-adrenoceptors to promote an increase in heart 
rate, while α1-adrenoceptors in the vasculature mediate vasoconstriction. While 
each of these effects can contribute to an increase in blood pressure, the role of 
the sympathetic nervous system in long-term blood pressure regulation is derived 





Overview of the Renal Nerves 
The renal nerves are comprised of the afferent renal nerves, which carry 
sensory information from the kidney to the brain, and the efferent renal sympathetic 
nerves, which convey sympathetic outflow to the kidney. The afferent and efferent 
renal nerves travel intermingled along the renal artery. Human and animal studies 
suggest that the efferent renal nerve fibers are far more abundant than afferent 
renal nerve fibers, with efferent fibers outnumbering afferent fibers by an estimated 
ratio of approximately 25:1 (Tellez et al., 2013; Sakakura et al., 2014).   
 
The Sensory Afferent Renal Nerves 
The afferent renal nerves contain mechanosensitive and chemosensitive 
fibers that primarily innervate the renal pelvic wall, as well as the renal artery, renal 
vein, and ureter (Marfurt & Echtenkamp, 1991). The chemosensitive fibers respond 
to alterations in the chemical composition of urine in the renal pelvis, including 
increased sodium concentration, and are activated during renal ischemia 
(Recordati et al., 1980; Recordati et al., 1981). The mechanosensitive fibers are 
activated by increases in renal pelvic pressure within a physiological range (Smyth 
et al., 1991; Ma et al., 2002a; Ma et al., 2002b; Kopp et al., 2003) and by the 
physiological challenge of an intravenous volume expansion, which increases 
renal pelvic pressure (Genovesi et al., 1993; Chien et al., 1997; Chien et al., 2000). 
 Afferent renal nerve fibers activated by increased renal pelvic pressure also 




released from sensory afferent nerve terminals during stimulation. A mechanistic 
role for substance P in afferent renal nerve activation is further supported by 
evidence that renal pelvic administration of a substance P antagonist blunts renal 
pelvic pressure-evoked afferent renal nerve activity (Kopp & Smith, 1993). While 
the molecular underpinnings of substance P release and subsequent afferent renal 
nerve activation are incompletely understood, mechanistic studies have implicated 
bradykinin, prostaglandin E2, and calcitonin gene-related peptide (Kopp et al., 
1997; Gontijo et al., 1999; Kopp et al., 2000).  
 Afferent renal nerve activation results in physiological responses that are 
integrated within the central nervous system (Francisco et al., 1980; Kopp et al., 
1985). The cell bodies of the afferent renal nerves are contained within the 
ipsilateral dorsal root ganglia spanning vertebral levels T6-L3 (Donovan et al., 1983; 
Weiss & Chowdhury, 1998), and there is evidence for both monosynaptic 
projections to the brainstem (Wyss & Donovan, 1984) and polysynaptic signal 
transmission to sympathetic and cardiovascular regulatory sites within the 
brainstem and central nervous system that include the rostral ventrolateral 
medulla, the circumventricular organs, and the paraventricular nucleus of the 
hypothalamus (Solano-Flores et al., 1997).  
 
The Efferent Renal Sympathetic Nerves 
 The efferent renal nerves are comprised of postganglionic sympathetic 




nervous system, including the paraventricular nucleus of the hypothalamus, and 
innervate the renal vasculature, all segments of the nephron, and the renal pelvis. 
The renal sympathetic nerves synthesize and release norepinephrine, a 
neurotransmitter which in turn acts upon 1) α1-adrenoceptors, promoting renal 
sodium reabsorption directly via increased activity of sodium transporters including 
the NCC and indirectly via a decrease in renal blood flow, and 2) β1-adrenoceptors, 
driving renin release and activating the renin angiotensin aldosterone system. 
 
The Reno-Renal Reflexes 
 Together, the sensory afferent renal nerves and sympathetic efferent renal 
nerves comprise a reno-renal reflex arc whereby activation of the afferent renal 
nerves promotes alterations in sympathetic outflow to the contralateral kidney. Two 
functionally distinct reflexes, one sympathoinhibitory and the other 




Studies in healthy, normotensive animals in which renal pelvic pressure was 
increased either by direct manipulation (Smyth et al., 1991; Ma et al., 2002a; Ma 
et al., 2002b; Kopp et al., 2003)  or by an intravenous volume expansion (Genovesi 
et al., 1993; Chien et al., 1997; Chien et al., 2000) have demonstrated that acute 
activation of the mechanosensitive afferent renal nerves is associated with the 
suppression of efferent renal sympathetic nerve activity and a natriuretic and 
diuretic response. These findings indicate that the mechanosensitive afferent renal 
nerves mediate a sympathoinhibitory reno-renal reflex that facilitates acute sodium 
homeostasis.  
 
Figure 1.4. Model of the contralateral reno-renal reflexes. (A) Arrows 
delineate a reno-renal reflex arc composed of the sensory afferent renal nerves 
originating in one kidney (arrow pointing towards brain) and the renal 
sympathetic nerves innervating the contralateral kidney (arrow pointing towards 
kidney), (B) the sympathoinhibitory reno-renal reflex, in which afferent renal 
nerve activation results in the suppression of sympathetic outflow and a 
contralateral natriuretic response, and (C) the sympathoexcitatory reno-renal 
reflex, in which afferent renal nerve activation promotes an increase in 




In contrast, activation of an acute sympathoexcitatory reno-renal reflex has 
been observed following intrarenal infusion of adenosine (Katholi et al., 1983; 
Katholi et al., 1984) and bradykinin (Barry & Johns, 2015) and during renal 
ischemia and direct renal pelvic administration of concentrated urine, which 
activate renal chemoreceptors (Recordati et al., 1982; Rogenes, 1982). The 
sympathoexcitatory reno-renal reflex promotes sodium retention and has been 
primarily implicated in disease states that include renal ischemia and heart failure 
(Zheng et al., 2018).  
While afferent renal nerve activity modulates efferent sympathetic outflow 
to the kidney via the reno-renal reflexes, efferent renal sympathetic nerve activity 
can also directly influence the afferent renal nerves. Afferent and efferent renal 
nerve terminals are often found in tight proximity in the renal pelvis, and the efferent 
renal sympathetic nerves release norepinephrine that can act at α1- and α2-
adrenoceptors to increase and decrease afferent renal nerve activity, respectively 
(Kopp et al., 2007). 
 
Central Integration of the Reno-Renal Reflexes 
Studies using spinal cord transection indicate that the reno-renal reflexes 
are integrated in the central nervous system (Francisco et al., 1980; Kopp et al., 
1985), and direct electrical stimulation of the afferent renal nerves results in Fos 
induction – a marker of neuronal activation – in a number of brainstem and central 




hypothalamus, which plays an important role in the modulation of sympathetic 
nervous system activity, sodium and fluid homeostasis, and blood pressure 
regulation  (Solano-Flores et al., 1997; Guyenet, 2006; Stocker et al., 2010; Zheng 
& Patel, 2017). 
The paraventricular nucleus contains magnocellular and parvocellular 
divisions that are functionally distinct. The magnocellular division contains neurons 
that project to the posterior pituitary and release oxytocin or vasopressin into the 
circulation there (Ferguson et al., 2008). The parvocellular division contains 
neurosecretory neurons, which modulate the release of hormones including 
adrenocorticotropin hormone and thyroid-stimulating hormone, and preautonomic 
neurons, which project to brainstem and spinal autonomic control centers including 
the nucleus tractus solitarius, rostral ventrolateral medulla, and intermediolateral 
cell column of the spinal cord to influence sympathetic outflow (Guyenet, 2006; 
Ferguson et al., 2008; Zheng & Patel, 2017). 
A potential role for the paraventricular nucleus in the integration of the reno-
renal reflexes is suggested by studies in which an acute volume expansion 
stimulates sympathoinhibitory neurons in the paraventricular nucleus (Haselton et 
al., 1994; Patel & Zhang, 1994; Randolph et al., 1998; Cunningham et al., 2002; 
Howe et al., 2004) and drives the suppression of renal sympathetic outflow 
(Haselton et al., 1994; Kapusta et al., 2012). Further, direct electrical stimulation 
of the afferent renal nerves activates RVLM-projecting neurons in the 




neurons contributes to increased sympathetic outflow, indicating a potential role 
for the paraventricular nucleus in the sympathoexcitatory reno-renal reflex (Xu et 
al., 2015). 
There is evidence that the paraventricular nucleus also plays a role in 
hypertension and salt sensitivity of blood pressure. In salt-resistant animal models, 
the PVN plays a role in sympathoinhibition, natriuresis, and maintenance of 
normotension (Sly et al., 2001; Akine et al., 2003; Badoer et al., 2003; O'Donaughy 
& Brooks, 2006; Frithiof et al., 2014; Larson et al., 2015). In contrast, the PVN 
evokes sympathoexcitation – due in part to impaired sympathoinhibition – 
accompanied by sodium retention and hypertension in salt-sensitive animal 
models (Budzikowski et al., 1998; Huang & Leenen, 1998; Huang et al., 1998; 
Huang et al., 2001; Dampney et al., 2005; Li & Pan, 2006; Shi et al., 2007; Gabor 
& Leenen, 2009, 2012; Kim et al., 2013; Bardgett et al., 2014; Choe et al., 2015; 
Holbein & Toney, 2015). While the mechanistic role of the PVN in the reno-renal 
reflexes and long-term blood pressure regulation is incompletely understood, 
several studies have indicated a potential role for central nervous system and 
PVN-specific Gαi2 proteins in the determination of salt sensitivity versus salt 
resistance of blood pressure (Kapusta et al., 2012; Kapusta et al., 2013; Wainford 





Central Gαi2 Proteins in Sodium Homeostasis 
The Gαi2 subunit protein is one of several subtypes of α-subunits that serve 
as effector molecules for G-proteins. In general, G-proteins are composed of α-, 
β- and γ-subunits and associated with G-protein coupled receptors. Ligand binding 
at the receptor ultimately results in the dissociation of a linked βγ complex from the 
α-subunit, which then initiates a distinct signaling pathway that depends on the 
subtype of the α-subunit. A number of studies indicate that Gαi2 signaling pathways 
in the central nervous system are involved in the homeostatic responses to acute 
and chronic sodium challenges.  
In salt-resistant Sprague Dawley, Dahl Salt Resistant, and Brown Norway 
rats, high salt intake promotes a PVN-specific increase in Gαi2 protein expression 
(Kapusta et al., 2012; Kapusta et al., 2013; Wainford et al., 2015). In contrast, Dahl 
Salt Sensitive rats fail to upregulate PVN Gαi2 protein expression during high salt 
intake (Wainford et al., 2015). Importantly, experimental downregulation of central 
Gαi2 proteins to prevent sodium-evoked increases in PVN Gαi2 protein expression 
resulted in sympathoexcitation, sodium retention, and the development of salt-
sensitive hypertension during high salt intake in salt-resistant strains (Kapusta et 
al., 2013; Wainford et al., 2015). Dietary sodium-evoked sympathoexcitation and 
salt-sensitive hypertension were prevented in normally salt-resistant rats that 
underwent renal denervation prior to manipulation of central Gαi2 proteins 




Several studies have also demonstrated that central Gαi2 proteins are 
required for renal sympathetic nerve-mediated homeostatic responses to an acute 
volume expansion and a non-pressor acute hypertonic saline infusion (Kapusta et 
al., 2012; Wainford et al., 2013). Critically, experimental downregulation of central 
Gαi2 during a pressor hypertonic saline challenge resulted in impaired 
sympathoinhibitory and blood pressure responses accompanied by impaired 
activation of PVN parvocellular neurons (Carmichael et al., 2016).  Although further 
studies using PVN-specific manipulation of Gαi2 proteins during acute and chronic 
sodium challenge are required, these findings raise the possibility that PVN Gαi2 
proteins are critical to the renal nerve-dependent sympathoinhibitory and 
natriuretic responses that promote salt resistance during chronic dietary sodium 
intake. 
 
Bilateral Renal Nerve Ablation 
 A central role of the renal nerves in hypertension is supported by studies in 
which bilateral renal nerve ablation lowers blood pressure in multiple hypertensive 
animal models and in human hypertension (Kline et al., 1980; Iliescu et al., 2006; 
Esler et al., 2012; Foss et al., 2013; Intapad et al., 2013; Johns & Abdulla, 2013; 
Kapusta et al., 2013; Henegar et al., 2014; Hering et al., 2014; Krum et al., 2014; 
Bohm et al., 2015; Pires et al., 2015; Wainford et al., 2015; Fong et al., 2016; Foss 
et al., 2016; Gao et al., 2016). In humans, and often in larger animal models such 




In smaller animal models renal denervation is performed using an invasive surgical 
procedure in which the renal nerves are physically disrupted and then treated with 
a phenol solution that destroys any remaining intact fibers. Both techniques 
remove both the afferent renal nerves and the renal sympathetic nerves. 
 Although human trials of renal nerve ablation have shown largely positive 
results, a large, prospective, single-blind, randomized, sham-controlled trial 
termed SYMPLICITY HTN-3 failed to reproduce the anti-hypertensive effects of 
renal nerve ablation demonstrated by the smaller SYMPLICITY HTN-1 & 2 trials 
(Bhatt et al., 2014). However, procedural inconsistencies and an inability to verify 
renal nerve ablation may have confounded the results of SYMPLICITY HTN-3, and 
subsequent human trials – including DENER-HTN and three sham-controlled 
trials, SPYRAL HTN OFF-MED, SPYRAL HTN ON-MED, and Radiance-HTN 
SOLO – continue to highlight the renal nerves as a viable therapeutic target in 
hypertension (Azizi et al., 2015; Esler, 2015; Zaldivia et al., 2016; Townsend et al., 
2017; Kandzari et al., 2018).  
 While studies of renal denervation suggest that the renal nerves play a 
pathophysiological role in hypertension, it has historically been difficult to dissect 
out the specific roles of the afferent renal nerves versus the efferent renal nerves. 
The potential importance of the afferent renal nerves in the regulation of sodium 
handling and blood pressure is highlighted by an increase in afferent renal nerve 
activity during high sodium intake in salt resistant Sprague Dawley rats, and a 




(Kopp et al., 2007; Kopp et al., 2009; Kopp et al., 2011a; Kopp et al., 2011b). 
Further, general sensory denervation via dorsal rhizotomy or systemic capsaicin 
treatment, which removes all afferent inputs including the afferent renal nerves, 
evokes salt-sensitive hypertension in Sprague Dawley rats (Wang et al., 1998; 
Wang et al., 2001; Kopp et al., 2003). 
 
Selective Afferent Renal Nerve Ablation 
 The recent development of a novel technique to selectively ablate the 
afferent renal nerves has provided a powerful tool in the investigation of the 
differential roles of the afferent renal nerves and the renal sympathetic nerves in 
sodium homeostasis and blood pressure regulation (Foss et al., 2015). The 
technique uses direct application of capsaicin to the renal nerves to activate 
TRPV1 cation channels expressed on the afferent renal nerves, but not the efferent 
renal nerves, resulting in selective afferent renal nerve ablation (Foss et al., 2015). 
Selective afferent renal nerve ablation does not alter baseline cardiovascular 
parameters or cause localized tissue injury or kidney damage assessed both 
functionally and histologically.  
 Studies performed using selective afferent renal nerve ablation indicate that 
the role of the afferent renal nerves in hypertension depends on both the model 
and the stage of hypertension under investigation. The afferent renal nerves are 
not involved in angiotensin II hypertension (Foss et al., 2018), for instance, while 




hypertension (Foss et al., 2015; Banek et al., 2016; Banek et al., 2018), which is 
characterized by an increase in afferent renal nerve activity (Banek et al., 2016). 
Although a high sodium diet enhances afferent renal nerve responsiveness and 
non-selective sensory denervation evokes salt-sensitive hypertension in Sprague 
Dawley rats, suggesting a role for the afferent renal nerves in the maintenance of 
sodium homeostasis (Wang et al., 1998; Wang et al., 2001; Kopp et al., 2003; 
Kopp et al., 2009), ablation of the afferent renal nerves had no impact on the blood 
pressure responses to stepped increases in dietary sodium intake (Foss et al., 
2015). However, dietary sodium manipulations were carried out during a time 
frame in which functional afferent renal nerve reinnervation could have occurred 
and compensatory mechanisms could have masked the effects of afferent renal 
nerve ablation, and as such these studies require further clarification (DiBona & 
Sawin, 1983; Mulder et al., 2013; Foss et al., 2015). Further, while most 
mechanistic studies of both the afferent renal nerves and the renal sympathetic 
nerves have been conducted in young adult animal models, age-related alterations 
in blood pressure regulation, sympathetic nervous system activity, and renal 
sodium handling raise the possibility that the renal nerves may be particularly 
important in the context of age-related hypertension.  
  
Hypertension in the Aging Population 
The prevalence of hypertension rises from roughly one in three adults aged 




Whelton et al., 2018). Importantly, while aging is associated with increased risk of 
hypertension-associated morbidity and mortality, the proportion of patients able to 
achieve therapeutic blood pressure control declines with age (Writing Group et al., 
2016; Muntner et al., 2018; Whelton et al., 2018). Although the mechanisms driving 
age-related hypertension are incompletely understood, aging is associated with an 
increase in the prevalence of the salt sensitivity of blood pressure, and there is 
evidence that sympathetic tone is elevated and renal sodium handling is altered in 
aging animal models and elderly humans (Bengele et al., 1981a; Bengele et al., 
1981b; Luft et al., 1987; Luft et al., 1991; Fish et al., 1994).  
 
Modeling Age-Related Hypertension 
Despite the marked increase in the prevalence of hypertension and the 
increased risk of hypertension-associated morbidity and mortality in human aging, 
relatively few human studies have focused on the mechanisms driving 
hypertension and salt sensitivity of blood pressure in the specific context of aging. 
Human studies often set an upper age limit for recruitment due to safety concerns 
or the presence of comorbidities that could confound the interpretation of the study 
(Buford, 2016). Conversely, studies in which elderly hypertensive patients are 
specifically recruited often exclude younger and normotensive individuals, instead 
focusing on comparisons of treatment groups within the aging, hypertensive study 
population (Beckett et al., 2008). Human studies of salt sensitivity of blood 




standardized methods of defining salt sensitivity that limit these investigations 
irrespective of aging.  
Animal studies of age-related hypertension and salt sensitivity are similarly 
scarce, perhaps due in part to the ready availability of genetic and experimentally 
induced models of hypertension and the paucity of models of aging that 
appropriately mimic age-related alterations observed in humans (Leong et al., 
2015). Some animal models of aging are resistant to hypertension and other 
pathophysiological changes, while others develop hypertension but also exhibit 
functional renal damage that renders the isolation of aging as a potential casual 
factor quite difficult (Coleman et al., 1977; Owen & Heywood, 1986; Erdely et al., 
2003; Bilusic et al., 2008). In this section, the available human and animal studies 
of age-related changes that could promote hypertension and salt sensitivity are 
summarized, with particular focus on the sympathetic nervous system and renal 
sodium handling.  
 
The Sympathetic Nervous System in Age-Related Hypertension 
An age-related increase in sympathetic nervous system activity has been 
observed in studies using a number of methods, including the assessment of 
plasma norepinephrine concentration and plasma norepinephrine spillover (Esler 
et al., 1995; Esler et al., 2002). A direct positive relationship between sympathetic 




that increased sympathetic tone may be particularly relevant to age-related 
hypertension (Narkiewicz et al., 2005).  
Despite this evidence, relatively few studies have investigated the impact of 
aging on renal sympathetic outflow. While one study failed to demonstrate an age-
related increase in renal norepinephrine spillover in human patients, other studies 
have demonstrated that human aging is characterized by inappropriate renal artery 
vasoconstriction, mediated by the renal sympathetic nerves in response to acute 
physiological challenges, suggesting that renal sympathetic nerve responsiveness 
may be enhanced in aging (Esler et al., 1995; Kuipers et al., 2009; Patel et al., 
2013). Further, electrophysiological studies have provided evidence that aged 
beagles exhibit increased renal sympathetic nerve activity at baseline and impaired 
suppression of renal sympathetic nerve activity following an acute volume 
expansion (Hajduczok et al., 1991a; Hajduczok et al., 1991b). Demonstrating a 
potential mechanistic link between increased renal sympathetic tone and 
hypertension in aged animals, an increase in renal norepinephrine content is 
associated with renal sodium retention and elevated blood pressure in aging 
Wistar-Kyoto rats and spontaneously hypertensive rats (Pinto et al., 2011). 
Importantly, a recent clinical trial verified that renal denervation effectively reduces 





Renal Sodium Handling and the NCC in Age-Related Hypertension 
Human aging is characterized by a reduction in the ability to maximally 
concentrate and dilute urine that may promote impaired homeostatic responses to 
acute and chronic sodium challenge (Schlanger et al., 2010). Increasing age is 
associated with blunted and delayed natriuretic responses to acute saline infusion, 
an effect that persists after adjustment for renal damage (Luft et al., 1980; Luft et 
al., 1982; Fish et al., 1994). Conversely, aging individuals exhibit a delayed return 
to sodium balance following the initiation of a low sodium diet (Schlanger et al., 
2010). While aging is associated with a number of changes in the vascular, 
neurohumoral, and renal systems that could contribute to sodium retention and 
hypertension (Frame & Wainford, 2018), age-related increases in sympathetic 
tone and salt sensitivity and the established interaction of sympathetic nervous 
system activity and dietary sodium intake in the regulation of the NCC raise the 
possibility that the NCC is involved in age-related hypertension. 
 Studies in animal models of aging have yielded conflicting results regarding 
a potential role of the NCC in age-related hypertension. Aging Fischer Brown 
Norway rats exhibit increased baseline NCC expression and fail to increase NCC 
expression in response to water deprivation, and separate studies have 
demonstrated that these animals develop age-related hypertension (Tian et al., 
2006; Chugh et al., 2012; Chugh et al., 2013; Pokkunuri et al., 2015). However, 
NCC activity was not assessed and evidence from another model of aging, the 




indicating that the driving force for NCC activity is reduced (Scherzer et al., 2015). 
Importantly, while aged C57Bl6 / CBA / 129 mice exhibit decreased baseline NCC 
activity, the observation that angiotensin II-evoked increases in NCC activity and 
blood pressure are exacerbated in aged mice suggests that impaired NCC 
regulation could promote sodium retention and hypertension regardless of 
baseline NCC activity (Tiwari et al., 2009). Further, increased age was associated 
with an enhanced blood pressure response to thiazide diuretics in a small study of 
hypertensive humans, supporting a potential pathological role of NCC activity in 














Hypothesis and Specific Aims 
Hypothesis 
An age-related impairment in the afferent renal nerve sympathoinhibitory reno-
renal reflex contributes to sympathoexcitation, leading to sodium chloride 
cotransporter-mediated sodium retention and age-related hypertension. 
Specific Aims 
Specific Aim 1: To establish that an age-related reduction in afferent renal nerve 
activity contributes to impaired neural and renal responses to acute challenges to 
fluid and sodium homeostasis in Sprague Dawley rats. 
Specific Aim 2: To establish that an age-related reduction in afferent renal nerve 
activity contributes to sodium retention and the development of hypertension in 





CHAPTER TWO: General Methods 
 
 This chapter contains a detailed description of the surgical procedures, in 
vivo and ex vivo protocols, and molecular and analytical techniques used in studies 
described in Chapters 3-5. In turn, Chapters 3-5 each contain a brief, chapter-




Male Sprague Dawley, Dahl Salt Resistant, and Dahl Salt Sensitive rats 
weighing 275-300g (approximately 3 months old) and male Sprague Dawley rats 
aged 8 and 16 months were purchased from Envigo (Indianapolis, IN, USA). Rats 
were pair-housed until surgical intervention or body weight required individual 
housing. All rats were maintained in a temperature-controlled (68-79°F) and 
humidity-controlled (30-70%) facility under a 12-hour light-dark cycle. Tap water 
and standard rodent diet or experimental high sodium diet (Table 2.1) were 
provided ad libitum. In all studies, rats were randomly assigned to experimental 
groups. All animal protocols were approved by the Institutional Animal Care and 
Use Committee in accordance with the guidelines of the Boston University School 








Osmotic mini-pump implantation 
Rats were anesthetized with sodium methohexital (20mg/kg administered 
intraperitoneally). An incision was made on the ventral neck and a subcutaneous 
pocket was gently opened in the subscapular region. An osmotic mini-pump with 
a flow rate of 5µL/hour (Model 2ML2, Alzet, CA) containing an experimental 
infusion (Table 2.2) was inserted and the surgical incision site was sutured closed. 
Rats received penicillin (300,000 units/kg, administered intramuscularly) and were 
returned to their home cages.  
The 2ML2 pump model, which is designed for a 14-day infusion but offers 
the highest available flow rate (5µL/hour), was used in all studies due to limitations 
of drug solubility that prevented the use of pumps designed to deliver longer 
infusions at a smaller flow rate. For studies longer than 14 days, the pump was 
replaced on day 14.  
Normal salt High salt




Crude fat 5% 5%
Fiber 5% 3%
Total NaCl content
Table 2.1. Nutritional content of normal salt diet 
and high salt diet obtained from Envigo Teklad
able 2.1. Nutritional content of normal salt diet and 





Acute femoral vein, femoral artery, and bladder cannulation 
On the day of acute study, rats were anesthetized with sodium methohexital 
(20mg/kg administered intraperitoneally, supplemented with 10mg/kg 
administered intravenously as required) and cannulation of the femoral vein, 
femoral artery, and bladder was performed as previously described (Wainford et 
al., 2013; Carmichael et al., 2016; Walsh et al., 2016). An incision was made in the 
left femoral triangle and the femoral artery and femoral vein were carefully 
separated from surrounding tissue. Cannulas made of PE-50 tubing were inserted 
into the left femoral vein, allowing for the maintenance of intravenous anesthesia 
during the remainder of the acute surgery and isotonic saline, experimental sodium 
challenges, or pharmacological agents following recovery, and in the left femoral 
artery, allowing for the measurement of mean arterial pressure and heart rate and 
the collection of arterial blood samples in some studies. The surgical incision site 
Infusion Dose Reference
Isotonic saline N/A
Sonalker et al., 2008
Walsh et al., 2016
Terazosin 10mg/kg/day Maranon et al., 2015





Hydrochlorothiazide 4mg/kg/day Ashek et al., 2012
Losartan 3mg/kg/day Walsh et al., 2016
Norepinephrine + 
Propranolol
Table 2.2. Doses of pharmacological agents used in 
subcutaneous osmotic minipumps.
Norepinephrine 600ng/min
Table 2.2. Doses of pharmacological agents used in 




was then sutured closed, leaving the free ends of the vein and artery cannulas 
externalized. A second incision was made in the pelvic region in order to place a 
cannula made of PE-240 tubing directly into the bladder to allow for the collection 
of urine. The surgical incision site was then sutured, again leaving the free end of 
the cannula externalized. Rats were placed in a Plexiglas rat holder and the 
femoral vein and artery cannulas were connected to an infusion pump and an 
external pressure transducer, respectively. Rats underwent a 2-hour surgical 
recovery period during which an intravenous infusion of isotonic saline (20µL/min) 
was maintained and rats returned to full consciousness and stable renal and 
cardiovascular function. Mean arterial pressure and heart rate were recorded 
continuously via the femoral artery cannula using computer-driven data acquisition 
software (MP150 and AcqKnowledge 3.8.2, BIOPAC, CA) connected to the 
external pressure transducer (P23XL, Viggo Spectramed Inc, CA).  
 
Renal artery cannulation 
In a subset of animals, intravenous sodium methohexital anesthesia was 
maintained after acute cannulation of the femoral vein, femoral artery, and bladder 
to allow for cannulation of a renal arteriole before the surgical recovery period. In 
these animals, a flank incision was made and the distal end of the left renal artery 
and its arterioles were carefully separated from surrounding tissue. A cannula 
made of PE-10 tubing was inserted into a branch of the renal artery, allowing for 




Renal pelvis cannulation 
Rats were anesthetized with sodium thiopental (20mg/kg administered 
intraperitoneally). The femoral vein was cannulated as described above in the 
Acute femoral vein, femoral artery, and bladder cannulation section in order to 
maintain sodium thiopental anesthesia for the duration of the experiment (0.04 
mmol/kg/hour at a rate of 50µL/min in isotonic saline administered intravenously). 
An incision was made in the left lateral abdomen and the left ureter was carefully 
separated from surrounding tissue. A cannula made of PE-50 tubing containing 
three heat-pulled tips of PE-10 tubing was inserted into the left renal pelvis via the 
left ureter to allow 1) renal pelvic perfusion and manipulation of renal pelvic 
pressure, 2) drainage of effluent, and 3) recording of renal pelvic pressure (Kopp 
et al., 1994; Lin et al., 2015). The surgical incision site was closed, leaving the free 
end of the cannula externalized. The right ureter was then cannulated via a second 
incision site using the same techniques but with simple PE-50 tubing to allow for 
contralateral urine collection. After the second incision site was sutured closed, 
anesthesia was maintained during a 90-minute rest period that allowed collection 
of stable steady-state urine followed by an experimental period described in the 
Manipulation of renal pelvic pressure or Manipulation of renal pelvic sodium 
concentration sections of this chapter. Renal pelvic pressure was recorded 
continuously via the left renal pelvic cannula using computer-driven data 
acquisition software (MP150 and AcqKnowledge 3.8.2, BIOPAC, CA) connected 




Radiotelemetry probe implantation 
Rats were anesthetized with ketamine combined with xylazine (30mg/kg 
ketamine with 3mg/kg xylazine, administered intraperitoneally) and a 
radiotelemetry probe (PA-C40, DSI, MN) was implanted as previously described 
(Brouwers et al., 2015; Foss et al., 2015; Wainford et al., 2015). An incision was 
made in the left femoral triangle and the femoral artery was carefully separated 
from surrounding tissue. The catheter of a radiotelemetry probe was inserted into 
the femoral artery and a subcutaneous flank pocket was created to house the body 
of the radiotelemetry probe. Rats received penicillin (300,000 units/kg, 
administered intramuscularly) and were returned to their home cages. In all 
radiotelemetry studies, rats were allowed to recover for 5-7 days prior to the start 
of baseline experimental data collection. During experimentation, rats remained in 
their home cages placed on top of receiver plates. Blood pressure and heart rate 
data were collected, stored, and analyzed using Dataquest A.R.T. 4.2 software 
(DSI, MN).  
 
Total Bilateral Renal Denervation, Selective Afferent Renal 
Nerve Ablation, and Sham Denervation 
Rats were anesthetized with sodium thiopental (20mg/kg administered 
intraperitoneally). A dorsal flank incision was made and the renal artery and vein 
were carefully separated from surrounding tissue. Rats underwent one of three 




denervation, in which visible nerve bundles were physically disrupted and then 
coated with a 10% phenol solution in ethanol to destroy remaining nerve fibers, 2) 
selective afferent renal nerve ablation, in which the nerves were not physically 
disrupted but a capsaicin solution (33mM in isotonic saline with 5% ethanol and 
5% tween-20) was applied to activate TRPV1 cation channels selectively 
expressed on afferent fibers, or 3) sham denervation, in which the renal artery and 
vein were visualized (Foss et al., 2015). During bilateral renal denervation and 
selective afferent renal nerve ablation, care was taken to isolate the dissected 
neurovascular bundle from the surrounding tissue and excess solution was dried 
carefully to avoid off-target exposure to phenol and capsaicin, respectively. The 
flank incision was then sutured closed and the procedure was repeated on the 
contralateral side.  
 
In Vivo Studies in Conscious Animals 
Assessment of NCC activity 
Rats underwent acute cannulation of the femoral vein, femoral artery, and 
bladder followed by a 2-hour surgical recovery period during which rats returned 
to full consciousness and stable cardiovascular and renal function. At the close of 
the 2-hour recovery, rats underwent an acute NCC activity assessment consisting 
of a 1-hour control period (isotonic saline, 20µL/min), a 1-hour ENaC blockade 
period (amiloride, ENaC antagonist; 2mg/kg bolus followed by 2mg/kg/hour at a 




was maintained (hydrochlorothiazide, NCC antagonist; 2mg/kg bolus followed by 
2mg/kg/hour hydrochlorothiazide combined with 2mg/kg/hour amiloride at a total 
rate of 20µL/min) (Ashek et al., 2012; Walsh et al., 2016). Urine was collected in 
consecutive 10-minute periods for the assessment of renal sodium excretion. 
Baseline blood pressure and heart rate were assessed as the average during the 
1-hour control period. Activity of the ENaC was assessed as the peak natriuretic 
response to amiloride, calculated by subtracting baseline natriuresis during the 
final two 10-minute periods of the control period from the maximal natriuresis 
during ENaC blockade. Similarly, NCC activity was assessed as the peak 
natriuretic response to hydrochlorothiazide, calculated by subtracting baseline 
natriuresis during the final two 10-minute periods of ENaC blockade from the 
maximal natriuresis during NCC blockade (during which ENaC blockade was 
maintained). For both amiloride and hydrochlorothiazide, maximal natriuresis 
occurred within the first two 10-minute periods of blockade.  
 
Acute volume expansion 
Rats underwent acute femoral vein, femoral artery, and bladder cannulation 
with or without renal artery cannulation followed by a 2-hour surgical recovery 
period during which rats returned to full consciousness and stable cardiovascular 
and renal function. At the close of the 2-hour recovery period, conscious rats 
underwent an acute intravenous volume expansion protocol consisting of a 20-




expansion (isotonic saline infused at a rate calculated to deliver 5% of the rat’s 
body weight over 30 minutes), and a 90-minute recovery period (isotonic saline, 
20µL/min) (Wainford & Kapusta, 2010; Kapusta et al., 2012). Mean arterial 
pressure and heart rate were monitored continuously and urine was collected in 
consecutive 10-minute increments throughout the protocol. At the close of the 
experimental protocol, all rats underwent transcardiac perfusion; in the subset of 
rats in which the renal artery was cannulated, the pressor response to intrarenal 
bradykinin was assessed to validate selective afferent renal nerve ablation prior to 
perfusion. Perfused brain and kidney tissue were collected for Fos 
immunohistochemistry and assessment of renal norepinephrine content and renal 
pelvic calcitonin gene-related peptide to further validate the efficacy and selectivity 
of selective afferent renal nerve ablation or bilateral renal denervation. In separate 
sets of rats, perfusion was performed immediately following the 2-hour surgical 
recovery and a 20-minute control period and perfused brains were collected for the 
assessment of baseline Fos expression.  
 
Acute 1M NaCl infusion 
Rats underwent acute femoral vein, femoral artery, and bladder cannulation 
with or without renal artery cannulation followed by a 2-hour surgical recovery 
period during which rats returned to full consciousness and stable cardiovascular 
and renal function. At the close of the 2-hour recovery period, conscious rats 




control period (isotonic saline, 20µL/min), followed by a 2-hour 1M NaCl infusion 
during which the rate of delivery was not altered (1M NaCl, 20µL/min) (Wainford 
et al., 2013). At the close of the experimental protocol, all rats underwent 
transcardiac perfusion; in the subset of rats that underwent renal artery 
cannulation, the pressor response to bradykinin was assessed to validate selective 
afferent renal nerve ablation prior to perfusion. Perfused brain and kidney tissue 
were collected for Fos immunohistochemistry and assessment of renal 
norepinephrine content and renal pelvic calcitonin gene-related peptide to further 
validate the efficacy and selectivity of selective afferent renal nerve ablation or 
bilateral renal denervation. In separate sets of rats, perfusion was performed 
immediately following the 2-hour surgical recovery and a 20-minute control period 
and perfused brains were collected for the assessment of baseline Fos expression.  
 
Assessment of glomerular filtration rate and renal blood flow 
during acute sodium challenge 
In select groups of rats that underwent acute volume expansion or 1M NaCl 
infusion, glomerular filtration rate and renal blood flow were assessed beginning 
30 minutes after the start of the surgical recovery period. Rats were infused with 
inulin (300mg/kg/hour) and para-amminohippurate (40mg/kg/hour) during the 
remaining 90 minutes of the 2-hour surgical recovery period and throughout the 
entire experimental protocol. In these animals, urine collection was performed as 




Transcutaneous assessment of glomerular filtration rate 
In select groups of rats that underwent acute volume expansion, 1M NaCl 
infusion, or assessment of NCC activity, glomerular filtration rate was assessed 
using a preclinical transdermal glomerular filtration rate monitor (Medibeacon 
GmbH, Mannheim, Germany) capable of exciting a fluorescent label and absorbing 
subsequent emissions (Schock-Kusch et al., 2011). Following acute cannulation 
of the femoral vein, femoral artery, and bladder, sodium methohexital anesthesia 
was briefly maintained while the monitor was secured on a depilated region on the 
back of the rat. An intravenous bolus of FITC-sinistrin (5mg per 100g body weight), 
a commercially available glomerular filtration rate marker modified with a 
fluorescent label, was administered 30 minutes after the start of the surgical 
recovery period, and the optical device was recovered at the end of the acute 
experimental protocol. The elimination kinetics of FITC-sinistrin were analyzed 
using proprietary software supplied with the transdermal monitor (Medibeacon 
GmbH, Mannheim, Germany) and glomerular filtration rate was calculated using 
the previously established formula below (Schock-Kusch et al., 2011):  
 
 
In vivo validation of selective afferent renal nerve ablation 
In select groups of rats that underwent selective afferent renal nerve 




cannulation of the femoral vein, femoral artery, and bladder prior to an acute 
volume expansion or 1M NaCl infusion. In these animals, the efficacy of selective 
afferent renal nerve ablation was confirmed in vivo as the absence of a pressor 
response to intrarenal bradykinin (Foss et al., 2015; Foss et al., 2016). Immediately 
following the completion of the volume expansion protocol or the 1M NaCl infusion 
protocol, and prior to transcardiac perfusion, mean arterial pressure and heart rate 
were recorded during a 5-minute baseline and a 5-minute intrarenal bradykinin 
infusion (40µg/kg/min). The pressor response to bradykinin was calculated as the 
difference in blood pressure between the baseline period and the final 2 minutes 
of the bradykinin infusion period. 
 
In vivo validation of adrenoceptor blockade 
In rats that underwent acute femoral vein, femoral artery, and bladder 
cannulation following a chronic subcutaneous infusion of an α1- or β-adrenoceptor 
antagonist alone, the cardiovascular responses to an intravenous bolus of 
phenylephrine (selective α1-adrenoceptor agonist; 4µg in 100µL) and a 
subsequent bolus of isoproterenol (non-selective β-adrenoceptor agonist; 0.7µg in 
100µL) were assessed prior to sacrifice at the end of the acute in vivo protocol 
(Walsh et al., 2016). Selective α1-adrenoceptor blockade was confirmed as the 
absence of a pressor response to phenylephrine with an intact tachycardic 




as the absence of a tachycardic response to isoproterenol with an intact pressor 
response to phenylephrine.  
 
Assessment of peak depressor response to ganglionic blockade 
In subsets of animals that underwent acute femoral vein, femoral artery, and 
bladder cannulation, the peak depressor response to ganglionic blockade 
(hexamethonium, 30mg/kg intravenous bolus) was assessed as a measure of 
vascular sympathetic tone (Walsh et al., 2016). The peak depressor response was 
calculated as the difference between the lowest blood pressure achieved, which 
occurred within 5 minutes of the bolus, and baseline blood pressure, defined as 
the average blood pressure during the 10 minutes preceding bolus delivery.  
 
Metabolic balance studies 
Rats were housed individually in metabolic cages designed to separate 
fecal matter and food waste from urine for collection. Rats were allowed to 
acclimatize to the cages with ad libitum access to tap water and food for 48-hours 
prior to experimental data collection. During data collection periods, food and water 
consumption were measured in 24-hour periods and 24-hour urine was collected 
into beakers containing mineral oil to prevent evaporation over the course of each 
day. Daily sodium balance was calculated as the difference between dietary 




2015; Walsh et al., 2016). At the end of the dietary manipulation protocol, rats were 
sacrificed and kidney tissue and plasma were collected for further analysis. 
 
Radiotelemetry studies 
Rats underwent radiotelemetry probe implantation followed by a 5-7 day 
surgical recovery period prior to the start of baseline experimental data collection. 
During experimental data collection, blood pressure data were recorded by 
radiotelemetry via scheduled sampling for 10 seconds every 10 minutes (Walsh et 
al., 2016). Data were collected, stored, and analyzed using Dataquest A.R.T. 4.2 
software (DSI, MN). At the end of the dietary manipulation protocol, rats were 
sacrificed and kidney tissue and plasma were collected for further analysis. 
 
In Vivo Studies in Anesthetized Animals 
Manipulation of renal pelvic pressure 
Rats that underwent renal pelvis cannulation were maintained under 
intravenous sodium thiopental anesthesia (0.04mmol/kg/hour at a rate of 50µL/min 
in isotonic saline) for a 90-minute rest period prior to manipulation of renal pelvic 
pressure to allow collection of stable steady-state urine. A fluid-filled syringe was 
connected to the renal pelvis cannula and elevated to increase renal pelvic 
pressure across a physiological range in 2.5mmHg increments across a 
physiological range of 0-10mmHg. Renal pelvic pressure was maintained for 10 




recovery period at 0mmHg. Renal pelvic pressure was recorded continuously and 
contralateral urine was collected during each 10-minute incremental period. 
 
Manipulation of renal pelvic sodium concentration 
Rats that underwent renal pelvis cannulation were maintained under 
intravenous sodium thiopental anesthesia (0.04 mmol/kg/hour at a rate of 
50µL/min in isotonic saline) for a 90-minute rest period prior to manipulation of 
renal pelvic pressure to allow collection of stable steady-state urine. An infusion 
pump was connected to the renal pelvis cannula and used to deliver a 10-minute 
infusion of isotonic (154mM) saline at a rate of 20µL/min followed by a 10-minute 
infusion of hypertonic (450mM) saline at the same rate, such that renal pelvic 
pressure was not altered throughout the course of the experiment. Renal pelvic 
pressure was recorded continuously and contralateral urine was collected during 
each 10-minute incremental period. 
 
Ex Vivo Studies 
Ex vivo renal pelvis assay 
Rats underwent conscious decapitation and the renal pelvis from each 
kidney was carefully dissected. Each renal pelvis was placed individually into a 
separate well of a 24-well plate containing 400 µL HEPES and maintained at 37ºC. 
The medium was aspirated and replaced every 10 minutes during a 2-hour 




renal nerves was then assessed as the release of substance P in response to 
norepinephrine, a general stimulus that acts at α1-adrenoceptors to activate the 
afferent renal nerves, or hypertonic saline, a chemoreceptor stimulus (Kopp et al., 
2007; Kopp et al., 2009; Kopp et al., 2011a; Kopp et al., 2011b). In brief, the 
medium was collected for storage and replaced every 5 minutes during four control 
periods (HEPES), one experimental treatment period (1250pM norepinephrine or 
450mM NaCl in HEPES), and four recovery periods (HEPES). As two renal 
pelvises were available from each rat, each rat served as its own internal control 
with one renal pelvis treated with 1250pM norepinephrine and the other treated 
with 450mM NaCl. The medium collected during control, experimental treatment, 
and recovery periods was stored at -80°C prior to analysis of substance P content 
via ELISA (ADI-901-018, Enzo Life Sciences, NY). Norepinephrine- and sodium-
evoked substance P release were calculated as the difference in substance P 
release between the experimental treatment period and the average of the four 
control periods.  
 
Molecular and Analytical Techniques 
Urinalysis 
Urine volume was determined gravimetrically assuming 1g = 1mL. Urinary 
sodium concentration was assessed using flame photometry (IL-943, 





Biochemical validation of selective afferent renal nerve ablation 
The efficacy and selectivity of selective afferent renal nerve ablation versus 
bilateral renal denervation were confirmed in kidney tissue via the assessment of 
renal pelvic calcitonin gene-related peptide content and renal norepinephrine 
content (calcitonin gene-related peptide ELISA #589001, Cayman Chemicals, MI; 
NE ELISA IB89537, IBL America, MN). Selective afferent renal nerve ablation is 
reflected by a loss of renal pelvic calcitonin gene-related peptide but not renal 
norepinephrine content (Foss et al., 2015). 
 
Biochemical validation of bilateral renal denervation 
The efficacy of bilateral renal denervation was confirmed via the 
assessment of renal norepinephrine content (NE ELISA IB89537, IBL America, 
MN). Bilateral renal nerve ablation is reflected by a reduction in renal 
norepinephrine content. 
 
Fos immunohistochemistry following acute sodium challenge 
In rats that underwent acute volume expansion or 1M NaCl infusion, or were 
sacrificed immediately following completion of the 2-hour recovery and control 
periods, Fos expression was assessed in the paraventricular nucleus as previously 
described (Randolph et al., 1998; Carmichael et al., 2016). Upon completion of the 
in vivo study, rats were anesthetized using sodium methohexital (10mg/kg 




phosphate buffered saline (150-200mL) followed by 4% paraformaldehyde in 0.1M 
phosphate buffered saline (200-300mL). Brains were dissected and fixed overnight 
in 4% paraformaldehyde at 4°C followed by cryo-preservation in a 30% 
weight/volume sucrose solution for 48 hours, replacing the sucrose solution once 
after 24 hours. The brain was then embedded in OCT Tissue Tek, frozen using dry 
ice, and sectioned coronally on a cryostat using a rat brain atlas to identify the 
rostral and caudal limits of the paraventricular nucleus. The paraventricular 
nucleus was serially sectioned into three sets of 40µm sections, each set spanning 
the entire paraventricular nucleus. Sections were stored at -20°C in cryoprotectant 
(30% weight/volume sucrose, 30% ethylene glycol, and 1% polyvinyl-pyrrolidone 
in 0.1M PBS) (Watson et al., 1986). 
Fos immunohistochemistry was then performed on one set of free-floating 
sections from each brain (Carmichael et al., 2016). Sections stored in 
cryoprotectant were allowed to come to room temperature and 
immunohistochemistry was performed using an anti-Fos primary antibody (Ab-5, 
Calbiochem, CA) and a biotinylated horse anti-rabbit IgG secondary antibody 
(Vector Laboratories, CA) according to the steps described in Table 2.3. Sections 
incubated in antibody diluent without the primary antibody were also processed 






Stained sections were then mounted onto gelatin-coated slides and 
dehydrated via a graded series of alcohols followed by xylenes. Slides were 
coverslipped using Permount mounting medium and imaged using an Olympus 
microscope (BX41) and an Olympus DP70 digital camera with DP MANAGER 
software (v 2.2.1) (Olympus, PA, USA). For each animal, Fos-positive cells were 
counted in two sections from each of 3 rostral-caudal levels using ImageJ (NIH, 





Wash 0.1M PBS 4 x 5 minutes, RT
Block endogenous peroxidases 0.3% hydrogen peroxide 30 minutes, RT
Wash 0.1M PBS 4 x 5 minutes, RT
3% normal horse serum
0.25% Triton X-100
1 hour, RT prior to
48 hours, 4°C
Wash 0.1M PBS 4 x 5 minutes, RT
Biotinylated Biotinylated horse anti-rabbit IgG 
secondary antibody 1:200 in blocking solution
Wash 0.1M PBS 4 x 5 minutes, RT
Peroxidase labeling/
amplification
Wash 0.1M PBS 4 x 5 minutes, RT
0.04% 3,3’-diaminobenzidene 
hydrochloride 
0.04% nickel ammonium sulphate
Wash 0.1M PBS 4 x 5 minutes, RT
Chromogenic detection 11 minutes, RT
Table 2.3. Detailed protocol for Fos immunohistochemistry. All solutions are in 0.1M 
phosphate buffered saline (PBS). RT = room temperature.
Block non-specific binding 2 hours, RT
Primary antibody




Vectastain Kit; Vector 
Laboratories)
1 hour,RT
Table 2.3. Detailed protocol for Fos immunohistochemistry. All solutions 
are in 0.1M phosphate buffered saline (PBS) unless otherwise noted. RT = 





Assessment of renal cortex protein expression 
Kidneys were harvested and the renal cortex and pelvis were carefully 
dissected and stored separately at -80°C prior to isolation of a renal cortical 
membrane preparation and assessment of protein expression as previously 
described (Walsh et al., 2016). Approximately 200mg of renal cortex from each 
animal was homogenized on ice via hand-pestle in ice-cold homogenizing buffer 
with protease inhibitors (10mM triethanolamine, 250mM sucrose, 100mM NaN3, 
10mM PMSF, and 1mM leupeptin) and then centrifuged at 4,000g for 10 minutes 
at 4°C. The pellet containing unhomogenized tissue and nuclei and mitochondria 
from homogenized tissue was discarded, while the supernatant was isolated and 
centrifuged again at 17,000g for 1 hour at 4°C to yield a pellet containing the 
plasma membrane fraction. The pellet was resuspended in cell lysis buffer (9803S, 
Cell Signaling Technology, MA) and a bicinchoninic acid protein assay (BCA 
Protein Assay, Thermo Scientific Pierce, IL) was performed to quantify total protein 
content. The membrane preparation was stored at -80°C until use in 
immunoblotting. Immunoblotting was conducted using 20µg of protein per lane in 
7.5% or 10% SDS-PAGE gels. Proteins were transferred from the gels to 
nitrocellulose membranes that were then blocked in 5% milk for 30 minutes prior 
to overnight incubation at 4°C in primary antibody (Table 2.4). Membranes were 
then washed and incubated in secondary antibody (Table 2.4) for 1 hour at room 





Membranes were imaged using an ImageQuant LAS 4000 imager (GE 
Healthcare Life Sciences, MA) and semi-quantified using Image J (NIH, MD). 
Protein levels were normalized to β-actin abundance assessed using the same 
membrane or total protein loading assessed using coomassie blue staining of a 
gel run simultaneously with the same samples. 
  
Assessment of plasma norepinephrine concentration 
Plasma norepinephrine was assessed via ELISA (IB89552, IBL America, 
MN) according to manufacturer’s directions. 
 
Table 2.4. Antibody dilutions used for immunoblotting. NCC = 
sodium chloride cotransporter; pNCC (pT53) = phosphorylated 
NCC (phospho-Thr53); WNK1 = with no lysine kinase 1; OxSR1 = 
oxidative stress responsive kinase 1; SPAK = STE20/SPS1-





Assessment of renal norepinephrine content 
Renal norepinephrine content was assessed via ELISA (IB89537, IBL 
America, MN) according to manufacturer’s directions.  
 
Assessment of urinary kidney injury molecule-1 concentration 
Urinary kidney injury molecule-1 was assessed via ELISA (ab119757, 
Abcam, MA) according to manufacturer’s directions. 
 
Assessment of proteinuria 
Urinary protein content was assessed via bicinchoninic acid protein assay 
(BCA Protein Assay, Thermo Scientific Pierce, IL) according to manufacturer’s 
directions.  
 
Assessment of urinary angiotensinogen 
Urinary angiotensinogen was assessed via ELISA (IB27414, IBL America, 
MN) according to manufacturer’s directions. 
 
Assessment of plasma renin activity 
Plasma renin activity was assessed as generated angiotensin I via ELISA 






Assessment of plasma angiotensin II 
Plasma angiotensin II content was assessed via ELISA (ADI-900-204, Enzo 
Life Sciences, NY) according to manufacturer’s directions. 
 
Assessment of plasma aldosterone 
Plasma aldosterone content was assessed via ELISA (ADI 901-173, Enzo 
Life Sciences, NY) according to manufacturer’s directions.  
 
Assessment of glomerulosclerosis and mesangial expansion 
Kidneys were bisected and immersed in neutral buffered formalin. The 
tissue was stored in formalin at room temperature until processing, embedding, 
and Periodic Acid-Schiff staining with a hematoxylin counterstain were performed 
by the Boston University School of Medicine Experimental Pathology Laboratory 
Service Core. Approximately 40 glomeruli per animal were imaged at 60X 
magnification using an Olympus microscope (BX41) and an Olympus DP70 digital 
camera with DP MANAGER software (v 2.2.1) (Olympus, PA, USA). 
Glomerulosclerosis and mesangial expansion, two pathological changes observed 
in human aging (Zhou et al., 2008), were evaluated and scored separately by two 
blinded reviewers (Raij et al., 1984; Maric et al., 2004). The scores noted by each 
reviewer were averaged. Glomerulosclerosis was defined as the obliteration of 
capillary lumens, folding and thickening of the glomerular basement membrane, 




was defined as the present of periodic acid-Schiff-positive material in the 
mesangium. Semi-quantitative scores were obtained using a previously 
established scale in which the percentage of each individual glomerulus involved 
was denoted as 0 (no lesion) or 1, 2, 3, or 4, corresponding to 25%, 50%, 75%, 
and 100% glomerular area involvement. An overall score for each measure was 
then calculated for each animal using the formula below:  
 
 
Assessment of substance P release in the ex vivo renal pelvic assay 
Substance P concentration in supernatant generated during the ex vivo 
renal pelvis assay was assessed via ELISA (ADI-901-018, Enzo Life Sciences, 
NY) according to manufacturer’s directions. Norepinephrine- and sodium-evoked 
substance P release were calculated as the difference in substance P release 




All data in Chapters 3-5 are expressed as mean ± SEM. The magnitude of 
change in cardiovascular and renal excretory parameters at different time points 
after initiation of acute sodium challenge or chronic dietary sodium intake was 




analysis of variance (ANOVA) with subsequent Dunnett’s test. Differences 
between treatment groups or age groups were assessed by a two-way repeated 
measure ANOVA, with treatment or age being one fixed effect and time the other, 
with the interaction included. The time (minutes) was used as the repeated factor. 
Post-hoc analysis was performed using Bonferroni’s test to compare variations 
among the groups. Statistical analysis was carried out using Prism 7 (GraphPad 









Salt sensitivity of blood pressure is characterized by inappropriate 
sympathoexcitation and renal sodium reabsorption during high salt intake, and 
exogenous norepinephrine infusion promotes salt-sensitive hypertension and 
prevents dietary sodium-evoked suppression of sodium chloride cotransporter 
(NCC) activity in classically salt-resistant animal models. Studies of the adrenergic 
signaling pathways that promote NCC activity during norepinephrine infusion have 
yielded conflicting results implicating α1- and/or β-adrenoceptors and a 
downstream kinase network that phosphorylates and activates the NCC, including 
with no lysine kinases (WNKs), STE20/SPS1-related Proline-Alanine-rich kinase 
(SPAK), and oxidative stress responsive kinase 1 (OxSR1). In these studies, we 
used selective adrenoceptor antagonism in norepinephrine-infused male Sprague 
Dawley rats to investigate the differential roles of α1- and β-adrenoceptors in NCC 
regulation. Norepinephrine infusion evoked salt-sensitive hypertension and 
prevented dietary sodium-evoked suppression of NCC mRNA and protein 
expression, phosphorylation, and in vivo activity. Impaired NCC suppression 
during high salt intake in norepinephrine-infused rats was paralleled by impaired 
suppression of WNK1, SPAK, and OxSR1 expression and an increase in OxSR1 
phosphorylation. Antagonism of α1-adrenoceptors initiated prior to high salt intake 




evoked suppression of the NCC and its regulatory kinases and abolished the salt-
sensitive component of hypertension. In contrast, β-adrenoceptor antagonism 
attenuated norepinephrine-evoked hypertension independently of dietary sodium 
intake and did not restore the suppression of the NCC or its regulatory kinases 
during high salt intake. Together, these findings suggest that a selective α1-
adenoceptor-gated WNK1/OxSR1 signaling pathway prevents dietary sodium-




Dietary sodium intake plays a significant role in blood pressure regulation, 
as increased sodium retention is a well-established precursor of hypertension 
(Kannel, 2000; World Health, 2013; Olsen et al., 2016). Approximately 50% of 
hypertensive individuals and 25% of normotensive individuals exhibit the salt 
sensitivity of blood pressure (Morimoto et al., 1997; Appel et al., 2011), a 
phenomenon that can promote the development of salt-sensitive hypertension. 
Multiple factors contribute to the development of salt-sensitive hypertension 
including increased renal sodium reabsorption. Given that salt sensitivity is driven, 
in part, by an inappropriate sympathoexcitatory response to dietary sodium intake 
(Brooks et al., 2005; Stocker et al., 2013) that drives an increase in salt and water 





The sodium chloride cotransporter (NCC), a thiazide-sensitive transporter 
predominantly found on the apical side of the distal convoluted tubule, contributes 
to the fine-tuning of sodium reabsorption (Huang & Cheng, 2015; Hadchouel et al., 
2016; Shekarabi et al., 2017). Multiple recent studies have suggested a direct 
influence of the sympathetic nervous system release of norepinephrine on the 
expression and activity of the NCC. In salt-resistant Sprague-Dawley rats, 
increased dietary salt intake suppresses sympathetic outflow and circulating 
norepinephrine levels (Kapusta et al., 2012; Kapusta et al., 2013; Wainford et al., 
2015) and persistently reduces the expression and activity of the NCC (Sandberg 
et al., 2006; Walsh et al., 2016). Subcutaneous norepinephrine infusion during 
normal salt intake appears to evoke a species-specific NCC response with no 
alteration in NCC expression in Sprague-Dawley rats (Sonalker et al., 2008; Walsh 
et al., 2016) versus an increase in total and phosphorylated NCC in C57Bl/6J mice 
(Mu et al., 2011; Uchida et al., 2012).  
The regulation of the NCC involves a complex kinase network including with 
no lysine kinases WNK1 and WNK4, STE20/SPS1-related Proline-Alanine-rich 
kinase (SPAK), and oxidative stress responsive kinase 1 (OxSR1) (Huang & 
Cheng, 2015; Hadchouel et al., 2016; Shekarabi et al., 2017). The regulation of 
the NCC by norepinephrine remains an area of controversy. It was initially reported 
that norepinephrine acts via a β2-adrenoceptor-gated WNK4-mediated signal 
transduction pathway to evoke long-term upregulation of the NCC, driving sodium 




Significantly, the proposed β2-WNK4-NCC signaling pathway in salt-sensitive 
hypertension was questioned following the failure to reproduce the role of WNK4 
in the development of salt-sensitive hypertension in norepinephrine-infused mice 
(Uchida et al., 2012). Further, a recent study demonstrated that following direct 
pharmacological stimulation, α1- and β- adrenoceptors act synergistically to drive 
acute increases in NCC expression (Terker et al., 2014). At present the 
mechanisms by which long-term alterations in norepinephrine levels, such as 
those seen in animal models of salt-resistance or salt-sensitivity, influence NCC 
regulation remain to be fully delineated. 
Our prior study, conducted in salt-resistant Sprague Dawley rats, did not 
investigate the mechanisms or signal transduction pathways by which 
norepinephrine influences chronic NCC activity during long-term alterations in 
dietary salt intake. As such, we hypothesized that in salt-sensitive hypertension, 
sympathoexcitation increases NCC-mediated activity via an adrenoceptor-
mediated signal transduction pathway that increases the expression and/or activity 
of NCC regulatory kinases. To test our hypothesis, we used norepinephrine-
infused male Sprague Dawley rats as a model of sympathetically-mediated salt-
sensitive hypertension (Walsh et al., 2016). We administered a chronic 
norepinephrine infusion during normal and high dietary salt intake and used co-
infusions of terazosin (α1-adrenoceptor antagonist) or propranolol (β-adrenoceptor 




pathways regulating NCC activity and expression during both the development and 
maintenance of salt-sensitive hypertension.  
 
Methods 
All methods used in the studies of adrenergic regulation of the NCC in 
young adult animals in this chapter are briefly outlined in this section and described 
in further detail in Chapter 2. In brief, 3 month old male Sprague Dawley rats were 
used as an established model of salt resistance in which norepinephrine infusion 
evokes the development of salt-sensitive hypertension. 
To validate previous physiological findings, miniosmotic pumps delivering 
isotonic saline or norepinephrine infusions were placed in animals immediately 
prior to the start of a 21-day normal or high salt diet and blood pressure and in vivo 
NCC activity were assessed on day 21 in conscious animals (Figure 3.1A). 
Extending previous studies with mechanistic insight into the signaling pathways 
mediating NCC regulation in norepinephrine-infused rats, mRNA and protein 
expression and phosphorylation of the NCC and its regulatory kinases WNK1, 
SPAK, and OxSR1 were assessed in renal cortex tissue isolated from these 
animals immediately following the acute study (Figure 3.1A). 
To determine the role of α1- and β-adrenoceptor signaling pathways in 
norepinephrine-evoked salt-sensitive hypertension and NCC regulation, the same 
studies were performed in animals receiving infusions of terazosin (α1-




combination with norepinephrine during a 21-day normal or high salt diet (Figure 
3.1A). 
To determine whether α1-adrenoceptor antagonism is capable of 
attenuating established salt-sensitive hypertension and reversing established 
impairments in NCC regulation, miniosmotic pumps delivering isotonic saline or 
norepinephrine infusions were placed in animals immediately prior to the start of a 
42-day high salt diet (Figure 3.1B). On day 21 of high salt intake, a timepoint at 
which norepinephrine-infused rats exhibit established salt-sensitive hypertension, 
the miniosmotic pump was replaced as follows: saline-infused rats received a new 
saline-filled pump, while sets of norepinephrine-infused rats received pumps 
delivering norepinephrine alone or in combination with terazosin (Figure 3.1B). The 
high salt diet was then continued for 21 days and blood pressure and NCC activity 
were assessed on cumulative day 42 of high salt intake (Figure 3.1B). 
Figure 3.1. Overview of methods used in Chapter 3. All studies were performed 
using 3-month old male Sprague Dawley rats. White = dietary sodium 
assignments; green = surgical procedures; orange = in vivo studies in conscious 
animals; blue = analytical techniques. n = 6/group unless otherwise specified. 





Chronic norepinephrine infusion evokes the salt sensitivity of blood pressure and 
prevents dietary sodium-evoked suppression of NCC activity, expression, and 
phosphorylation 
In saline-infused rats, high salt intake had no impact on blood pressure and 
promoted the suppression of NCC activity, assessed as the natriuretic response 
to the NCC antagonist hydrochlorothiazide (Figure 3.2A&B). Dietary sodium-
evoked suppression of NCC activity in vivo in saline-infused rats was paralleled by 
a reduction in NCC mRNA, protein expression, and phosphorylation at Thr58 
(Figure 3.2C-E, Figure 3.3A).  
Norepinephrine-infused rats maintained on a normal salt diet exhibited an 
increase in blood pressure that occurred independently of altered NCC activity 
(Figure 3.2A&B). A 21-day high salt diet exacerbated hypertension in 
norepinephrine-infused rats, indicating the development of salt-sensitive 
hypertension (Figure 3.2A&B). Critically, norepinephrine-evoked salt-sensitive 
hypertension was associated with a failure to suppress NCC activity during high 
salt intake (Figure 3.2A&B). Mirroring these findings, while norepinephrine had no 
impact on the NCC during normal salt intake, norepinephrine-infused rats failed to 
suppress NCC mRNA and total protein expression and NCC phosphorylation at 






Figure 3.2. Impact of chronic norepinephrine infusion on blood pressure and 
NCC regulation. (A) Mean arterial pressure (MAP; mmHg) and (B) peak natriuretic 
response (ΔUNaV) to intravenous hydrochlorothiazide (HCTZ; 2mg/kg bolus, 
2mg/kg hour infusion) in conscious 3-month old male Sprague Dawley (SD) rats 
receiving a subcutaneous (s.c.) infusion of saline or norepinephrine (NE) during a 
21-day normal salt (NS; 0.6% NaCl) or high salt (HS; 4% NaCl) diet and (C) 
representative immunoblots of renal cortical (D) total NCC expression, (E) NCC 
phosphorylation (Thr58), (F) WNK1 expression, (G) SPAK expression, (H) OxSR1 
expression, and (I) OxSR1 phosphorylation. n = 6/group. *P < 0.05 vs. respective 






Figure 3.3. Impact of chronic norepinephrine infusion on mRNA expression 
of the NCC, its regulatory kinases, and adrenoceptor subtypes. Renal cortex 
mRNA expression of (A) the NCC and its regulatory kinases and (B) adrenoceptor 
subtypes in 3-month old male Sprague Dawley rats that received a subcutaneous 
(s.c.) infusion of saline or norepinephrine (NE) during a 21-day normal salt (NS; 
0.6% NaCl) or high salt (HS; 4% NaCl) diet. n = 6/group. *P < 0.05 vs. respective 




Chronic norepinephrine infusion impairs the dietary sodium-evoked suppression 
of NCC regulatory kinases WNK1, SPAK, and OxSR1 
Total protein expression of WNK1, SPAK, and OxSR1, as well as OxSR1 
phosphorylation, were suppressed during high salt intake in saline-infused rats 
(Figure 3.2F-I). In contrast, while norepinephrine did not alter the expression of the 
NCC or its regulatory kinases during normal salt intake, impaired dietary sodium-
evoked NCC suppression in norepinephrine-infused rats was accompanied by a 
failure to suppress WNK1, SPAK, and OxSR1 protein expression during high salt 
intake and a dietary sodium-evoked increase in OxSR1 phosphorylation (Figure 
3.2F-I).  
At the mRNA level, WNK1 expression was increased by norepinephrine 
infusion in rats maintained on a normal salt diet and remained elevated during high 
salt intake (Figure 3.3A). In contrast, WN3 and WNK4 mRNA expression were not 
influenced by treatment or diet (Figure 3.3A). In norepinephrine-infused rats 
maintained on a 21-day high salt diet, OxSR1 mRNA expression was elevated 
compared to saline-infused rats during high salt intake, and SPAK mRNA 
expression was increased compared to both saline-infused rats during high salt 
intake and norepinephrine-infused rats during normal salt intake (Figure 3.3A). 
Interestingly, while mRNA expression of the α1A, α1B, α2A, and β1-adrenoceptor 
subtypes was not altered by norepinephrine or high salt intake, saline-infused rats 
exhibited a dietary sodium-evoked suppression of α2B1 and α2B2-adrenoceptors 




norepinephrine infusion evoked an increase in α1D-adrenoceptor mRNA 
expression to a similar degree during both normal and high salt intake, and 
norepinephrine and high salt intake both alone or in combination promoted a 
decrease in β2-adrenoceptor mRNA expression compared to saline-infused rats 
on a normal salt diet (Figure 3.3B).  
 
Chronic α1-adrenoceptor antagonism prevents the development of 
norepinephrine-evoked salt sensitivity of blood pressure and restores dietary 
sodium-evoked NCC suppression 
Chronic antagonism of α1-adrenoceptors using subcutaneous terazosin 
infusion alone had no impact on blood pressure or in vivo NCC activity in rats 
maintained on a normal salt diet (Figure 3.4A&B). Moreover, terazosin-infused rats 
maintained baseline blood pressure and retained the ability to suppress NCC 
activity during a 21-day high salt diet initiated immediately following the start of α1-
adrenoceptor antagonism (Figure 3.4A&B). Significantly, while α1-adrenoceptor 
blockade did not alter blood pressure or NCC activity in norepinephrine-infused 
rats during normal salt intake, terazosin prevented the development of the salt-
sensitive component of hypertension in norepinephrine-infused rats and restored 
dietary sodium-evoked NCC suppression in vivo (Figure 3.4A&B). In all rats, 
selective α1-adrenoceptor antagonism was confirmed as the loss of a pressor 
response to phenylephrine while the tachycardic response to isoproterenol 






Figure 3.4. Impact of chronic α1-adrenoceptor antagonism on the 
development of norepinephrine-evoked salt-sensitive hypertension. (A) 
Mean arterial pressure (MAP; mmHg), (B) peak natriuretic response (ΔUNaV; 
µeq/min) to intravenous (i.v.) hydrochlorothiazide (HCTZ; 2mg/kg bolus, 2mg/kg 
hour infusion), (C) peak pressor response (ΔMAP; mmHg) to i.v. phenylephrine 
(PE; 4µg/kg bolus), and (D) peak tachycardic response (ΔHR; beats per minute 
[bpm]) to i.v. isoproterenol (ISO; 0.7µg/kg  bolus) in conscious 3-month old male 
Sprague Dawley (SD) rats that received a subcutaneous (s.c.) infusion of saline, 
saline + terazosin, norepinephrine (NE), or NE + terazosin during a 21-day normal 
salt (NS; 0.6% NaCl) or high salt (HS; 4% NaCl) diet. n = 6/group. *P < 0.05 vs. 
respective NS group, τP < 0.05 vs. respective NE-infused group, ΦP < 0.05 vs. 





Chronic β-adrenoceptor antagonism attenuates hypertension but fails to restore 
dietary sodium-evoked NCC suppression 
Chronic antagonism of β-adrenoceptors using subcutaneous propranolol 
infusion alone had no impact on blood pressure or NCC activity during normal or 
high salt intake (Figure 3.5A&B). In norepinephrine-infused rats, propranolol 
infusion reduced blood pressure to a similar level regardless of dietary sodium 
intake and had no impact on NCC activity during either diet compared to rats 
infused with norepinephrine alone, suggesting that norepinephrine-mediated NCC 
regulation occurs independently of β-adrenoceptor signaling (Figure 3.5A&B). In 
all rats, selective β-adrenoceptor antagonism was confirmed as the loss of a 
tachycardic response to isoproterenol while the pressor response to phenylephrine 






Figure 3.5. Impact of chronic β-adrenoceptor antagonism on the 
development of norepinephrine-evoked salt-sensitive hypertension. (A) 
Mean arterial pressure (MAP; mmHg), (B) peak natriuretic response (ΔUNaV; 
µeq/min) to intravenous (i.v.) hydrochlorothiazide (HCTZ; 2mg/kg bolus, 
2mg/kg hour infusion), (C) peak tachycardic response (ΔHR; beats per minute 
[bpm]) to i.v. isoproterenol (ISO; 0.7µg/kg  bolus), and (D) peak pressor 
response (ΔMAP; mmHg) to i.v. phenylephrine (PE; 4µg/kg bolus) in conscious 
3-month old male Sprague Dawley (SD) rats that received a subcutaneous 
(s.c.) infusion of saline, saline + terazosin, norepinephrine (NE), or NE + 
terazosin during a 21-day normal salt (NS; 0.6% NaCl) or high salt (HS; 4% 
NaCl) diet. n = 6/group. *P < 0.05 vs. respective NS group, τP < 0.05 vs. 




Chronic α1- and β-adrenoceptor antagonism differentially modulate the 
expression and phosphorylation of the NCC and its regulatory kinases 
Terazosin infusion, which did not alter NCC activity during normal salt 
intake, prevented the norepinephrine-evoked increase in OxSR1 protein 
expression but otherwise had no impact on the NCC and its regulatory kinases at 
the protein level during normal salt intake (Figure 3.6A-F). Critically, the restoration 
of dietary sodium-evoked suppression of NCC activity by α1-adrenoceptor 
blockade was paralleled by restored suppression of NCC expression and 
phosphorylation during high salt intake (Figure 3.6A-B). Similarly, α1-adrenoceptor 
blockade restored dietary sodium-evoked suppression of WNK1 and SPAK protein 
expression and OxSR1 phosphorylation in norepinephrine-infused rats (Figure 
3.6C-F). While these animals did not suppress OxSR1 protein expression during 
high salt intake compared to normal salt intake, OxSR1 protein expression 
remained significantly reduced compared to animals infused with norepinephrine 
alone (Figure 3.6E).  
Propranolol infusion, which reduced blood pressure irrespective of sodium 
intake but failed to restore dietary sodium-evoked suppression of NCC activity in 
norepinephrine-infused rats, also failed to restore the suppression of NCC 
expression and phosphorylation during high salt intake (Figure 3.6A-B). Further, 
while β-adrenoceptor blockade restored suppression of SPAK expression during 




of the expression and phosphorylation of the NCC and OxSR1, as well as total 
WNK1 expression, remained impaired (Figure 3.6A-F). 
 
Figure 3.6 Impact of chronic α1- and β-adrenoceptor antagonism on the NCC 
and its regulatory kinases. Renal cortex (A) total NCC expression, (B) NCC 
phosphorylation (Thr58), (C) WNK1 expression, (D) SPAK expression, (E) OxSR1 
expression, (F) OxSR1 phosphorylation, and (G) representative immunoblots from 
3-month old male Sprague Dawley rats that received a subcutaneous (s.c.) 
infusion of saline, norepinephrine (NE), NE + terazosin, or NE + propranolol during 
a 21-day normal salt (NS; 0.6% NaCl) or high salt (HS; 4% NaCl) diet. n = 6/group. 




Chronic α1-adrenoceptor antagonism reverses the salt sensitivity of blood 
pressure and restores dietary sodium-evoked NCC suppression in established 
norepinephrine-evoked salt-sensitive hypertension 
A 42-day high salt diet had no impact on blood pressure and promoted the 
suppression of NCC activity in vivo in saline-infused rats (Figure 3.7). A 42-day 
norepinephrine infusion evoked hypertension but had no impact on NCC activity 
during normal salt intake and promoted the development of salt-sensitive 
hypertension accompanied by a failure to suppress NCC activity during high salt 
intake (Figure 3.7). Terazosin infusion had no impact on blood pressure or NCC 
activity in norepinephrine-infused rats maintained on a normal salt diet (Figure 3.7). 
Critically, however, α1-adrenoceptor blockade reversed the salt-sensitive 
component of established norepinephrine-evoked salt-sensitive hypertension and 










The current studies were designed to delineate the adrenergic signaling 
pathways that promote NCC activity in norepinephrine-evoked salt-sensitive 
hypertension. Previous studies have demonstrated that exogenous 
norepinephrine drives increased NCC activity and salt-sensitive hypertension in 
Sprague Dawley rats (Walsh et al., 2016), which are classically salt resistant 
(Kapusta et al., 2012; Kapusta et al., 2013), and that salt-sensitive animal models 
exhibit excess sympathetic outflow during high salt intake that could contribute to 
inappropriate NCC activation (Mu et al., 2011; Terker et al., 2014). Critically, 
several studies have demonstrated that salt sensitivity in human subjects is 
characterized by a failure to suppress sympathetic tone during high salt intake 
Figure 3.7 Impact of chronic α1-adrenoceptor antagonism on established 
norepinephrine-evoked salt-sensitive hypertension. (A) Mean arterial pressure 
(MAP; mmHg) and (B) peak natriuretic response (ΔUNaV; µeq/min) to intravenous 
(i.v.) hydrochlorothiazide (HCTZ; 2mg/kg bolus, 2mg/kg hour infusion), in 3-month 
old male Sprague Dawley rats on a 42-day normal salt (NS; 0.6% NaCl) or high 
salt (HS; 4% NaCl) diet that received a subcutaneous (s.c.) infusion of saline (42 
days; black bars), norepinephrine (NE) alone (42 days; red bars), or NE alone for 
21 days followed by NE + terazosin for 21 days (blue bars). n = 6/group. *P < 0.05 




(Campese et al., 1982; Gill et al., 1988); however, the potential mechanistic link 
between sympathetic tone, NCC regulation, and salt sensitivity is incompletely 
understood.  
Here, we confirmed our previous observation that norepinephrine infusion 
in the normotensive salt-resistant Sprague Dawley rat evokes the development of 
salt-sensitive hypertension (Walsh et al., 2016). Further, we used α1- and β-
adrenoceptor antagonism to provide novel mechanistic insight into a selective α1-
adrenoceptor-gated WNK1/OxSR1 signaling pathway that prevents the 
suppression of NCC expression, phosphorylation, and activity during high salt 
intake in norepinephrine-infused Sprague Dawley rats. Using chronic α1-
antagonism, initiated at the start of high salt intake or after three weeks of high salt 
intake, we demonstrate that α1-adrenergic signaling pathways are required for both 
the development of salt sensitivity and the maintenance of established salt-
sensitive hypertension in norepinephrine-infused rats. Together, our findings 
provide novel insight into the mechanisms through which elevated plasma 
norepinephrine concentration and impaired dietary sodium-evoked suppression of 
sympathetic tone may promote NCC-mediated sodium retention and salt-sensitive 
hypertension.  
In the current studies, we observed that saline-infused Sprague Dawley rats 
maintain normotension during high salt intake and exhibit dietary sodium-evoked 
suppression of NCC mRNA and protein expression, phosphorylation, and 




sensitive hypertension characterized by impaired dietary sodium-evoked 
suppression of the NCC by multiple techniques, suggesting that the suppression 
of sympathetic tone during high salt intake is critical to NCC suppression and salt 
resistance. These observations are consistent with previous studies reporting 
dietary sodium-evoked suppression of the NCC in normotensive Sprague Dawley 
rats (Yang et al., 2008; Walsh et al., 2016) and linking sympathetic stimulation of 
the NCC with salt-sensitive hypertension in Sprague Dawley rats and other rodent 
models (Mu et al., 2011; Terker et al., 2014; Walsh et al., 2016). 
During normal salt intake, norepinephrine infusion had no impact on NCC 
activity or expression but resulted in an increase in blood pressure that could be 
attributed to the effects of norepinephrine in other systems, including the 
vasculature, that are beyond the scope of these studies. Although studies in mice 
have reported a norepinephrine-evoked increase in NCC expression during normal 
salt intake (Mu et al., 2011; Terker et al., 2014), our finding that norepinephrine 
alone does not alter NCC activity or expression is consistent with previous studies 
in Sprague Dawley rats (Sonalker et al., 2008; Walsh et al., 2016) and suggests 
that there may be species differences in the adrenergic regulation of the NCC.  
Building upon these previous studies that largely support our in vivo 
findings, we assessed protein expression of the kinase network known to influence 
NCC activity. A number of studies support with no lysine kinases WNK1 and WNK4 
as regulators of NCC activity. WNK1 stimulates NCC activity via SPAK and OxSR1 




translocation to the plasma membrane (Subramanya et al., 2009) or increases 
NCC activity via SPAK and OxSR1 (San-Cristobal et al., 2009). An initial study 
specifically assessing adrenergic regulation of the NCC in the context of salt-
sensitive hypertension suggested that norepinephrine activates a β2-adrenergic 
pathway involving WNK4, but not WNK1 (Mu et al., 2011). Two subsequent studies 
failed to replicate the role of WNK4 but did not further assess WNK1 (Uchida et 
al., 2012; Terker et al., 2014), and as such the potential role of WNK1 in 
norepinephrine-mediated NCC activation remains largely unaddressed. In the 
current studies, we observed that total WNK1, OxSR1, and SPAK protein 
expression was suppressed during high salt intake in salt-resistant saline-infused 
rats but not in norepinephrine-infused rats exhibiting salt-sensitive hypertension. 
These changes parallel the impairments in dietary sodium-evoked suppression of 
NCC activity, expression, and phosphorylation that likely contribute to salt-
sensitive hypertension in norepinephrine-infused animals, providing evidence for 
a novel role of WNK1 in norepinephrine-mediated NCC regulation in this particular 
animal model of salt sensitivity.  
Importantly, phosphorylation of OxSR1 – which occurs downstream of 
WNK1 and reflects activation of OxSR1 (Moriguchi et al., 2005), leading to NCC 
phosphorylation and activation (Richardson et al., 2008) – is suppressed during 
high salt intake in saline-infused rats but increases during high salt intake in 
norepinephrine-infused animals. While previous studies have suggested a critical 




finding is consistent with a previous in vivo study in which kidney-specific deletion 
of OxSR1 severely attenuated acute norepinephrine-evoked NCC phosphorylation 
assessed after 30 minutes of norepinephrine stimulation (Terker et al., 2014). Our 
in vivo assessment of physiological NCC activity builds upon this previous study, 
which relied upon NCC phosphorylation as an established marker of NCC activity.  
The activity of the NCC can be enhanced via phosphorylation at a number 
of key residues. In the current studies, we observed an increase in phosphorylation 
at Thr58, which can occur downstream of OxSR1 and SPAK (Moriguchi et al., 
2005; Vitari et al., 2005; Richardson et al., 2008)  and both stabilizes the NCC in 
the plasma membrane and increases its intrinsic activity (Yang et al., 2013). 
Previous studies have demonstrated that mutations that prevent phosphorylation 
at Thr58, which corresponds to Thr60 in the human NCC protein, also prevent 
phosphorylation at other residues and significantly reduce NCC activity 
(Richardson et al., 2008; Glover et al., 2009). This evidence suggests that the 
observed increase in Thr58 phosphorylation contributes significantly to the 
increase in NCC activity in the current studies. However, the potential role of 
phosphorylation at other residues relevant to NCC activation, and the role of other 
posttranslational modifications including ubiquitylation, which reduces NCC activity 
(Arroyo et al., 2011) and may be prevented by OxSR1- and SPAK-mediated NCC 
phosphorylation (Hossain Khan et al., 2012), requires further studies beyond the 
scope of this investigation. While the mechanisms governing the observed 




demonstrated that both SPAK and OxSR1 can modulate NCC protein expression 
(McCormick et al., 2011; Ferdaus et al., 2016).  
To investigate the differential roles of α1- and β-adrenoceptors in 
norepinephrine-evoked salt-sensitive hypertension, we assessed the impact of 
chronic adrenoceptor antagonism on blood pressure, NCC activity, and the WNK1 
signaling cascade observed in norepinephrine-infused rats. Antagonism of α1- or 
β-adrenoceptors had no impact on blood pressure or NCC activity in saline-infused 
rats regardless of dietary sodium intake, suggesting that blood pressure and NCC 
activity are determined by other physiological factors under basal normotensive 
conditions. Interestingly, total OxSR1 expression was increased in norepinephrine-
infused rats during normal salt intake, raising the possibility that the established 
impact of OxSR1 on other sodium transporters not studied in the present work, 
such as NKCC2 (Moriguchi et al., 2005), could contribute to increased blood 
pressure in these animals.  
In norepinephrine-infused animals placed on a high salt diet, the 
development of the salt-sensitive component of hypertension was abolished by α1 
blockade, which may reflect the restoration of dietary sodium-evoked suppression 
of NCC activity, expression, and phosphorylation. In contrast, antagonism of β-
adrenoceptors attenuated norepinephrine-evoked hypertension independently of 
dietary sodium intake but failed to restore dietary sodium-evoked suppression of 
NCC activity, expression, and phosphorylation. These data suggest a potential 




evoked NCC dysregulation and salt-sensitive hypertension that conflicts 
somewhat with previous studies. In a study of norepinephrine-infused C57Bl/6J 
mice, antagonism of β-adrenoceptors, but not α1-adrenoceptors, attenuated 
norepinephrine-induced downregulation of WNK4 mRNA and upregulation of NCC 
protein expression (Mu et al., 2011). The reasons for the discrepancies between 
these observations, which have not been replicated (Uchida et al., 2012; Terker et 
al., 2014), and our own, which suggest a selective role for α1-adrenoceptors, are 
unclear but may include species differences. Supporting this reasoning, the same 
study also reported that norepinephrine infusion evoked an increase in NCC 
expression and phosphorylation during normal salt intake in mice, which we did 
not observe in Sprague Dawley rats in our current and previously published studies 
(Mu et al., 2011; Walsh et al., 2016). Interestingly, our observation of a role for α1-
adrenoceptor signaling is supported to a degree by a subsequent study in 
C57Bl/6J mice, which failed to replicate a role of WNK4 in norepinephrine-evoked 
upregulation of NCC protein expression during high salt intake but confirmed a role 
of β-adrenoceptors and provided evidence that α1-adrenoceptors play a 
synergistic, albeit minor, part in acute NCC regulation (Terker et al., 2014).  
Further supporting our in vivo observation of a role for α1-adrenoceptor 
signaling, α1D-adrenoceptor mRNA expression was increased by norepinephrine 
infusion and remained elevated in norepinephrine-infused rats during high salt 
intake. Although the role of the α1D-adrenoceptor in the kidney is incompletely 




knockout mice (Tanoue et al., 2002) and it is possible that increased signaling via 
α1D-adrenoceptors contributes to salt sensitivity in our model. Interestingly, mRNA 
expression of α2B1- and α2B2-adrenoceptors is suppressed during high salt intake 
in saline-infused rats but not in norepinephrine-infused rats. Although the role of 
α2B-receptor signaling in renal sodium handling is also poorly understood, a role 
for dietary sodium-evoked suppression of renal α2-adrenoceptor signaling in the 
sympathoinhibitory reno-renal reflex that promotes sodium homeostasis in salt-
resistant models has been proposed (Kopp et al., 2011b). It is therefore possible 
that the failure to suppress α2B1- and α2B2-adrenoceptor mRNA during high salt 
intake in norepinephrine-infused animals is functionally relevant. Similarly to α2-
adrenoceptors, β2-adrenoceptor mRNA expression is reduced during high salt 
intake in saline-infused rats; however, β2-adrenoceptor mRNA expression is 
reduced to a similar degree in norepinephrine-infused rats irrespective of sodium 
intake, supporting a specific role for α-adrenoceptor signaling in our model of salt 
sensitivity.  
The important role of α1-adrenoceptor signaling supported by our current 
studies may reflect species differences but may also reflect differences in 
experimental paradigm, as the minor role of α1-adrenoceptors in mice was only 
assessed as the change in NCC phosphorylation following 30 minutes of α1- and/or 
β-adrenoceptor stimulation (Terker et al., 2014). In comparison, the current studies 
evaluated NCC activity, mRNA and protein expression, and phosphorylation 




both normal and high salt intake, and selective adrenoceptor blockade was 
validated in all animals as the loss of cardiovascular response to the respective 
adrenoceptor agonist. It is possible that the selective role of α1-adrenoceptor 
signaling is relevant in the longer term, while β-adrenoceptors play a more 
important role in the short term, although the role of β-adrenoceptors was initially 
proposed in a chronic study (Mu et al., 2011). A long-term regulatory role of α1-
adrenoceptors is supported by our observation that α1-antagonism initiated 
following 3 weeks of high salt intake in norepinephrine-infused rats, a timepoint at 
which salt-sensitive hypertension is already established, attenuates the salt-
sensitive component of hypertension and restores suppression of NCC activity. 
Importantly, while chronic norepinephrine infusion evokes salt-sensitive 
hypertension in mice, blood pressure is only mildly elevated by chronic 
norepinephrine infusion during normal salt intake (Terker et al., 2014). The acute 
adrenoceptor stimulation studies were performed in mice on a normal salt diet and 
blood pressure was not measured (Terker et al., 2014), raising the possibility that 
a role for α1-adrenoceptors in NCC regulation exists in mice but is limited to the 
context of salt-sensitive hypertension, as observed in the current studies. It is also 
worth considering the contrasting approaches of isolated adrenoceptor stimulation 
using pharmacological agonists versus adrenoceptor antagonism during 
norepinephrine infusion, which may better reflect the balance of α- /β-adrenoceptor 




observed during high salt intake in salt sensitive individuals (Campese et al., 1982; 
Gill et al., 1988). 
While these discrepancies between species and potential acute versus 
chronic NCC regulation require further clarification, our observation of a selective 
role of α1-antagonism, which abolishes salt sensitivity and restores dietary sodium-
evoked suppression of NCC activity, expression, and phosphorylation, is 
supported by our finding that antagonism of α1-adrenoceptors, but not β-
adrenoceptors, restores dietary sodium-evoked suppression of WNK1 and 
phosphorylated OxSR1 and reduces OxSR1 expression in norepinephrine-infused 
rats regardless of dietary sodium intake. Interestingly, β-adrenoceptor antagonism 
does restore dietary sodium-evoked suppression of SPAK in norepinephrine-
infused animals. Although this is not associated with restoration of appropriate 
NCC regulation, suggesting a specific role for an α1-adrenoceptor-OxSR1 
signaling cascade in NCC regulation, β-antagonism does abolish the salt-sensitive 
component of hypertension. It is possible that future studies of simultaneous α1- 
and β-adrenoceptor antagonism could reveal a synergistic role of the two receptors 
as previously reported (Terker et al., 2014). Further studies are also required to 
determine the mechanism by which β-adrenoceptor signaling contributes to salt 
sensitivity in the absence of altered NCC regulation, which may be mediated by 
SPAK. 
The interpretation of our studies is limited in part by the systemic 




of adrenoceptors outside of the kidney, including those in the vasculature and the 
heart. Future studies involving renal infusion of norepinephrine and kidney-specific 
lentiviral knockdown of NCC regulatory kinases would be particularly enlightening. 
It is also important to note that plasma norepinephrine levels observed in a 
previous study using norepinephrine in Sprague Dawley rats (Walsh et al., 2016) 
reached levels higher than those generally observed in human subjects (Campese 
et al., 1982; Gill et al., 1988). However, the authors noted that plasma 
norepinephrine content in norepinephrine-infused Spague Dawley rats was similar 
to that observed in Dahl Salt Sensitive rats (Walsh et al., 2016) and reasonably 
reflects the failure of dietary sodium-evoked sympathoinhibition that characterizes 
salt sensitivity in human subjects (Campese et al., 1982; Gill et al., 1988). This 
model may also be particularly relevant to the context of human aging, which is 
characterized by lifelong exposure to excessive dietary sodium intake (Powles et 
al., 2013), increased sympathetic tone (Esler et al., 1995), and a dramatic increase 
in the prevalence of hypertension (Muntner et al., 2018) as well as salt sensitivity 
(Luft et al., 1991). Given the apparent species specificity of our findings, further 
studies in other animal models of salt sensitivity could yield important information. 
In models including the Dahl Salt Sensitive rat, in which the development of salt 
sensitivity does not require exogenous norepinephrine, the specific role of renal 
norepinephrine could be elucidated using renal denervation.  
Together, our findings suggest that norepinephrine drives the development 




adrenoceptor gated, WNK1-SPAK/OxSR1 signaling pathway that promotes NCC 
activity. Further, we have demonstrated that targeting this pathway prevents the 
development of salt-sensitive hypertension and, critically, abolishes salt sensitivity 
in established hypertension, which more reasonably reflects the stage at which 
human hypertension is diagnosed and treated. The novel role of WNK1 suggested 
by our findings is especially important given the recent development of selective 
small-molecule WNK inhibitors that improve blood pressure in rodent models in 
which human WNKs are overexpressed (Yamada et al., 2017). Overall, our studies 
provide important insight into the adrenergic signaling cascade that promotes 
NCC-mediated sodium retention, which represents a group of mechanistically 







CHAPTER FOUR: Role of the Afferent Renal Nerves in Sodium 
Homeostasis and Blood Pressure Regulation in Rats 
 
Abstract 
The afferent renal nerves influence natriuresis, sympathetic outflow, and 
blood pressure. However, the differential roles of the mechanosensitive and 
chemosensitive afferent renal nerves in the homeostatic responses to sodium 
challenges are incompletely understood. In this study, selective capsaicin-
mediated afferent renal nerve ablation was used to establish the roles of the 
afferent renal nerves in the natriuretic, sympathoinhibitory, and blood pressure 
responses to 1) an acute isotonic volume expansion versus hypertonic saline 
infusion in Sprague Dawley rats and 2) chronic high salt intake in Sprague Dawley, 
Dahl Salt Resistant, and Dahl Salt Sensitive rats. Afferent renal nerve 
responsiveness during high salt intake was assessed via 1) in vivo manipulation 
of renal pelvic pressure and sodium concentration, and 2) ex vivo norepinephrine- 
and sodium-evoked renal pelvic substance P release. We demonstrate that the 
afferent renal nerves are required for maximal natriuretic and sympathoinhibitory 
responses to an acute volume expansion that increases renal pelvic pressure, but 
not a hypertonic saline infusion that does not alter renal pelvic pressure, in 
Sprague Dawley rats. In vivo afferent renal nerve responsiveness to elevated renal 
pelvic pressure (mechanoreceptor stimulus) and ex vivo responsiveness to 
norepinephrine increased during high salt intake in Sprague Dawley, but not Dahl 




increased renal pelvic sodium concentration (chemoreceptor stimulus) was 
unaltered during high salt intake. Afferent renal nerve ablation evoked 
sympathetically-mediated salt-sensitive hypertension in Sprague Dawley and Dahl 
Salt Resistant rats and exacerbated Dahl Salt Sensitive rat hypertension. Together 
these findings indicate that the mechanosensitive afferent renal nerves contribute 
to the responses to acute and chronic challenges to sodium homeostasis.  
 
Introduction 
The sensory afferent renal nerves, comprised of mechanosensitive and 
chemosensitive fibers originating primarily from the renal pelvic wall, contribute to 
sympathoinhibitory and sympathoexcitatory reno-renal reflexes that modulate 
efferent renal sympathetic nerve activity, natriuresis, and blood pressure (Johns, 
2014; Kopp, 2015). The sympathoinhibitory reno-renal reflex, likely driven by 
mechanosensitive afferent renal nerve fibers, has been implicated in the tonic 
regulation of renal sympathetic nerve activity in healthy, normotensive animal 
models (Kopp, 1993; Chien et al., 2000; Ma et al., 2002a; Johns & Abdulla, 2013; 
Johns, 2014; Kopp, 2015). In this reflex, activation of the afferent renal nerves 
results in the suppression of efferent renal sympathetic nerve activity, promoting a 
natriuretic response facilitating sodium homeostasis and normotension (Kopp, 
1993; Johns & Abdulla, 2013; Johns, 2014; Kopp, 2015). In contrast, the 
sympathoexcitatory reno-renal reflex, which increases renal sympathetic outflow 




fibers that are activated in animal models of disease states, including heart failure 
and renal failure (Kopp, 1993; Johns & Abdulla, 2013; Johns, 2014; Barry & Johns, 
2015; Kopp, 2015). 
Salt sensitivity of blood pressure is characterized by an exaggerated 
pressor response to dietary sodium intake that independently predicts 
hypertension risk (Franco & Oparil, 2006; Appel et al., 2011). In salt-resistant 
individuals, dietary sodium evokes a sympathoinhibitory response that facilitates 
natriuresis and normotension (Lohmeier et al., 1999; Johns, 2014). In contrast, in 
most salt-sensitive individuals, sympathoexcitation promotes sodium retention and 
hypertension in response to dietary sodium intake (Brooks et al., 2005; Stocker et 
al., 2013). It was recently postulated that neurohumoral control of renal excretory 
function is the first line of defense against dietary sodium intake in the 
pathogenesis of hypertension (Evans & Bie, 2016); however, the role of the 
afferent renal nerves in this process is unknown. A potential role for afferent renal 
nerve regulation of natriuresis and blood pressure is suggested by increased 
afferent renal nerve activity during high dietary sodium intake in the salt-resistant 
Sprague Dawley rat (Kopp et al., 2006; Kopp et al., 2009; Kopp et al., 2011b). The 
removal of all sensory afferent inputs from multiple end organs, including the 
afferent renal nerves, innervating multiple levels of the spinal cord, surgically via 
dorsal rhizotomy or pharmacologically by subcutaneous capsaicin evokes salt-
sensitive hypertension in Sprague Dawley rats (Wang et al., 1998; Wang et al., 




renal nerves, a non-specific stimulus that does not preferentially target 
mechanosensitive or chemosensitive afferent renal nerve terminals, activates 
hypothalamic paraventricular nucleus (PVN) parvocellular neurons and increases 
blood pressure (Solano-Flores et al., 1997; Xu et al., 2015). These data, likely 
reflecting activation of the sympathoexcitatory reno-renal reflex, raise the 
possibility that the PVN could also integrate the afferent and efferent arms of the 
afferent renal nerve-mediated sympathoinhibitory reno-renal reflex. 
In the current study, we hypothesized that the afferent renal nerves 
contribute to the sympathoinhibitory reno-renal reflex that maintains sodium 
homeostasis and normotension during acute and chronic challenges to fluid and 
electrolyte homeostasis. To address this hypothesis, we used in vivo and ex vivo 
preparations to test the impact of dietary salt intake on afferent renal nerve 
reflexes. Selective afferent renal nerve ablation was used to investigate the role of 
the afferent renal nerves in the sympathoinhibitory, natriuretic, and blood pressure 
responses to 1) acute sodium challenges designed to differentially activate the 
mechanosensitive and chemosensitive afferent renal nerves and 2) a chronic high 
sodium diet in salt-resistant and salt-sensitive rat models.    
 
Methods 
All methods used in the studies of afferent renal nerve function in young 
adult animals in this chapter are briefly outlined in this section and described in 




Dahl Salt Resistant rats were used as established models of salt resistance and 
Dahl Salt Sensitive rats were used as a model of salt sensitivity. 
                To test the role of the afferent renal nerves in the mechanosensitive and 
chemosensitive reno-renal reflexes in vivo, the cardiovascular, renal, and PVN 
neuronal responses to acute volume expansion and 1M NaCl infusion were 
assessed 10 days after selective afferent renal nerve ablation or a sham surgical 
procedure in conscious Sprague Dawley rats (Figure 4.1A). Glomerular filtration 
rate during volume expansion and 1M NaCl infusion was assessed in a subset of 
these animals (studies conducted during protocols shown in Figure 4.1A). In 
separate sets of anesthetized Sprague Dawley rats, renal pelvic pressure was 
measured during volume expansion and 1M NaCl infusion to validate volume 
expansion as a putative mechanoreceptor stimulus and 1M NaCl infusion as a 
selective chemoreceptor stimulus (Figure 4.1B). 
                To assess afferent renal nerve function in isolation, norepinephrine- and 
sodium-evoked substance P release was determined using an ex vivo renal pelvis 
assay in Sprague Dawley, Dahl Salt Resistant, and Dahl Salt Sensitive rats after 
a 21-day normal or high salt diet (Figure 4.1C). These studies were validated and 
extended in vivo via the direct manipulation of renal pelvic pressure and renal 
pelvic sodium concentration in anesthetized Sprague Dawley and Dahl Salt 
Sensitive rats following 21 days of normal or high salt intake (Figure 4.1D). 
                To investigate the contribution of the afferent renal nerves to sodium 




studies were conducted in Sprague Dawley, Dahl Salt Resistant, and Dahl Salt 
Sensitive rats that underwent selective afferent renal nerve ablation or a sham 
surgical protocol prior to a 21-day experimental normal salt diet (Sprague Dawley 
only) or high salt diet (all strains) (Figure 4.1E&F). The role of the afferent renal 
nerves in the regulation of sympathetic outflow (all strains) and the renin 
angiotensin aldosterone system (Sprague Dawley only) was assessed using 
tissues collected during these studies. 
 
Figure 4.1. Overview of methods used in Chapter 4. All studies were performed 
using 3 month old male Sprague Dawley, Dahl Salt Resistant, and Dahl Salt 
Sensitive rats. White = dietary sodium assignments; green = surgical procedures; 
orange = in vivo studies in conscious animals; yellow = in vivo studies in 
anesthetized animals; grey = ex vivo studies; blue = analytical techniques. n = 






The afferent renal nerves modulate the cardiovascular, renal, and parvocellular 
PVN neuronal responses to an acute volume expansion 
Conscious sham afferent renal denervated (ADNX) Sprague Dawley rats, 
in which surgery was performed but application of capsaicin was omitted to leave 
the afferent renal nerves intact, exhibited robust natriuretic and diuretic responses 
with a transient increase in free water clearance and no change in blood pressure, 
heart rate or renal hemodynamics (glomerular filtration rate and renal blood flow) 
during an acute volume expansion (Figures 4.2A&4.3A). This challenge evokes an 
increase in renal pelvic pressure in anesthetized naïve Sprague Dawley rats with 
intact afferent renal nerves (Figure 4.3B). Further, in sham ADNX rats an acute 
volume expansion resulted in increased Fos staining in all PVN parvocellular and 
magnocellular subnuclei (Figure 4.2B&C).  
Selective ablation of the afferent renal nerves did not alter baseline 
cardiovascular or renal excretory parameters and had no impact on the baseline 
Fos staining in any region of the PVN (Figure 4.2A-C). In ADNX rats, the natriuretic, 
but not diuretic or renal hemodynamic response, to an acute volume expansion 
was significantly blunted and blood pressure was increased (Figure 4.2A). 
Similarly, volume expansion-evoked Fos staining of all PVN parvocellular neurons 
was attenuated in ADNX rats, while Fos activation in magnocellular PVN neurons 
remained intact (Figure 4.2B&C). The efficacy and selectivity of afferent renal 




artery bradykinin infusion, and b) the selective elimination of renal pelvic calcitonin 
gene-related peptide content, but not renal norepinephrine content (Figure 4.4).  
Figure 4.2. Effect of selective afferent renal nerve ablation on the 
cardiovascular, renal, and PVN neuronal responses to an acute volume 
expansion. (A) Cardiovascular and renal responses to a 30-minute 5% body 
weight isotonic saline volume expansion (VE) followed by a 90-minute recovery 
period in conscious male Sprague Dawley (SD) rats 10 days after a selective 
afferent renal nerve ablation (ADNX) or sham ADNX procedure, (B) neuronal 
activation (c-fos-positive cell count) in the lateral parvocellular, ventrolateral 
parvocellular, magnocellular, medial parvocellular, and dorsal parvocellular 
regions of the paraventricular nucleus (PVN) of the hypothalamus following VE 
or a 2-h surgical recovery and control period (baseline group) in conscious male 
SD rats 10 days after a sham or ADNX procedure and (C) representative images 
from level 2 of the PVN. HR = heart rate (bpm), MAP = mean arterial pressure 
(mmHg), V = urinary flow rate (µL/min), CH2O = free water clearance (ml/min), 
UNaV = urinary sodium excretion (µeq/min). n = 6/group. *P < 0.05 vs. group 





Figure 4.3. Impact of an acute 
volume expansion on renal 
hemodynamics and renal pelvic 
pressure. (A) Glomerular filtration 
rate [GFR; ml/min/100g body 
weight (BW)] and renal blood flow 
[RBF; ml/min/100g body weight 
(BW)] in the same conscious 3-
month old male Sprague Dawley 
rats presented in Figure 4.2 that 
underwent sham afferent renal 
nerve ablation (sham ADNX) or 
ADNX 10 days prior to an acute 
volume expansion protocol 
consisting of a control period 
(denoted C), a 30 minute 5% 
isotonic saline volume expansion 
(VE), and a 90 minute recovery 
period, and (B) renal pelvic 
pressure [mmHg] in a separate 
group of intact male Sprague 
Dawley rats that remained 
anesthetized throughout the VE 
protocol. n = 6/group. *P < 0.05 
versus group control value, 
denoted C. 
 
Figure 4.4. Validation of selective afferent renal denervation following acute 
sodium challenge. (A) Renal norepinephrine content [NE; pg/mg], (B) renal pelvic 
calcitonin gene related peptide content [CGRP; pg/mg] and (C) peak change in 
mean arterial pressure [MAP; mmHg] in response to 40g/kg/min intrarenal 
bradykinin infusion in subsets of 3-month old male Sprague Dawley rats that 
underwent acute volume expansion or 1M NaCl infusion 10 days after sham 
afferent renal nerve ablation (sham ADNX) or ADNX. n = 6/group. *P < 0.05 versus 




The afferent renal nerves are not required for the cardiovascular, renal, and PVN 
neuronal responses to an acute 1M NaCl infusion 
In conscious sham ADNX Sprague Dawley rats, acute 1M NaCl infusion 
evoked a natriuretic response in the absence of diuresis, with a corresponding 
reduction in free water clearance, and had no impact on blood pressure, heart rate, 
glomerular filtration rate or renal blood flow (Figures 4.5A&4.6A). Further, an acute 
1M NaCl infusion did not alter renal pelvic pressure in naïve intact anesthetized 
rats (Figure 4.6B). Fos staining was increased in all parvocellular and 
magnocellular PVN regions of sham ADNX rats following infusions of 1M NaCl 
(Figure 4.5B&C). Ablation of the afferent renal nerves did not alter cardiovascular, 
renal excretory or renal hemodynamic responses or PVN Fos staining during a 1M 






Figure 4.5. Effect of selective afferent renal nerve ablation on the 
cardiovascular, renal, and PVN neuronal responses to an acute 1M NaCl 
infusion. (A) Cardiovascular and renal responses to a 2-hour 1M NaCl infusion in 
conscious 3-month old male Sprague Dawley (SD) rats 10 days after a sham 
afferent renal nerve ablation (sham ADNX) or ADNX procedure, (B) neuronal 
activation (c-fos-positive cell count) in the lateral parvocellular, ventrolateral 
parvocellular, magnocellular, medial parvocellular, and dorsal parvocellular 
regions of the paraventricular nucleus (PVN) of the hypothalamus following a 2-h 
NaCl infusion or a 2-h surgical recovery and control period (baseline group) in 
conscious male SD rats 10 days after a sham ADNX or ADNX procedure and (C) 
representative images from level 2 of the PVN. HR = heart rate (bpm), MAP = 
mean arterial pressure (mmHg), V = urinary flow rate (µL/min), CH2O = free water 
clearance (ml/min), UNaV = urinary sodium excretion (µeq/min). n = 6/group. *P < 




High salt intake increases afferent renal nerve responsiveness in salt-resistant 
but not salt-sensitive rat models 
Ex vivo afferent renal nerve release of substance P in response to 
norepinephrine stimulation was comparable among Sprague Dawley, Dahl Salt 
Resistant, and Dahl Salt Sensitive rats on a normal salt diet (Figure 4.7A). A 21-
day high salt diet enhanced ex vivo norepinephrine-evoked substance P release 
in salt-resistant Sprague Dawley and Dahl Salt Resistant rats, a response that was 
absent in Dahl Salt Sensitive rats (Figure 4.7A). In vivo, Sprague Dawley rats on 
a normal salt diet exhibit a natriuretic response to increased renal pelvic pressure 
(direct mechanoreceptor stimulus), and a 21-day high salt diet dramatically 
enhanced the natriuretic response to graded increases in renal pelvic pressure in 
Figure 4.6. Impact of an acute 1M 
NaCl infusion on renal 
hemodynamics and renal pelvic 
pressure. (A) Glomerular filtration rate 
[GFR; ml/min/100g body weight (BW)] 
and renal blood flow [RBF; ml/min/100g 
body weight (BW)] in the same 
conscious male Sprague Dawley (SD) 
rats presented in Figure 4.5 that 
underwent sham afferent renal nerve 
ablation (sham ADNX) or ADNX 10 days 
prior to an acute 1M NaCl infusion 
protocol consisting of a 1-hour control 
period and a 2-hour 1M NaCl infusion 
(20µL/min), and (B) renal pelvic 
pressure [mmHg] in a separate group of 
intact male SD rats that remained 
anesthetized throughout the 1M NaCl 
infusion protocol. n = 6/group. *P<0.05 





Sprague Dawley rats (Figure 4.7B-C). In contrast, increased renal pelvic pressure 
did not alter natriuresis in Dahl Salt Sensitive rats fed a normal salt diet and a 
dietary sodium-induced increase in natriuresis was only observed at the upper limit 
of the physiological range of increased renal pelvic pressure (Figure 4.7B-C).  
Ex vivo afferent renal nerve release of substance P in response to 450mM 
NaCl, a chemoreceptor stimulus, was similar in Sprague Dawley, Dahl Salt 
Resistant, and Dahl Salt Sensitive rats on a normal salt diet and the response was 
unaffected by a 21 day high salt diet (Figure 4.7D). Further, manipulation of renal 
pelvic sodium concentration did not alter natriuresis in Sprague Dawley or Dahl 











Figure 4.7. Effect of high salt intake on afferent renal nerve responsiveness. 
(A) Ex vivo renal pelvis substance P release (pg/min) in response to 1250 pM 
norepinephrine (NE) on day 21 of a normal salt (NS; 0.6% NaCl) or high salt (HS; 
4% NaCl) diet in 3-month old male Sprague Dawley (SD), Dahl Salt Resistant 
(DSR), and Dahl Salt Sensitive (DSS) rats and urinary sodium excretion (UNaV) 
in response to graded increases in renal pelvic pressure in male (B) SD and (C) 
DSS rats following a 21-day NS or HS diet, (D) ex vivo renal pelvis substance P 
release in response to 450mM NaCl on day 21 of a NS or HS diet in male SD, 
DSR, and DSS rats and urinary sodium excretion in response to increased renal 
pelvic sodium concentration in male (E) SD and (F) DSS rats. n = 6/group. *P < 




The afferent renal nerves are required for Sprague Dawley and Dahl Salt 
Resistant rats to maintain a salt-resistant phenotype 
In Sprague Dawley rats fed a normal salt diet, sham ADNX and ADNX did 
not impact blood pressure, urine volume, or sodium balance (Figure 4.8A-C). 
Similarly, markers of renal and global sympathetic tone and renin-angiotensin 
system activity were similar in sham ADNX and ADNX Sprague Dawley rats on 
day 21 of normal salt intake (Figure 4.8D-G). A 21-day high salt diet did not alter 
blood pressure in sham ADNX Sprague Dawley and Dahl Salt Resistant rats, 
which possess intact afferent renal nerves (Figures 4.8A&4.9A). In contrast, 
Sprague Dawley and Dahl Salt Resistant rats that underwent ADNX to remove the 
influence of the afferent renal nerves immediately prior to high salt intake exhibited 
an increase in blood pressure during the first three days of high salt intake that 
was maintained for the remainder of the 21-day experimental period (Figures 
4.8A&4.9A). These high salt-fed Sprague Dawley and Dahl Salt Resistant rats 
exhibited an increase in urine volume that was similar among sham and ADNX 
treatment groups (Figures 4.8B&4.9B). Further, high salt intake transiently 
increased daily sodium balance in sham ADNX Sprague Dawley and Dahl Salt 
Resistant rats, while this increase was significantly exacerbated in ADNX Sprague 
Dawley rats (Figures 4.8C&4.9C). The 21-day high salt diet evoked a reduction in 
plasma and renal norepinephrine content in sham ADNX Sprague Dawley rats and 
this reduction was abolished following ADNX (Figure 4.8D&E). In contrast, both 




evoked reductions in plasma renin activity and urinary angiotensinogen (Fig 
4.8F&G). Plasma and renal norepinephrine content were increased on day 21 of 
high salt intake in ADNX Dahl Salt Resistant rats compared to sham ADNX (Figure 
4.9D&E). The efficacy of the ADNX procedure was confirmed in subgroups of rats 
via the absence of a pressor response to intrarenal bradykinin infusion and a 













Figure 4.8. Effect of selective afferent renal nerve ablation on the 
cardiovascular, renal, and sympathetic responses to high salt intake in 
Sprague Dawley rats. Daily (A) mean arterial pressure (MAP; mmHg), (B) 24-
hour urine volume (mL), and (C) 24-hour sodium balance (meq) in male Sprague 
Dawley rats that underwent sham afferent renal nerve ablation (sham ADNX) or 
ADNX immediately prior to a 21-day experimental normal salt (NS; 0.6% NaCl) or 
high salt (HS; 4% NaCl) diet and (D) renal norepinephrine (NE) content (pg/mg), 
(E) plasma NE concentration (nmol/L), (F) plasma renin activity (PRA; angiotensin 
I [ang I] generation, ng/ml/h) and (G) urinary angiotensinogen (UAGT; ng/mL) on 
day 21 of NS or HS intake. n = 6/group. *P < 0.05 vs. baseline (NS intake); τP < 







Figure 4.9. Effect of selective afferent renal nerve ablation on the 
cardiovascular, renal, and sympathetic responses to high salt intake in Dahl 
Salt Resistant rats. Daily (A) mean arterial pressure (MAP; mmHg), (B) 24-hour 
urine volume (mL), and (C) 24-hour sodium balance (meq) in 3-month old male 
Dahl Salt Resistant rats that underwent sham afferent renal nerve ablation (sham 
ADNX) or ADNX immediately prior to a 21-day experimental high salt diet (HS; 4% 
NaCl) and (D) renal norepinephrine (NE) content (pg/mg) and (E) plasma NE 
concentration (nmol/L) on day 21 of HS intake. n = 6/group. *P < 0.05 vs. baseline 




The afferent renal nerves attenuate the development of Dahl Salt Sensitive 
hypertension 
Sham ADNX Dahl Salt Sensitive rats placed on a high salt diet exhibited a 
significant increase in blood pressure by day 7 of high salt intake (Figure 4.11A). 
Afferent renal nerve ablation immediately prior to high salt intake exacerbated the 
increase in blood pressure (Figure 4.11A). Sham and ADNX Dahl Salt Sensitive 
rats exhibited similar increases in urine output during high salt intake (Figure 
Figure 4.10. Validation of selective afferent renal nerve ablation following 
chronic dietary sodium intake studies. (A) Change in blood pressure (mmHg) 
in response to intrarenal bradykinin infusion in 3-month old male Sprague Dawley 
(SD) (n = 5/group) and Dahl Salt Resistant (DSR) rats (n = 3/group) and renal  
calcitonin gene-related peptide (CGRP) content (pg/mg) in SD (n = 6/group), DSR 
(n = 6/group), and Dahl Salt Sensitive (DSS) rats (n = 12/group) maintained on a 
normal salt (NS; 0.6% NaCl) or high salt diet (HS; 4% NaCl) following sham surgery 






4.11B), with an increase in 24-hour sodium balance that was exacerbated in ADNX 
rats (Figure 4.11C). Consistent with increased sympathetic tone, plasma and renal 
norepinephrine content was increased in ADNX versus sham ADNX Dahl Salt 
Sensitive rats (Figure 4.11D&E). In contrast to the impact of ADNX conducted prior 
to high salt intake, ADNX performed after 16 days of high salt intake had no impact 
on the progression of Dahl Salt Sensitive hypertension (Figure 4.12A). Afferent 
renal nerve ablation was confirmed via a reduction of renal pelvic calcitonin gene-








Figure 4.11. Effect of selective afferent renal nerve ablation on the 
cardiovascular, renal, and sympathetic responses to high salt intake in Dahl 
Salt Sensitive rats. Daily (A) mean arterial pressure (MAP; mmHg), (B) 24-hour 
urine volume (mL), and (C) 24-hour sodium balance (meq) in 3-month old male 
Dahl Salt Sensitive rats that underwent sham afferent renal nerve ablation (sham 
ADNX) or ADNX immediately prior to a 21-day experimental high salt (HS; 4% 
NaCl) diet and (D) renal norepinephrine (NE) content (pg/mg), and (E) plasma NE 
concentration (nmol/L) on day 21 of HS intake. N = 6/group. *P < 0.05 vs. baseline 




Figure 4.12. Effect of selective afferent renal nerve ablation on established 
Dahl Salt Sensitive hypertension. Daily (A) mean arterial pressure (MAP; 
mmHg) in 3-month old male Dahl Salt Sensitive rats that underwent sham afferent 
renal nerve ablation (sham ADNX) or ADNX after 16 days of high salt (4% NaCl) 
intake and (B) renal calcitonin gene-related peptide (CGRP) content (pg/mg) 
assessed on day 40. *P < 0.05 vs. baseline (normal salt intake; 0.6% NaCl), τP < 
0.05 vs. sham ADNX. 
 
Discussion 
The current studies were designed to determine the role of the sensory 
afferent renal nerves in the regulation of renal sodium excretion and blood 
pressure during acute and chronic challenges to sodium homeostasis. Previous 
studies have identified a sympathoinhibitory reno-renal reflex mediated by the 
mechanosensitive afferent renal nerves that results in the suppression of efferent 
renal sympathetic outflow, natriuresis, and normotension (Kopp, 1993; Johns & 
Abdulla, 2013; Johns, 2014; Kopp, 2015). Further, non-selective global sensory 
afferent denervation evokes salt-sensitive hypertension in normally salt-resistant 
Sprague Dawley rats (Wang et al., 1998; Wang et al., 2001; Kopp et al., 2003). 
The current results extend these observations in three ways. First, they suggest a 




sympathoinhibitory natriuretic reno-renal reflex. Second, the results suggest that 
the PVN, previously implicated in the sympathoexcitatory reno-renal reflex (Xu et 
al., 2015), contributes to the sympathoinhibitory reno-renal reflex. Finally, our data 
extend previous studies that used non-selective global afferent denervation 
techniques that eliminate all sensory afferent inputs, including systemic capsaicin 
and dorsal rhizotomy, by employing selective ADNX to demonstrate that the 
afferent renal nerves are required for the maintenance of sodium balance and 
normotension during high salt intake in two models of salt resistance and attenuate 
dietary sodium-evoked hypertension in a salt-sensitive model.  
Our initial studies into the potential actions and central sites of afferent renal 
nerve signal integration were conducted in conscious normotensive Sprague 
Dawley rats that underwent an acute volume expansion. There were technical 
limitations preventing the determination of renal pelvic pressure in conscious rats. 
We did, however, demonstrate that acute volume expansion increases renal pelvic 
pressure in anesthetized intact Sprague Dawley rats. Further, this same volume 
expansion produced a robust diuretic response in conscious sham Sprague 
Dawley rats. Together these results indicate that the acute volume expansion 
protocol used in the current study activates afferent renal nerve 
mechanoreceptors. This is consistent with previous work demonstrating that 
afferent renal nerve mechanoreceptors that selectively respond to increased renal 
pelvic pressure also respond to intravenous volume expansion (Chien et al., 2000). 




sympathoinhibitory parvocellular PVN neurons (Haselton et al., 1994; Randolph et 
al., 1998; Ng et al., 2004), resulting in the suppression of renal sympathetic outflow 
and a robust natriuretic response (Haselton et al., 1994; Ng et al., 2004). 
Consistent with these studies, in response to an acute volume expansion we 
observed an increase in Fos-positive cell bodies in all parvocellular PVN subnuclei 
and a strong natriuretic response with robust diuresis and increased free water 
clearance in sham ADNX Sprague Dawley rats. The lack of activation of PVN 
neurons in control baseline animals matches that reported by many laboratories, 
including our own prior study conducted in the same acute cardiovascular and 
renal experimental preparation used in these studies (Carmichael et al., 2016). 
Selective afferent renal nerve ablation, validated biochemically and 
functionally, blunted volume expansion-evoked parvocellular, but not 
magnocellular, PVN neuronal activation and natriuresis. In ADNX rats, volume 
expansion evoked a delayed and mild increase in blood pressure. Interestingly, 
there was a time delay between the impaired natriuretic response, which was most 
marked during volume expansion, and the increase in blood pressure, which was 
observed only during the final 40 minutes of the 90-minute recovery period. This 
time delay could reflect the failure of initial mechanisms activated to accommodate 
volume expansion (e.g., vasodilation), but require further study. Overall, these data 
suggest that the mechanosensitive afferent renal nerve-mediated 
sympathoinhibitory reno-renal reflex may be critical to the maintenance of 




immunostaining clearly suggests that ADNX reduces activation of PVN 
sympathoinhibitory neurons, this technique does possess limitations (Dampney & 
Horiuchi, 2003). For example, Fos staining does not always equate to neuron 
activation and additional evidence, including direct recording of both afferent and 
efferent renal nerve traffic, will be needed to confirm these PVN neurons are 
functionally activated and sympathoinhibitory in nature. 
Collectively, these data suggest a specific role for the afferent renal nerves 
in volume expansion-evoked parvocellular PVN Fos induction and subsequent 
natriuresis. While the PVN has been previously implicated as a site of integration 
for the sympathoexcitatory reno-renal reflex (Xu et al., 2015), these findings 
represent the first evidence, to our knowledge, functionally implicating afferent 
renal nerve-mediated PVN neuronal activation in the mechanosensitive 
sympathoinhibitory reno-renal reflex. While our findings in ADNX rats support a 
specific role for the afferent renal nerves, volume expansion is also known to 
stimulate non-renal sensory afferent signaling pathways, including those mediated 
by atrial stretch, to activate parvocellular PVN neurons (Pyner et al., 2002) and 
suppress renal sympathetic outflow (Karim et al., 1972; Pyner et al., 2002). We 
speculate these non-renal pathways may contribute to the observed residual 
parvocellular PVN neuronal activation observed in some subnuclei following 
volume expansion in ADNX rats.  
Conscious Sprague Dawley rats received a 1M NaCl infusion to assess the 




chemical composition of fluid in the renal pelvis including alterations in sodium 
concentration (Wainford et al., 2013). The 1M NaCl infusion did not alter renal 
pelvic pressure in anesthetized Sprague Dawley rats. In sham ADNX Sprague 
Dawley rats, 1M NaCl infusion evoked robust natriuresis in the absence of diuresis, 
resulting in a profound reduction in free water clearance that reflects a highly 
concentrated urine product without a change in volume that could activate 
mechanoreceptors. Together, combined with our prior study that reported this 
infusion rate does not increase plasma sodium content (Wainford et al., 2013), 
these results indicate that this was a selective chemoreceptor stimulus. In the 
current study, selective removal of the afferent renal nerves does not alter the 
profound natriuresis or PVN parvocellular and magnocellular neuronal activation 
evoked by a 1M NaCl infusion. Our prior study reported that a 1M NaCl infusion 
suppresses central sympathetic outflow (Wainford et al., 2013), raising the 
possibility that the observed activated parvocellular PVN neurons could contribute 
to sympathoinhibition. Supporting our current observation of no role of the afferent 
renal nerves in 1M NaCl-evoked natriuresis is our previous finding that the 
sympathoinhibitory and natriuretic responses to 1M NaCl remain intact following 
bilateral renal denervation (Wainford et al., 2013). Together, these findings 
suggest that mechanisms independent of the sympathoinhibitory reno-renal 
reflexes, potentially involving other sodium/osmosensitive visceral afferents or 
circumventricular organs (Kinsman et al., 2017a; Kinsman et al., 2017b), mediate 




the mechanosensitive sympathoinhibitory afferent renal nerve reno-reflex is a 
specific and rapid critical component of the neurohumoral control of renal excretory 
function proposed to act as the first line defense against salt and water retention 
and salt-sensitive hypertension (Evans & Bie, 2016). 
A limitation of our 1M NaCl and volume expansion studies is that baseline 
blood pressure is mildly elevated compared to that observed in radiotelemetred 
rats. However, these baseline values are in line with previous studies performed 
in conscious animals in our laboratory in these rat models (Wainford & Kapusta, 
2010; Kapusta et al., 2012; Wainford et al., 2013; Wainford et al., 2015; Carmichael 
et al., 2016; Walsh et al., 2016) and baseline pressures are identical between 
sham and ADNX treatment groups, strongly suggesting this mild elevation has not 
adversely impacted the data generated in this study. Additionally, it is not possible 
to selectively inhibit or ablate mechano- versus chemoreceptors to more directly 
assess their differential roles in the responses to acute and chronic challenges, 
and our afferent renal nerve ablation technique eliminates both afferent renal nerve 
subtypes. Given our careful characterization of the effects of a volume expansion 
and 1M NaCl infusion we believe it is plausible to evaluate these as preferentially 
mechano- versus chemosensitive stimuli. 
To extend our in vivo data and more directly assess the afferent renal 
nerves in isolation, an ex vivo renal pelvis assay was used to test the effects of 
high salt intake on the afferent renal nerves in salt-resistant versus salt-sensitive 




in response to norepinephrine (a general afferent renal nerve stimulus that acts at 
α1-adrenoceptors to drive an increase in afferent renal nerve activity) (Kopp et al., 
2007) is enhanced by a 21-day high salt diet in normotensive salt-resistant 
Sprague Dawley and Dahl Salt Resistant rats but not in hypertensive Dahl Salt 
Sensitive rats. This suggests that enhanced afferent renal nerve responsiveness 
during high salt intake may be protective and critical for salt resistance. A high salt 
diet has no impact on afferent renal nerve responsiveness to a direct 
chemoreceptor stimulus (450 mM NaCl – the upper range of urinary sodium 
content) in either salt-resistant or salt-sensitive rats. This suggests that enhanced 
responsiveness to norepinephrine may reflect a selective increase in the 
responsiveness of the mechanosensitive afferent renal nerves during high salt 
intake. Despite the lack of an enhanced response to a high salt diet, our data 
indicate that the afferent renal nerves in Dahl Salt Sensitive rats are fully 
responsive to direct afferent renal nerve stimuli and may be playing a functional 
role during normal salt intake. The results also indicate that a high salt diet 
significantly enhances the natriuretic response to increased renal pelvic pressure, 
which activates the mechanosensitive afferent renal nerves (Ma et al., 2002a; Ma 
et al., 2002b; Kopp et al., 2003), across a full physiological range in Sprague 
Dawley rats, while in Dahl Salt Sensitive rats renal pelvic pressure-evoked 
natriuresis is enhanced only near the upper physiological limit. Consistent with a 
specific role for the mechanosensitive afferent renal nerves in salt resistance, high 




stimulus (increased renal pelvic sodium concentration) (Ma et al., 2002a; Ma et al., 
2002b) in Sprague Dawley or Dahl Salt Sensitive rats. Given the identical 
responses observed in the ex vivo renal pelvis preparation in Sprague Dawley and 
Dahl Salt Resistant rats, we elected to conduct anesthetized in vivo renal pelvic 
studies only in Sprague Dawley and Dahl Salt Sensitive rats. Our in vivo findings, 
in concert with our ex vivo data, suggests that the mechanosensitive 
sympathoinhibitory afferent renal nerve-mediated reno-renal reflex is selectively 
enhanced during high salt intake in salt-resistant rats and may play a protective 
role to maintain sodium balance and normotension.  
Given our observation of an alteration in afferent renal nerve 
responsiveness during high salt intake, we extended our studies to delineate the 
impact of the afferent renal nerves on blood pressure, sodium balance, and 
sympathoinhibition during chronic dietary sodium loading, we performed ADNX 
immediately prior to high salt intake. In salt-resistant Sprague Dawley and Dahl 
Salt Resistant rats, removal of the afferent renal nerves abolished dietary sodium-
evoked global and renal sympathoinhibition and induced salt-sensitive 
hypertension. Immediately upon high salt intake there was a rapid and transient 
increase in positive sodium balance while blood pressure remained elevated over 
the protocol duration, suggesting resetting of the set-point blood pressure to 
facilitate pressure-natriuresis and sodium homeostasis. The observed sodium 
retention and hypertension may reflect a loss of a protective mechanosensitive 




dramatically increase urine output to approximately 90ml/day. This would increase 
renal pelvic pressure within a physiological range that would active 
mechanosensitive afferent renal nerves.  
Our observations contrast with prior work suggesting the afferent renal 
nerves have no impact on blood pressure during stepped increases in dietary 
sodium intake that concluded 7 weeks post-ADNX in Sprague Dawley rats (Foss 
et al., 2015). However, in the prior study (Foss et al., 2015), a) afferent renal nerve-
independent adaptive mechanisms could have been activated during the two-week 
period between ADNX and high salt intake to facilitate sodium homeostasis and 
normotension – as demonstrated following total renal denervation (DiBona & 
Sawin, 1983) and b) afferent renal nerve functional re-innervation, which was 
detected biochemically as the return of 50% of renal pelvic calcitonin gene-related 
peptide content (Foss et al., 2015) and has been reported following total renal 
denervation as the return of substance P-immunoreactive fibers in the renal pelvic 
wall reaching 50% by 4 weeks and 100% by 9 weeks post-denervation (Mulder et 
al., 2013), could have occurred. To address the potential confounding effects of 
non-afferent renal nerve-mediated compensatory mechanisms and afferent renal 
nerve reinnervation, ADNX was performed immediately prior to the start of high 
salt intake, and absence of a pressor response to bradykinin and significantly 
reduced renal pelvic calcitonin gene-related peptide was confirmed 21-days post-
ADNX to validate the functional efficacy of our approach. Critically, our data, 




removal of the afferent renal nerves as a causal mechanism in the salt sensitivity 
of blood pressure that develops following generalized sensory afferent denervation 
of all sensory afferent inputs via dorsal rhizotomy or subcutaneous capsaicin 
treatment in Sprague Dawley rats (Wang et al., 1998; Wang et al., 2001; Kopp et 
al., 2003). Our data in Dahl Salt Sensitive rats suggest that afferent renal nerve 
function changes during Dahl Salt Sensitive hypertension and high salt intake. 
Previous studies in which ADNX was performed after 3 or 9 weeks of high salt 
intake, when blood pressure is moderately and severely elevated, respectively, 
demonstrate that the afferent renal nerves do not play a role in the maintenance 
of early or late phase Dahl Salt Sensitive hypertension (Foss et al., 2016). In the 
current studies, we confirmed that removal of the afferent renal nerves after 16 
days of high salt intake – approximately one week after a dietary sodium-evoked 
increase in blood pressure above baseline is first observed – has no impact on 
Dahl Salt Sensitive hypertension. In contrast, ADNX immediately prior to high salt 
intake, a time point at which our ex vivo data demonstrate the afferent renal nerves 
are functional and responsive, evokes a more severe blood pressure phenotype 
accompanied by exacerbated renal and global sympathoexcitation in Dahl Salt 
Sensitive rats, suggesting that the sympathoinhibitory afferent renal nerve-
mediated reno-renal reflex has a potential minor role in countering the 
development of Dahl Salt Sensitive hypertension.  
A limitation of the current studies is that the specific mechanisms underlying 




potentially include sympathetic modulation of a) renal sodium transporter activity, 
or b) the renin-angiotensin axis remain to be established. Additionally, the 
phenotype of PVN neurons regulated by mechanosensitive afferent renal nerves, 
their role in sympathoinhibitory reno-renal reflex signal integration during high salt 
intake, and the molecular and synaptic mechanisms driving afferent renal nerve-
mediated PVN neuronal activation require clarification. 
Our data suggest that the impact of the afferent renal nerves on blood 
pressure regulation depends on the model and stage of hypertension being 
investigated. Recent studies have demonstrated that Angiotensin II hypertension 
does not involve the afferent renal nerves (Foss et al., 2018). Significantly, there 
is an increase in resting afferent renal nerve activity in DOCA-salt hypertension 
(Banek et al., 2016), and selective ADNX reduces blood pressure in established 
DOCA-salt hypertension (Foss et al., 2015; Banek et al., 2016; Banek et al., 2018). 
These data suggest that excess afferent renal nerve activity contributes to the 
DOCA-salt model of hypertension and may reflect activation of the 
sympathoexcitatory reno-renal reflex that has been described in heart failure and 
ischemia (Zheng et al., 2018). In contrast, in the spontaneously hypertensive rat 
model, sympathoinhibitory afferent renal nerve reno-renal reflex activity is 
attenuated and renal sympathetic outflow is enhanced (Kopp et al., 1987). Thus, 
hypertension may involve impaired sympathoinhibitory reno-renal reflex activity, 
enhanced sympathoexcitatory reno-renal reflex activity, or a shift in the balance of 




proposed as a contributing factor to the mixed results of clinical trials employing 
bilateral renal nerve ablation to reduce blood pressure (Fudim et al., 2018).  
The current findings indicate that there is a pivotal role of the 
mechanosensitive afferent renal nerve-mediated sympathoinhibitory reno-renal 
reflex in the homeostatic responses to acute sodium challenge in healthy 
normotensive Sprague Dawley rats. These data also provide evidence suggesting 
that the PVN can be regulated by mechanosensitive afferent renal nerve activity 
and may be a critical site of central integration of the acute sympathoinhibitory 
reno-renal reflex. Additionally, our studies, generated via ex vivo and in vivo 
studies, suggest that the afferent renal nerves play a protective role in the 
maintenance of salt resistance by contributing to dietary sodium-evoked 
sympathoinhibition and sodium balance. Collectively our data support a central 
role for the mechanosensitive afferent renal nerve-mediated sympathoinhibitory 
reno-renal reflex as a homeostatic mechanism required for the sympathoinhibitory 
and natriuretic responses to acute sodium challenge and as a first line of defense 
against the development of salt-sensitive hypertension in animal models. These 
data add to a growing body of literature indicating that variability in afferent renal 
nerve activity and function could influence the efficacy of bilateral renal nerve 
ablation as an anti-hypertensive intervention. We speculate that renal nerve 
ablation in hypertensive individuals in whom the sympathoinhibitory reno-renal 
reflex is intact would remove an essential natriuretic pathway, potentially 




invasive challenges (e.g., intravenous volume expansion) to test 
sympathoinhibitory reno-renal reflexes could guide patient selection for 










Aging is associated with elevated sympathetic tone, increased prevalence 
of hypertension, and salt sensitivity of blood pressure. We hypothesized that 
impairments in the afferent renal nerve-mediated sympathoinhibitory reno-renal 
reflex contribute to sympathoexcitation and norepinephrine-evoked sodium 
chloride cotransporter (NCC) activity, promoting age-related hypertension. Using 
the Sprague Dawley rat as a model of normal aging, we assessed age-related 
changes in 1) the sympathoinhibitory, natriuretic, and blood pressure responses to 
an acute volume expansion (mechanoreceptor stimulus), acute hypertonic saline 
infusion (chemoreceptor stimulus), and chronic high salt intake, 2) ex vivo afferent 
renal nerve responsiveness, assessed as renal pelvic substance P release in 
response to norepinephrine (general stimulus) or sodium (chemoreceptor 
stimulus), and 3) NCC activity. Further, we used selective afferent renal nerve 
ablation and bilateral renal denervation to investigate the roles of the afferent renal 
nerves and efferent renal sympathetic nerves in age-related hypertension. We 
observed that aging rats develop salt-sensitive hypertension accompanied by 1) 
impaired homeostatic responses to volume expansion, but not hypertonic saline 
infusion, 2) a selective reduction in norepinephrine-evoked afferent renal nerve 
activity during normal salt intake and a failure to enhance afferent renal nerve 




and NCC activity and blunted dietary sodium-evoked suppression of sympathetic 
tone and NCC activity. Critically, while afferent renal nerve ablation did not alter 
sodium balance or blood pressure, bilateral renal denervation improved sodium 
balance and attenuated age-related hypertension. These findings suggest that 
aging is associated with impairments in the mechanosensitive afferent renal nerve-
mediated sympathoinhibitory reno-renal reflex that may promote 




Aging is associated with increases in the prevalence of both salt sensitivity 
of blood pressure and hypertension (Luft et al., 1991; Muntner et al., 2018; Whelton 
et al., 2018). Sympathetic nervous system activity, which promotes renal sodium 
reabsorption and plays a role in the pathophysiology of both salt sensitivity and 
hypertension, also rises with age, and sympathetic tone correlates positively with 
blood pressure only in adults above the age of 40 (Esler et al., 1995; Esler et al., 
2002; Narkiewicz et al., 2005). Studies in which bilateral renal denervation lowers 
blood pressure in hypertensive animal models and human patients highlight a 
pivotal role of the renal nerves in hypertension (Pires et al., 2015; Wainford et al., 
2015; Gao et al., 2016; Townsend et al., 2017; Azizi et al., 2018; Kandzari et al., 




primarily been investigated in animal models during young adulthood, and the 
contribution of the renal nerves to age-related hypertension is poorly understood.  
The renal nerves are composed of sensory afferent renal nerves and 
efferent renal sympathetic nerves that comprise sympathoinhibitory and 
sympathoexcitatory reno-renal reflexes critical to sodium homeostasis and blood 
pressure regulation (Recordati et al., 1982; Katholi et al., 1983; Katholi et al., 1984; 
Ma et al., 2002a; Ma et al., 2002b; Kopp et al., 2003). In Chapter 4, we used 
selective afferent renal nerve ablation in healthy, normotensive young adult (3 
month old) Sprague Dawley rats to delineate a specific role for the 
mechanosensitive afferent renal nerves in the acute sympathoinhibitory reno-renal 
reflex and provided evidence for a role of the paraventricular nucleus (PVN) in the 
central integration of this reflex. We demonstrated that young, salt-resistant 
Sprague Dawley rats exhibit enhanced afferent renal nerve activity during high salt 
intake, which likely reflects activation of the mechanosensitive afferent renal 
nerves. Further, extending studies in which that general sensory denervation using 
capsaicin or dorsal rhizotomy evokes salt-sensitive hypertension, we showed that 
the afferent renal nerves are required for the maintenance of salt resistance and 
may be a first line of defense against the salt sensitivity of blood pressure.  
The sympathoinhibitory reno-renal reflex has been described primarily in 
young, normotensive animals, while the sympathoexcitatory reno-renal reflex 
appears to be more relevant to disease states that include renal ischemia and 




hypertension could involve an impairment in sympathoinhibitory reno-renal reflex 
function, an exacerbation of sympathoexcitatory reno-reflex activity, or a shift in 
the balance of the opposing reflexes that promotes an increase in renal 
sympathetic outflow. Regardless of its origin, an increase in renal sympathetic 
outflow promotes sodium retention through its effects on the renal vasculature and 
several renal sodium transporters, including the sodium chloride cotransporter 
(NCC) (Walsh et al., 2016). During high salt intake, NCC activity and 
phosphorylation are suppressed in rats and mice, respectively (Mu et al., 2011; 
Terker et al., 2014; Walsh et al., 2016). Further, norepinephrine infusion increases 
NCC phosphorylation and expression in mice and prevents dietary sodium-evoked 
suppression of NCC activity and expression in rats, resulting in salt-sensitive 
hypertension (Mu et al., 2011; Terker et al., 2014; Walsh et al., 2016). While 
putative roles for both α1- and β-adrenoceptors and various downstream kinases 
in NCC regulation have been proposed (Mu et al., 2011; Terker et al., 2014), we 
delineated a specific α1-adrenoceptor-gated WNK1-OxSR1 signaling pathway 
activating the NCC in norepinephrine-infused young adult Sprague Dawley rats in 
Chapter 3.  
In the current studies, we hypothesized that impairments in the afferent 
renal nerve-mediated sympathoinhibitory reno-renal reflex contribute to 
sympathoexcitation and norepinephrine-evoked NCC activity to promote age-
related hypertension and salt sensitivity of blood pressure. To address this 




the impact of age on the sympathoinhibitory, natriuretic, and blood pressure 
responses to an acute volume expansion (mechanoreceptor stimulus), an acute 
hypertonic saline infusion (chemoreceptor stimulus), or a chronic high salt diet. 
Further, we used an ex vivo renal pelvic preparation to investigate the impact of 
age on afferent renal nerve responsiveness to norepinephrine (general afferent 
renal nerve stimulus) or sodium (chemosensitive afferent renal nerve stimulus) 
during normal and high salt intake. Finally, we investigated the impact of aging on 
dietary sodium-evoked sympathoinhibition, NCC suppression, sodium 
homeostasis, and blood pressure regulation and used bilateral renal denervation 
and selective afferent renal nerve ablation to dissect the roles of the efferent renal 
sympathetic nerves and afferent renal nerves in these responses.  
 
Methods 
All methods used in the aging studies in this chapter are briefly outlined in 
this section and described in further detail in Chapter 2. For all studies, n = 6/group 
unless otherwise specified in this section. In brief, male Sprague Dawley rats aged 
3 months, 8 months, and 16 months were used as a model of normal aging. In 
observational studies, all age groups were used to assess the development of age-
related changes (Figure 5.1A-D). In interventional studies, only 3 month old and 
16 month old animals were used (Figure 5.1E-G). 
To test the mechanosensitive and chemosensitive afferent renal nerve-




responses (assessed as C-Fos-positive cell count) to acute volume expansion and 
1M NaCl infusion were assessed in animals maintained on a normal salt diet 
(Figure 5.1A). To investigate afferent renal nerve function in isolation, rats were 
placed on a 21-day normal or high salt diet and norepinephrine and sodium-evoked 
substance P release were determined in an ex vivo renal pelvis assay (Figure 
5.1B).  
The activity and expression of the NCC and is regulatory kinases were 
assessed after a 21-day normal or high salt diet (Figure 5.1C&D). The contribution 
of α1-adrenoceptors to age-related hypertension and NCC regulation were 
investigated using a chronic subcutaneous infusion of terazosin (α1-adrenoceptor 
antagonist) (Figure 5.1E; n = 3 for 16-month old terazosin infusion group) and the 
contribution of increased NCC activity to age-related hypertension was assessed 
using a chronic subcutaneous infusion of hydrochlorothiazide (NCC antagonist) in 
animals maintained on a normal salt diet (Figure 5.1F; n = 4 for 16-month old 
hydrochlorothiazide group). 
Global sympathetic tone following a 21-day normal or high salt diet was 
assessed as plasma norepinephrine content (Figure 5.1D). Renal sympathetic 
tone was determined in the same animals as renal norepinephrine content (Figure 
5.1D). Vascular sympathetic tone was determined as the peak depressor response 
to ganglionic blockade in animals that underwent the assessment of NCC activity 




nerves to age-related hypertension and NCC regulation were assessed using 
selective afferent renal nerve ablation or bilateral renal denervation.  
To assess the potential contribution of renal damage and the renin 
angiotensin aldosterone system to age-related impairments in renal sodium 
handling and blood pressure regulation, blood, kidney tissue and urine samples 
were collected after a 21-day normal or high salt diet (Figure 5.1D). Measures of 
renal damage, including glomerulosclerosis and mesangial expansion, urinary 
kidney injury molecule-1 concentration, and proteinuria, and measures of renin 
angiotensin aldosterone system activity, including plasma aldosterone and plasma 
angiotensin II, were assessed in these samples (Figure 5.1D). Glomerular filtration 
rate was also assessed in vivo in a small subset of animals that underwent acute 
volume expansion or 1M NaCl infusion (not shown; studies conducted during 
protocols shown in Figure 5.1A; n = 2/group due to very recent availability of 




Figure 5.1. Overview of methods used in Chapter 5. All studies were performed 
using male Sprague Dawley rats aged (A-D) 3, 8 and 16 months old or (E-G) 3 
and 16 months old only. White = dietary sodium assignments; green = surgical 
procedures; orange = in vivo studies; grey = ex vivo studies; blue = analytical 
techniques. n = 6/group unless otherwise specified. Detailed protocols are 




Aged rats exhibit impaired cardiovascular, renal, and parvocellular PVN neuronal 
responses to an acute volume expansion 
Male Sprague Dawley rats maintained on a normal salt diet exhibit a 




decrease in heart rate in 16-month old rats (Figure 5.2A&B). An acute volume 
expansion evoked robust natriuretic and diuretic responses that allowed the 
excretion of almost 80% of the sodium and 95% of the fluid delivered in 3-month 
old rats (Figure 5.2C&D). In contrast, the natriuretic and diuretic responses to 
acute volume expansion were progressively blunted in 8-month old and 16-month 
old rats (Figure 5.2C&D). Despite the age-related impairment in renal excretory 
responses, an acute volume expansion did not alter blood pressure or heart rate 
in any age group (Figure 5.2A&B). 
Figure 5.2. Impact of aging on 
the cardiovascular and renal 
responses to an acute volume 
expansion. (A) Mean arterial 
pressure (MAP; mmHg), (B) 
heart rate (HR; beats per minute 
[bpm]), (C) percentage of 
sodium load excreted and (D) 
percentage of volume load 
excreted during a control period 
(denoted ‘C’), a 30-minute 5% 
body weight isotonic saline 
volume expansion (VE), and a 
90-minute recovery period in 
conscious 3, 8, and 16-month 
old male Sprague Dawley (SD) 
rats maintained on a lifetime 
normal salt diet. In vivo data in 
this figure corresponds to Fos 
expression data in Figure 5.3 
(VE groups only). n = 6/group. 
*P < 0.05 vs. respective 3-month 
group value; τP < 0.05 vs. 




To assess the activation of sympathoinhibitory neurons in the PVN following 
surgical recovery (baseline) or acute volume expansion, the number of Fos-
positive neurons was counted in parvocellular and magnocellular subnuclei. 
Baseline Fos staining in all parvocellular and magnocellular regions was minimal 
in 3-month old rats and was not altered in aged rats (Figure 5.3). An acute volume 
expansion evoked an increase in Fos staining in all paraventricular nucleus 
parvocellular and magnocellular subnuclei in 3-month old rats (Figure 5.3). While 
volume expansion-evoked Fos induction in magnocellular neurons was intact in 8-
month and 16-month old rats, Fos staining in parvocellular subnuclei was 
significantly and progressively reduced following volume expansion in aged rats 





Figure 5.3. Impact of aging on the PVN 
neuronal responses to an acute volume 
expansion. Neuronal activation (c-fos-positive 
cell count) in the (A) lateral parvocellular, (B) 
ventrolateral parvocellular, (C) medial 
parvocellular, (D) dorsal parvocellular, and (E) 
magnocellular regions of the paraventricular 
nucleus (PVN) of the hypothalamus following an 
acute volume expansion protocol (VE; control 
period, 30-minute 5% body weight isotonic saline 
VE, 90-minute recovery period) or a control 
period only (denoted ‘C’) in conscious 3, 8, and 
16-month old male Sprague Dawley rats and (F) 
representative images from level 2 of the PVN. 
Fos expression data from VE groups in this figure 
corresponds to in vivo data in figure 5.2. n = 
6/group. *P < 0.05 vs. respective 3-month group 
value; τP < 0.05 vs. respective 8-month group 





Aged rats exhibit intact cardiovascular, renal, and parvocellular PVN neuronal 
responses to a hypertonic saline infusion 
In male Sprague Dawley rats that underwent an acute 1M NaCl infusion, 
blood pressure increased and heart rate decreased to a similar degree in 8-month 
and 16-month old rats compared to 3-month old rats. An acute 1M NaCl infusion 
had no impact on blood pressure or heart rate in any age group (Figure 5.4A&B). 
In all age groups, a 1M NaCl infusion evoked profound natriuresis in the absence 
of diuresis (Figure 5.4C&D). A 1M NaCl infusion evoked an increase in Fos 
staining in all parvocellular and magnocellular regions of the PVN in 3-month old 
rats that was not altered in aged rats (Figure 5.5).   
Figure 5.4. Impact of aging on the 
cardiovascular and renal 
responses to an acute 1M NaCl 
infusion. (A) Mean arterial pressure 
(MAP; mmHg), (B) heart rate (HR; 
beats per minute [bpm]), (C) 
natriuresis (UNaV; µeq/min) and (D) 
urinary flow rate (V; µL/min) excreted 
during a control period and a 2-hour 
1M NaCl infusion (20µL/min) in 
conscious 3, 8, and 16-month old male 
Sprague Dawley rats maintained on a 
lifetime normal salt diet. In vivo data in 
this figure corresponds to Fos 
expression data in Figure 5.5 (1M 
groups only). n = 6/group. *P < 0.05 






Figure 5.5. Impact of aging on the PVN 
neuronal responses to an acute 1M NaCl 
infusion. Neuronal activation (c-fos-positive 
cell count) in the (A) lateral parvocellular, (B) 
ventrolateral parvocellular, (C) medial 
parvocellular, (D) dorsal parvocellular, and 
(E) magnocellular regions of the 
paraventricular nucleus (PVN) of the 
hypothalamus following an acute 1M NaCl 
infusion protocol (1M; 2-hour 1M NaCl 
infusion, 20µL/min) or a control period only 
(denoted ‘C’) in conscious 3, 8, and 16-
month old male Sprague Dawley rats and (C) 
representative images from level 2 of the 
PVN. Fos expression data from 1M groups in 
this Figure corresponds to in vivo data in 
figure 5.4. n = 6/group. θP < 0.05 vs. 





Aged rats exhibit reduced ex vivo afferent renal nerve responsiveness and fail to 
enhance afferent renal nerve responsiveness during high salt intake 
Norepinephrine, a general afferent renal nerve stimulus, evoked an 
increase in ex vivo afferent renal nerve release of substance P in 3-month old male 
Sprague Dawley rats that was blunted in 8-month and 16-month old rats (Figure 
5.6A). Norepinephrine-evoked substance P release was enhanced during high salt 
intake in 3-month old rats, while this response was absent in 8-month and 16-
month old rats (Figure 5.6A). In contrast, afferent renal nerve responsiveness to 





Figure 5.6. Impact of aging on ex vivo afferent renal nerve responsiveness. 
Ex vivo renal pelvis substance P release (pg/min) in response to (A) 1250 pM 
norepinephrine (NE) or (B) 450mM NaCl on day 21 of a normal salt (NS; 0.6% 
NaCl) or high salt (HS; 4% NaCl) diet in male Sprague Dawley (SD) aged 3, 8, and 
16 months (mo). n = 6/group. #P < 0.05 vs age-matched NS group value, *P < 





Aged rats develop hypertension accompanied by increased sympathetic tone 
and NCC activity during normal salt intake 
Blood pressure increased progressively with age in male Sprague Dawley 
rats maintained on a normal salt diet (Figure 5.7A). The age-related increases in 
blood pressure were accompanied by increases in global, vascular, and renal 
sympathetic tone, assessed as plasma norepinephrine concentration, peak 
depressor response to intravenous hexamethonium, and renal norepinephrine 
content, respectively (Figure 5.7B-D). Only 16-month old rats exhibited an increase 
in global sympathetic tone, while both 8-month old and 16-month old rats exhibited 
similar increases in vascular sympathetic tone compared to 3-month old rats 
(Figure 5.7B&C). In comparison, renal norepinephrine was increased in 8-month 
old rats and further elevated in 16-month old rats, demonstrating a progressive 
age-related increase in renal sympathetic tone (Figure 5.7D).  
In vivo NCC activity, assessed as the peak natriuretic response to 
intravenous hydrochlorothiazide, is elevated to a similar degree in 8-month old and 
16-month old male Sprague Dawley rats compared to 3-month old rats maintained 
on a normal salt diet (Figure 5.8A). Suggesting a differential age-related 
contribution of the NCC to blood pressure regulation, chronic antagonism of the 
NCC via subcutaneous hydrochlorothiazide infusion reduced blood pressure in 16-












Figure 5.7. Impact of aging on blood pressure and sympathetic tone during 
normal and high salt intake. (A) Mean arterial pressure (MAP; mmHg) and (B) 
peak depressor response (ΔMAP, mmHg) to hexamethonium (30mg/kg, 
intravenous) assessed in conscious male Sprague Dawley rats aged 3, 8, and 16 
months (mo) after a 21-day normal salt (NS; 0.6% NaCl) or high salt (HS; 4% NaCl) 
diet and (C) plasma norepinephrine (NE) concentration (nmol/L) and (D) renal NE 
content (pg/mg) assessed following a 21-day NS or HS diet in separate groups of 
naïve male Sprague Dawley rats aged 3, 8, and 16mo. n = 6/group. *P < 0.05 vs 
respective 3mo group, τP < 0.05 vs respective 8mo group, #P < 0.05 vs respective 





To explore the signaling pathways underlying the observed physiological 
increase in NCC activity in aged animals, we assessed protein expression of the 
NCC and its regulatory kinases in the renal cortex of rats maintained on a normal 
salt diet, with a primary focus on the α1-adrenoceptor-gated WNK1/OxSR1 
pathway described in Chapter 3. While total expression of the NCC, SPAK, and 
OxSR1 was not altered in 8-month and 16-month old rats and phosphorylated NCC 
(Thr53) decreased in 16-month old rats, total WNK1 expression and 
phosphorylated SPAK/OxSR1 increased with age (Figure 5.9). Further, in a small 
subset of 16-month old animals, chronic α1-antagonism reduced in vivo NCC 
activity and attenuated age-related hypertension (Figure 5.10). 
Figure 5.8. Impact of aging on NCC activity in vivo. (A) Peak natriuretic 
response (ΔUNaV, µeq/min) to hydrochlorothiazide (HCTZ; 2mg/kg bolus followed 
by 1-hour 2mg/kg infusion, intravenous) in conscious male Sprague Dawley rats 
aged 3, 8, and 16 months (mo) following a 21-day normal salt (NS; 0.6% NaCl) or 
high salt (HS; 4% NaCl) diet and (B) mean arterial pressure (MAP, mmHg) in 
conscious 3mo and 16mo male Sprague Dawley rats under control (Ctl) conditions 
or following a 14-day subcutaneous hydrochlorothiazide infusion (HCTZ; 
4mg/kg/day). n = 6/group except n = 4 for 16mo HCTZ infusion group. *P < 0.05 
vs. respective 3mo group, #P < 0.05 vs. respective NS group, θP < 0.05 vs. 





Figure 5.9. Impact of aging on the NCC 
regulatory kinase network. Quantification of 
renal cortex protein expression of (A) total 
NCC, (B) phosphorylated NCC (pT53), (C) 
total WNK1, (D) total OxSR1, (E) total SPAK, 
and (F) phosphorylated SPAK/OxSR1 
normalized to β-actin and (G) representative 
immunoblots from 3, 8, and 16-month old (mo) 
male Sprague Dawley rats on a normal salt 
diet. n = 4/group. *P < 0.05 vs. respective 3-
month group value; τP < 0.05 vs. respective 8-




Aged rats develop salt sensitivity of blood pressure accompanied by suppression 
of sympathetic tone and NCC activity during high salt intake 
A 21-day high salt diet altered blood pressure, sympathetic tone, and NCC 
activity in an age-dependent manner. In normotensive 3-month old and 
hypertensive 8-month old male Sprague Dawley rats, high salt intake had no 
impact on blood pressure (Figure 5.7A). In contrast, age-related hypertension was 
exacerbated by a high salt diet in 16-month old rats, indicating the development of 
salt-sensitive hypertension (Figure 5.7A). 
In 3-month old male Sprague Dawley rats, salt resistance was accompanied 
by dietary sodium-evoked suppression of global and renal sympathetic tone, but 
not vascular sympathetic tone (Figure 5.7C&D). However, while 8-month old rats 
also exhibited salt resistance, suppression of global and renal sympathetic tone 
were attenuated (Figure 5.7C&D). Dietary sodium-evoked suppression of global 
Figure 5.10. Impact of α1-adrenoceptor antagonism on age-related 
hypertension and NCC activity. (A) Mean arterial pressure (MAP; mmHg) and 
(B) peak natriuretic response (ΔUNaV) to intravenous hydrochlorothiazide (HCTZ; 
2mg/kg bolus, 2mg/kg hour infusion) in conscious 3 and 16 month old male 
Sprague Dawley rats under control (ctl) conditions (n = 6) or following a 10-day 
subcutaneous infusion of terazosin (10mg/kg/day) (n = 3). *P < 0.05 vs. respective 






sympathetic tone was impaired in 16-month old rats to a similar degree observed 
in 8-month old rats, while suppression of renal sympathetic tone was abolished 
only in the salt-sensitive 16-month old group (Figure 5.7C&D). Vascular 
sympathetic tone was not altered during increased dietary sodium intake at any 
age (Figure 5.7B).  
High salt intake evoked the suppression of NCC activity in normotensive, 
salt-resistant 3-month old rats (Figure 5.8A). In contrast, hypertensive 8-month old 
rats and hypertensive, salt-sensitive 16-month old rats failed to suppress NCC 
activity during a high salt diet (Figure 5.8A).  
 
Age-related hypertension and salt sensitivity develop independently of functional 
renal damage and alterations in the renin-angiotensin-aldosterone system 
 To determine the potential contribution of renal damage to age-related 
hypertension and salt sensitivity, we assessed kidney function and pathology by 
several measures in male Sprague Dawley rats. In a small subset of 3-month old, 
8-month old, and 16-month old rats maintained on a normal salt diet, glomerular 
filtration rate was unchanged (Figure 5.11A&B). All age groups exhibited similar 
levels of proteinuria during normal salt intake, and a high salt diet increased 
proteinuria to a similar degree in all age groups (Figure 5.11C). Urinary kidney 
injury molecule-1, a marker of proximal tubular injury, and the glomerulosclerosis 




age and correlate with functional renal damage, were not altered by age or diet 





Figure 5.11. Impact of aging on renal function. (A) Glomerular filtration rate 
(GFR; mL/min/100g body weight [B.W.]) assessed using FITC-sinistrin clearance 
in a small subset (n = 2/group) of 3, 8, and 16 month (mo) male Sprague Dawley 
rats, (B) a representative FITC-sinistrin clearance curve, and (C) proteinuria 
(mg/24hr) and (D) urinary kidney injury molecule-1 (KIM-1; ng/24hr) assessed in 
urine collected from 3, 8, and 16mo male Sprague Dawley rats following a 21-day 
normal salt (NS; 0.6% NaCl) or high salt (HS; 4% NaCl) diet (n = 6/group). #P < 





 Suggesting that the renin-angiotensin-aldosterone system is not involved in 
the development of age-related hypertension in male Sprague Dawley rats, plasma 
aldosterone and angiotensin II levels were similar in 3-month, 8-month, and 16-
month old rats maintained on a normal salt diet (Figure 5.13A&B). Further, dietary 
sodium-evoked suppression of aldosterone was observed in 3-month old rats and 
Figure 5.12. Impact of aging on renal histopathology. (A) Glomerulosclerosis 
index and (B) mesangial expansion score based on semiquantitative assessment 
of both measures in period acid-Schiff stained renal tissue obtained from 3, 8, and 
16 month (mo) male Sprague Dawley rats following a 21-day normal salt (NS; 0.6% 
NaCl) or high salt (HS; 4% NaCl) diet and (C) representative images from each 





remained intact in 8-month old and 16-month old rats (Figure 5.13A). To 
investigate the role of the renin-angiotensin-aldosterone system in NCC regulation 
in aging animals, a small subset of 16-month old rats received a chronic 
subcutaneous infusion of losartan, an angiotensin II receptor blocker, prior to the 
assessment of NCC activity. Losartan infusion attenuated age-related 
hypertension but had no impact on NCC activity (Figure 5.13C&D).  
Figure 5.13. Role of the renin angiotensin aldosterone system in the 
regulation of blood pressure and NCC activity in aging rats. (A) Plasma 
aldosterone concentration (pg/mL) in 3, 8 and 16 month (mo) male Sprague 
Dawley (SD) rats maintained on a 21-day normal salt (NS; 0.6% NaCl) or high salt 
(HS; 4% NaCl) diet, (B) plasma angiotensin II concentration (pg/mL) in 3, 8, and 
16mo male Sprague Dawley rats maintained on NS intake (n = 6/group) and (C) 
mean arterial pressure (MAP; mmHg) and (D) peak natriuretic response (ΔUNaV, 
µeq/min) to hydrochlorothiazide (HCTZ; 2mg/kg bolus followed by 1-hour 2mg/kg, 
intravenous) in conscious 16mo male SD rats under control (Ctl) conditions (n = 6) 
or following a 14-day subcutaneous infusion of losartan (3mg/kg/day) (n = 3). #P 





Bilateral renal denervation, but not selective afferent renal nerve ablation, 
attenuates age-related hypertension 
 Bilateral renal denervation and selective afferent renal nerve ablation were 
used to dissect the roles of the renal sympathetic nerves and afferent renal nerves 
on sodium balance, NCC activity, and blood pressure regulation in 3-month old 
and 16-month old male Sprague Dawley rats during normal salt intake. Selective 
afferent renal nerve ablation had no impact on blood pressure, sodium balance, or 
NCC activity in either age group (Figure 5.14A-C). In contrast, bilateral renal 
denervation improved sodium balance and attenuated age-related hypertension in 
16-month old rats but had no impact on cardiovascular or renal excretory function 
in 3-month old rats (Figure 5.14A&B). Somewhat unexpectedly, bilateral renal 
denervation and selective afferent renal nerve ablation had no impact on in vivo 





Figure 5.14. Role of the renal nerves in the regulation of blood pressure, 
sodium balance, and NCC activity in aging rats. (A) Mean arterial pressure 
(MAP; mmHg), (B) 24 hour sodium balance (mEq), and (C) peak natriuretic 
response (ΔUNaV, µeq/min) to hydrochlorothiazide (HCTZ; 2mg/kg bolus followed 
by 1-hour 2mg/kg, intravenous) in conscious 3 and 16 month old (mo) male 
Sprague Dawley rats with intact renal nerves or 10 days after selective afferent 
renal denervation (ADNX) or bilateral renal denervation (RDNX) and (D) renal 
norepinephrine content assessed in renal tissue collected immediately after the 
assessment of MAP and NCC activity. n = 6/group. *P < 0.05 vs respective NS 






The current studies were designed to investigate whether changes in the 
integrated renal and neural mechanisms that modulate sodium homeostasis and 
blood pressure contribute to the development of age-related hypertension and salt 
sensitivity of blood pressure. Previous studies have demonstrated that 
norepinephrine-evoked NCC activity promotes salt-sensitive hypertension, and 
others have delineated an acute afferent renal nerve-mediated sympathoinhibitory 
reno-renal reflex that suppresses renal sympathetic outflow and promotes 
natriuresis and normotension (Kopp, 1993; Johns & Abdulla, 2013; Johns, 2014; 
Kopp, 2015). Further, a protective role for sensory afferent signaling in salt 
resistance has been suggested using non-selective global sensory denervation 
techniques (Wang et al., 1998; Wang et al., 2001; Kopp et al., 2003). In Chapter 
3, we established that norepinephrine promotes NCC activity via an α1-
adrenoceptor-gated WNK1-OxSR1 signaling pathway, ultimately driving the 
development of salt-sensitive hypertension in 3-month old rats. In Chapter 4, we 
demonstrated in 3-month old rats that the mechanosensitive afferent renal nerves 
are required for appropriate sympathoinhibitory reno-renal reflex activity, perhaps 
via activation of parvocellular neurons in the PVN, and provided evidence that the 
afferent renal nerves are a specific and critical component of salt resistance that 
is impaired in salt-sensitive animal models. The current studies extend these 
observations into a model of normal aging and demonstrate that aged rats develop 




selective impairment in the mechanosensitive sympathoinhibitory reno-renal 
reflex, 2) a reduction in afferent renal nerve activity and a failure to increase 
afferent renal nerve activity during high salt intake, which again likely reflects a 
selective impairment in the mechanosensitive afferent renal nerves, and 3) an 
increase in sympathetic outflow and NCC activity, likely via an α1-adrenoceptor 
gated WNK1-OxSR1 signaling pathway, and a failure to suppress sympathetic 
tone and NCC activity in response to a high salt diet.  
Age-related hypertension and salt sensitivity are difficult to model in 
rodents. Hypertension and salt sensitivity are typically investigated using young 
animal models in which genetic or experimental manipulations drive 
pathophysiology (Leong et al., 2015). Models of aging are used infrequently in the 
study of hypertension and salt sensitivity, perhaps in part because these models 
are either hypertension-resistant or develop hypertension in the presence of 
potentially confounding pathological changes to the systems involved in blood 
pressure regulation, including the kidney (Coleman et al., 1977; Bilusic et al., 
2008). In these studies, we used Sprague Dawley rats as a model of normal aging. 
Multiple studies have demonstrated that young adult (3-month) Sprague Dawley 
rats are salt-resistant (Kapusta et al., 2012; Kapusta et al., 2013; Wainford et al., 
2015) but develop salt sensitivity with norepinephrine infusion (Walsh et al., 2016). 
These findings may reflect similarities with human salt sensitivity of blood pressure, 
which is less common in younger individuals but becomes increasingly common 




al., 1987; Luft et al., 1991; Esler et al., 1995; Esler et al., 2002; Writing Group et 
al., 2016; Whelton et al., 2018). Further, while aging Sprague Dawley rats develop 
renal damage associated with structural alterations, such as glomerulosclerosis, 
and functional alterations, including reduced glomerular filtration rate, these 
features are primarily observed after the age of 20 months (Owen & Heywood, 
1986; Erdely et al., 2003). By using 3-month, 8-month, and 16-month old rats, we 
were able to temporally isolate the development of hypertension and salt sensitivity 
of blood pressure from the potentially confounding effect of functional renal 
damage, which could alter renal sodium handling and renal nerve function.  
To investigate the impact of aging on the acute reno-renal reflexes, we first 
used the classical sympathoinhibitory challenge of an acute volume expansion 
(Schad & Seller, 1976; Ricksten & Thoren, 1980; Haselton et al., 1994; Kapusta et 
al., 2012). We observed a progressive increase in baseline blood pressure in 8-
month and 16-month old rats, indicating the development of age-related 
hypertension. Further, an acute volume expansion produced a robust natriuretic 
and diuretic response in 3-month old animals that was significantly and 
progressively blunted in 8-month and 16-month old animals. While the current 
studies were conducted primarily in male rats, similar impairments were observed 
in preliminary studies in 8-month old female rats. In Chapter 4, we observed that 
an acute volume expansion evokes an increase in renal pelvic pressure in 
anesthetized 3-month old male Sprague Dawley rats and that the afferent renal 




(Figure 4.2). These findings, combined with prior work demonstrating that an acute 
volume expansion activates afferent renal nerve mechanoreceptors that 
selectively respond to increased renal pelvic pressure (Chien et al., 2000), strongly 
suggest that the age-related reduction in volume expansion-evoked natriuresis 
and diuresis reflects an impairment in the mechanosensitive afferent renal nerves.  
Consistent with this interpretation, the robust increase in Fos-positive cell 
bodies observed in all parvocellular PVN regions following volume expansion in 3-
month old rats, which requires intact afferent renal nerves (Chapter 4, Figure 4.2), 
was progressively attenuated in 8-month and 16-month old rats. Although volume 
expansion evoked an increase in magnocellular PVN Fos staining in 3-month old 
rats, this response remained intact in aged rats, suggesting that age-related 
impairments in volume expansion-evoked natriuresis and diuresis do not reflect 
altered magnocellular neuronal activation. Previous studies have established that 
sympathoinhibitory parvocellular neurons in the PVN are activated by an acute 
volume expansion and in turn promote the suppression of sympathetic outflow and 
a robust natriuretic response (Haselton et al., 1994; Randolph et al., 1998; Ng et 
al., 2004). While the functional nature of the parvocellular PVN neurons activated 
following volume expansion in aged animals in the current studies requires further 
clarification, the associated impairment in volume expansion-evoked natriuresis 
and diuresis suggests that the age-related reduction in parvocellular Fos staining 
in the PVN could reflect impaired activation of sympathoinhibitory neurons. 




that the suppression of renal sympathetic nerve activity following an acute dextran 
volume expansion was blunted in aged dogs (Hajduczok et al., 1991a). As 
indicated in Chapter 4, further studies in each age group will be required to confirm 
that the observed Fos staining reflects functional activation of sympathoinhibitory 
parvocellular PVN neurons. 
Collectively, our observations suggest that aging is associated with a 
selective impairment in the mechanosensitive afferent renal nerves, resulting in 
blunted natriuretic and diuretic responses to an acute volume expansion. Further, 
these impairments are associated with reduced Fos staining in the PVN, lending 
support to the putative role of the PVN in the central integration of the 
sympathoinhibitory reno-renal reflex proposed in Chapter 4. While our findings, 
particularly in light of the studies described in Chapter 4, suggest a specific 
impairment in sensory signaling originating in the kidney, an acute volume 
expansion also stimulates non-renal sensory afferent signaling pathways that 
activate parvocellular neurons in the PVN and suppress renal sympathetic outflow, 
including those activated by atrial stretch (Karim et al., 1972; Pyner et al., 2002). 
The impact of aging on these non-renal sensory afferent pathways has not been 
established and could contribute pathologically to the impaired homeostatic 
responses to volume expansion if impaired, or protectively to the residual 





To assess the function of the chemosensitive afferent renal nerves, we used 
a 1M NaCl infusion that does not increase renal pelvic pressure in 3-month old 
anesthetized Sprague Dawley rats (Chapter 4, Figure 4.6). The chemosensitive 
afferent renal nerves respond to changes in the chemical composition of fluid in 
the renal pelvis, including alterations in sodium concentration (Recordati et al., 
1980; Recordati et al., 1981). Given that the fluid that reaches the renal pelvis is 
not further altered before excretion as urine, our observation that a 1M NaCl 
infusion yields a highly concentrated urine output via a robust natriuresis in the 
absence of diuresis suggests that the 1M NaCl infusion should preferentially 
activate chemoreceptors present in the renal pelvis. Age had no impact on the 
profound natriuresis evoked by a 1M NaCl infusion, and rats in all age groups 
exhibited indistinguishable increases in Fos-positive cell count in all parvocellular 
and magnocellular regions of the PVN, suggesting that the chemosensitive afferent 
renal nerves remain functional. Of note, the chemosensitive afferent renal nerves 
have been implicated in a sympathoexcitatory reno-renal reflex that promotes 
sodium retention and has primarily been observed in disease states including renal 
ischemia and heart failure (Recordati et al., 1982; Rogenes, 1982; Zheng et al., 
2018). While 16-month old rats appear to exhibit normal natriuretic responses to a 
1M NaCl infusion, investigation of these responses in older animals (>20 months) 
could yield important information, as renal damage becomes more common and 
more severe and could potentially promote sympathoexcitatory reno-renal reflex 




  While the functional nature of the parvocellular PVN neurons activated by 
a 1M NaCl infusion has not been characterized, a previous study demonstrating 
that 1M NaCl infusion suppresses central sympathetic outflow indicates that some 
of the Fos-positive parvocellular neurons could be sympathoinhibitory in nature 
(Wainford et al., 2013). Importantly, our previous observations that 1M NaCl-
evoked parvocellular neuron activation in the PVN and natriuresis remain intact 
following selective ablation of the afferent renal nerves (Chapter 4, Figure 4.5) and 
bilateral renal denervation (Wainford et al., 2013) suggest that non-renal sensory 
signaling pathways may mediate these responses. Although our interpretation of 
the 1M NaCl studies is limited somewhat by the unusually high blood pressure of 
the 8-month age group, the fully intact responses observed in the 16-month age 
group, in which blood pressure was comparable to similarly aged rats in all in vivo 
studies, and subsequent ex vivo studies of afferent renal nerve responsiveness 
suggest that chemosensitive afferent renal nerve function is not altered in aged 
rats.  
To validate the potential age-related reduction in afferent renal nerve activity 
in isolation, an ex vivo renal pelvic preparation was used. While technical 
limitations prevent the experimental manipulation of renal pelvic pressure in this 
preparation, the afferent renal nerves were stimulated by treating the isolated renal 
pelvis with norepinephrine, a general stimulus that activates the afferent renal 
nerves via α1-adrenoceptors, and 450mM NaCl, a selective chemoreceptor 




Afferent renal nerve responsiveness was assessed as the release of substance P, 
which plays a mechanistic role in afferent renal nerve activation (Kopp & Smith, 
1993; Kopp et al., 1997; Kopp et al., 2000). In rats maintained on a normal salt 
diet, there was a reduction in norepinephrine-evoked substance P release in 8-
month old and 16-month old rats, while sodium-evoked substance P release was 
not altered with age. This suggests that aging is associated with a reduction in 
baseline afferent renal nerve function that does not reflect an impairment in the 
chemosensitive afferent renal nerves, indirectly supporting our in vivo observation 
of a selective impairment in the mechanosensitive afferent renal nerve-mediated 
sympathoinhibitory reno-renal reflex.  
Consistent with previous studies, 3-month old Sprague Dawley rats 
exhibited enhanced afferent renal nerve responsiveness to norepinephrine during 
high salt intake (Kopp et al., 2009). In contrast, afferent renal nerve 
responsiveness to sodium was not altered during high salt intake in 3-month old 
rats. We previously demonstrated that this selective enhancement is also present 
in Dahl Salt Resistant rats but abolished in Dahl Salt Sensitive rats, suggesting 
that a failure to enhance afferent renal nerve activity during high salt intake may 
be a pathological feature of salt-sensitive hypertension (Chapter 4, Figure 4.7). 
Here, we observed that hypertensive 8-month old rats and salt-sensitive, 
hypertensive 16-month old rats fail to increase afferent renal nerve responsiveness 
to norepinephrine, but not to the direct chemoreceptor stimulus. Together with our 




enhancement of the mechanosensitive afferent renal nerve-mediated reno-renal 
reflex that is impaired in aged animals. 
To determine whether age-related impairments in acute afferent renal nerve 
activation were associated with alterations in the long-term regulation of blood 
pressure, sodium homeostasis, and sympathetic tone, we assessed these 
parameters in rats fed on a 21-day normal versus high salt diet. In rats maintained 
on a normal salt diet, age-related hypertension was associated with an increase in 
global, vascular, and renal sympathetic tone. While blood pressure and renal 
sympathetic tone increased progressively in each age group, global and vascular 
sympathetic tone did not increase further after 8 months of age. Interestingly, while 
human aging is associated with increased global sympathetic tone, an organ-
specific study of norepinephrine turnover suggested that renal sympathetic outflow 
is not altered with age in humans (Esler et al., 1995; Esler et al., 2002). However, 
increased renal norepinephrine content is linked to sodium retention and 
hypertension in rodent models of hypertension, and baseline renal sympathetic 
nerve activity is elevated in aged beagles (Hajduczok et al., 1991a; Hajduczok et 
al., 1991b; Pinto et al., 2011). In humans, several studies have demonstrated that 
the responsiveness of the renal sympathetic nerves to various stimuli increases 
with age (Kuipers et al., 2009; Patel et al., 2013). A specific role for increased renal 
sympathetic tone in the development of age-related hypertension in Sprague 
Dawley rats is supported by our observation of a reduction in blood pressure, with 




efferent renal sympathetic nerves and afferent renal nerves via bilateral renal 
denervation in 16-month old rats. These findings are supported by a study 
demonstrating the efficacy of renal denervation in elderly hypertensive patients 
(Ziegler et al., 2015). Selective ablation of the afferent renal nerves had no impact 
on blood pressure or sodium homeostasis in 16-month old rats, which may in part 
reflect reduced basal afferent renal nerve activity in 16-month old rats. Importantly, 
this finding suggests that the beneficial effects of bilateral renal denervation, which 
removes both the efferent renal sympathetic nerves and the afferent renal nerves, 
are due to removal of the renal sympathetic nerves. Selective afferent renal nerve 
ablation and bilateral renal denervation had no impact on blood pressure in 3-
month old rats, perhaps reflecting a role of the renal nerves in the responses to 
altered homeostasis rather than baseline blood pressure regulation during normal 
salt intake.  
In 3-month old rats, which exhibited enhanced afferent renal nerve activity 
during high salt intake, a high salt diet resulted in suppression of global, vascular, 
and renal sympathetic tone and had no impact on blood pressure. These findings 
are consistent with previous studies establishing the role of dietary sodium-evoked 
sympathoinhibition in salt resistance in young Sprague Dawley rats (Walsh et al., 
2016). In 8-month old rats, although dietary sodium-evoked suppression of global 
and renal sympathetic tone is attenuated and suppression of vascular sympathetic 
tone is abolished, a high salt diet did not exacerbate age-related hypertension. In 




animals exhibited impairments in dietary sodium-evoked suppression of global and 
vascular tone similar to those observed in 8-month old rats, suppression of renal 
sympathetic outflow was fully abolished only in 16-month old rats. Our observation 
that age-related hypertension and salt sensitivity are associated with baseline 
sympathoexcitation and impaired dietary sodium-evoked sympathoinhibition 
assessed in multiple sympathetic nervous system targets is consistent with our 
understanding of hypertension as a disease with complex, multifactorial etiology. 
However, along with our renal denervation studies, the progressive age-related 
increase in baseline renal sympathetic outflow and impairment in dietary sodium-
evoked renal sympathoinhibition that accompany salt-sensitive hypertension in 
aged rats suggest that the renal sympathetic nerves play a pathophysiological role 
in age-related hypertension and salt sensitivity. Further, the development of 
impaired acute afferent renal nerve responsiveness in 8-month old rats prior to the 
development of salt sensitivity of blood pressure, combined with our previous 
observation that the afferent renal nerves are required for the maintenance of salt 
resistance in young Sprague Dawley rats (Chapter 4, Figure 4.8), support the 
proposed role for reduced afferent renal nerve function in the development of salt-
sensitive hypertension in aged rats. Taken together, these findings support the 
hypothesis that age-related impairments in the mechanosensitive afferent renal 
nerve sympathoinhibitory reno-renal reflex may promote sympathoexcitation, 




The renal sympathetic nerves release norepinephrine, which can influence 
sodium homeostasis and blood pressure through its effects on renal sodium 
transporters and the renal vasculature. While norepinephrine acts at α1-
adrenoceptors in the renal vasculature to promote vasoconstriction, resulting in 
reductions in renal plasma flow and glomerular filtration rate that enhance sodium 
reabsorption, our preliminary findings in small subgroups of aged animals indicate 
that glomerular filtration rate is not altered in 8-month old and 16-month old rats 
during normal salt intake. Although these findings must be interpreted cautiously 
due to a small sample size, previous studies have demonstrated that a functionally 
relevant age-related reduction in glomerular filtration rate in Sprague Dawley rats 
does not develop until 24 months of age (Lim et al., 2014), and suggests that age-
related hypertension develops independently of changes in renal hemodynamics.  
While the absence of an age-related alteration in glomerular filtration rate 
must be confirmed in a larger group of animals, several other findings also suggest 
that renal function is not impaired in our model of aging. Proteinuria, an indicator 
of renal damage, was similar in all age groups during normal salt intake and 
increased to a similar degree during high salt intake in all age groups. The similarity 
between age groups suggests that this measure of renal function is not linked to 
the age-related alterations in renal sodium handling and blood pressure regulation 
observed in the current studies. Urinary kidney injury molecule-1, a marker of 
proximal tubule injury, was not affected by age or dietary sodium intake was not 




score, two measures of histopathological changes observed in aging humans that 
may contribute to altered renal function, were also similar in all age groups and 
were not altered by dietary sodium intake. Together, these data suggest that age-
related sympathoexcitation, sodium retention, and hypertension develop 
independently of functional renal damage. 
In the renal tubules, norepinephrine can promote the activity of several 
sodium transporters both directly and indirectly, by stimulating renin secretion and 
activating the renin angiotensin aldosterone system. While studies of human aging 
indicate that systemic renin angiotensin aldosterone system activity is reduced with 
age (Weidmann et al., 1975; Noth et al., 1977; Messerli et al., 1983), aging in 
several animal models is characterized by enhanced sensitivity of the intrarenal 
renin angiotensin aldosterone system (Tank et al., 1994; Thompson et al., 2000). 
In the current study, in which Sprague Dawley rats were selected as a model of 
normal aging and develop increases in sympathetic tone, blood pressure, and salt 
sensitivity that mimic those observed in human aging, plasma aldosterone and 
angiotensin II were not altered in 8-month or 16-month old rats, and dietary 
sodium-evoked aldosterone suppression remained intact. These data suggest that 
the renin angiotensin aldosterone system does not drive age-related hypertension 
and salt sensitivity in Sprague Dawley rats and support a specific role for increased 
sympathetic nervous system activity. 
Previous studies have demonstrated that the direct influence of the 




of varying dietary sodium intake (Mu et al., 2011; Terker et al., 2014; Walsh et al., 
2016). Infusion of norepinephrine increases NCC expression and phosphorylation 
in mice and prevents the suppression of NCC expression and activity in rats, 
driving the development of salt-sensitive hypertension independently of the renin 
angiotensin aldosterone system (Mu et al., 2011; Terker et al., 2014; Walsh et al., 
2016). In the current studies, aging animals exhibiting a progressive increase in 
both blood pressure and renal norepinephrine content also exhibited increased 
NCC activity during normal salt intake. Further, while salt-resistant, normotensive 
3-month old rats exhibit dietary sodium-evoked suppression of NCC activity, a 
finding that is consistent with previous studies, NCC activity is not altered by 
dietary sodium intake and remains elevated in 8-month and 16-month old animals 
that also fail to suppress renal norepinephrine content.  
These findings add to a conflicted body of literature regarding age-related 
changes in NCC regulation. A study of aging Fischer Brown Norway rats 
suggested that aging is associated with an increase in NCC expression, and 
separate studies have established that these rats develop age-related 
hypertension (Tian et al., 2006; Chugh et al., 2012; Chugh et al., 2013; Pokkunuri 
et al., 2015). In contrast, the aged Sabra rat exhibits a decrease in distal 
convoluted tubule Na+/K+-ATPase activity, which drives and typically correlates 
directly with NCC activity (Scherzer et al., 2015). It is worth noting that blood 
pressure was not measured in the study of Sabra rats and the authors did not 




used (Ben-Ishay et al., 1980). This raises the possibility that the age-related 
decrease in Na+/K+-ATPase activity, and likely NCC activity, plays a protective or 
compensatory role in the hypertension-resistant or hypertension-prone rat, 
respectively. This possibility is supported by another study in which aging 
C57Bl6/CBA/129 mice, which do not develop age-related hypertension, exhibited 
decreased baseline NCC activity (Tiwari et al., 2009). Importantly, aged animals 
exhibited enhanced increases in both NCC activity and blood pressure during the 
exogenous administration of angiotensin II (Tiwari et al., 2009), supporting our 
observation that aging is associated with impairments in the dynamic regulation of 
the NCC that are relevant to blood pressure regulation. 
The signaling pathways through which norepinephrine influences NCC 
activity remain controversial, but in general NCC activation involves WNK kinases 
upstream of SPAK and OxSR1, which directly phosphorylate and activate the 
NCC. Initial studies of sympathetically-mediated NCC regulation implicated a β2-
adrenoceptor gated pathway involving WNK4 and SPAK, but subsequent work 
failed to replicate the role of WNK4 and a third study described a synergistic role 
for α1- and β2-adrenoceptors in a signaling pathway that requires OxSR1, but not 
SPAK (Mu et al., 2011; Uchida et al., 2012; Terker et al., 2014). Our studies in 
young Sprague Dawley rats demonstrate that norepinephrine infusion evokes 
NCC activation mediated by an α1-adrenoceptor-gated WNK1-OxSR1 signaling 
pathway that drives the development of salt-sensitive hypertension (see Chapter 




pathways that mediate age-related increases in NCC activity, our findings at the 
protein level suggest that WNK1 and phosphorylated SPAK/OxSR1, both of which 
increase in aged rats during normal salt intake, could be involved. Unexpectedly, 
however, 16-month old animals exhibited decreased NCC phosphorylation at the 
Thr53 residue. While this observation could reflect a compensatory response to 
increased NCC activity and sodium retention, further studies are required to 
assess other factors that modulate NCC activity, including phosphorylation at 
different residues, ubiquitinylation, and alterations in sub-cellular localization of the 
NCC. While the observed reduction in blood pressure and NCC activity in a small 
group of 16-month old rats treated with an α1-antagonist suggests that α1-
adrenoceptors play a role in the age-related increase in NCC activity, these 
findings must be replicated in a larger group and the selectivity of α1-adrenoceptor 
involvement must be tested. Importantly, chronic NCC antagonism reduces blood 
pressure in 16-month old rats but not 3-month old rats, suggesting that the NCC 
may play a specific role in blood pressure regulation in aged animals. 
 In light of the established role of norepinephrine-mediated NCC regulation 
in salt-sensitive hypertension and our data suggesting that age-related 
hypertension is characterized by increased NCC activity and renal sympathetic 
tone and attenuated by both NCC antagonism and renal denervation, our 
observation that NCC activity was not reduced following renal denervation in 16-
month old rats was unexpected. The failure of renal denervation to alter NCC 




reabsorption in the proximal tubule and the loop of Henle via increased sodium 
transporter activity and decreased glomerular filtration rate. It is possible that renal 
denervation results in decreased sodium reabsorption in the proximal nephron, 
resulting in an increase in sodium delivery to the distal nephron that can stimulate 
NCC activity. This effect could be further exacerbated by potential age-related 
increases in the activity of sodium transporters in the proximal tubule and loop of 
Henle, which have been summarized elsewhere (Frame & Wainford, 2018) but 
have not been linked to excess norepinephrine. It is worth noting that our previous 
studies indicate that norepinephrine alone does not alter NCC activity during 
normal salt intake and instead prevents NCC suppression only during high salt 
intake in young rats (see Chapter 3), while our renal denervation studies in aged 
animals were performed only during normal salt intake. This raises the possibility 
that while renal norepinephrine content is increased in aged hypertensive animals 
during normal salt intake, it may not be relevant to altered NCC regulation until a 
high salt diet is introduced. Further studies will be required to determine the 
mechanism and potential pathological role of increased NCC activity, was well as 
the role of norepinephrine in NCC regulation, in age-related hypertension and salt 
sensitivity of blood pressure.  
 While the contribution of impairments in the acute sympathoinhibitory reno-
renal reflex to the long-term dysregulation of renal sodium handling and blood 
pressure require further study, the current findings raise the possibility that a 




reno-renal reflex function promotes sympathoexcitation – perhaps due in part to 
reduced signaling of sympathoinhibitory neurons in the PVN – driving sodium 
retention and the development of salt-sensitive hypertension. Further, the data 
also provide evidence suggesting that the renal sympathetic nerves plays a 
pathophysiological role in age-related hypertension and salt sensitivity that may 
reflect inappropriate norepinephrine-mediated activation of the NCC. These 
findings are particularly significant given lifelong exposure to excessive dietary 
intake in elderly patients and evidence suggesting a pivotal role of sodium retention 
in treatment-resistant hypertension (Powles et al., 2013; Mozaffarian et al., 2014; 
Williams et al., 2015). We speculate that therapies reducing sympathetic outflow 
and sodium retention, including renal denervation, may be particularly useful in 







CHAPTER SIX: GNAI2 Polymorphic Variance Associates with Salt 
Sensitivity of Blood Pressure in the Genetic Epidemiology Network of Salt 
Sensitivity Study 
This section was previously published as: X. Zhang, A. A. Frame, J.S. Williams, 
and R. D. Wainford. GNAI2 polymorphic variance associates with salt sensitivity 
of blood pressure in the Genetic Epidemiology Network of Salt Sensitivity study. 
Physiological Genomics 50(9):724-725. PMID: 29906209 © 2018 The American 
Physiological Society. For the purposes of this dissertation, the introduction has 
been expanded to include a greater amount of relevant background information. 
 
Abstract 
Salt sensitivity of blood pressure increases hypertension risk and 
associated adverse cardiovascular outcomes. At present, there are no validated 
rapid tests or diagnostic markers to identify salt sensitivity of blood pressure in 
clinical practice. Based on our prior animal studies that report a role for brain Gαi2 
proteins in the salt sensitivity of blood pressure and evidence that GNAI2 single 
nucleotide polymorphisms (SNPs) associate with hypertension risk, we 
investigated the hypothesis that GNAI2 SNPs associate with salt sensitivity of 
blood pressure in humans. Our data provide the first evidence that a GNAI2 SNP 
(rs10510755) positively associates with salt sensitivity of blood pressure in the 
Genetic Epidemiology of Salt Sensitivity dataset (continuous phenotype P = 0.049, 




These observations suggest that genotyping at GNAI2 may be a useful biomarker 
in identifying individuals at risk for developing salt-sensitive blood pressure and 




Salt sensitivity of blood pressure, a clinical phenomenon characterized by 
an exaggerated pressor response to increased dietary sodium intake, is present in 
roughly 50% of hypertensive patients and 25% of normotensive individuals 
(Weinberger et al., 1986). Salt sensitivity promotes the development of 
hypertension and has been identified as an independent predictor of 
cardiovascular morbidity and mortality even in the absence of hypertension 
(Weinberger et al., 1986; Weinberger, 1996; Morimoto et al., 1997; Meneton et al., 
2005; Appel et al., 2011). Despite the broad clinical and prognostic relevance of 
salt sensitivity, particularly given excessive global dietary sodium intake, tests of 
salt sensitivity are cumbersome, poorly standardized, and rarely used in the clinical 
setting. The identification of a biomarker of salt sensitivity would aid in 
cardiovascular risk stratification and allow for better targeted recommendations for 
preventive and therapeutic interventions, including reduced dietary sodium intake. 
Further, such a biomarker would enable the pursuit of mechanistic studies and the 
assessment of anti-hypertensive drug efficacy in defined salt-sensitive versus salt-




interventions currently used to test for salt sensitivity and by the somewhat 
arbitrary and unstandardized blood pressure cutoffs used to interpret such tests. 
               Salt resistance is characterized by dietary sodium-evoked 
sympathoinhibition, which facilitates natriuresis and the maintenance of 
normotension (Lohmeier et al., 1999; Brooks et al., 2005; Gao et al., 2005; Osborn 
et al., 2008; Johns et al., 2011; Johns, 2014). In contrast, sympathoexcitation 
promotes sodium retention and increased blood pressure in salt sensitivity (Bayorh 
et al., 1998; Miyajima & Yamada, 1999; Huang et al., 2001; Dobesova et al., 2002; 
Brooks et al., 2005; Yatabe et al., 2010; Stocker et al., 2013; Johns, 2014). A 
number of studies have demonstrated that the paraventricular nucleus (PVN) of 
the hypothalamus, one of several central regulatory sites that modulate 
sympathetic tone, sodium homeostasis, and blood pressure, plays a role in these 
responses (Budzikowski et al., 1998; Huang & Leenen, 1998; Huang et al., 1998; 
Huang et al., 2001; Akine et al., 2003; Badoer et al., 2003; Dampney et al., 2005; 
O'Donaughy & Brooks, 2006; Gabor & Leenen, 2009; Frithiof et al., 2014; Holbein 
& Toney, 2015; Larson et al., 2015). Further, central GPCR-coupled Gαi2 subunit 
proteins are required for appropriate activation of parvocellular neurons in the 
PVN, sympathoinhibition, and normotension in response to acute volume 
expansion and hypertonic saline infusion (Kapusta et al., 2012; Wainford et al., 
2013; Carmichael et al., 2016). Central GPCR-coupled Gαi2 subunit proteins are 
also required for sympathoinhibition and the maintenance of salt resistance during 




dietary sodium-evoked upregulation of Gαi2 protein expression specifically in the 
PVN (Kapusta et al., 2012; Kapusta et al., 2013; Wainford et al., 2013; Wainford 
et al., 2015; Carmichael et al., 2016). In contrast, Dahl Salt Sensitive rats fail to 
increase PVN Gαi2 subunit protein expression during high salt intake (Wainford et 
al., 2015). These findings suggest that central Gαi2 proteins are required for the 
homeostatic responses to sodium challenge that characterize salt resistance. 
Importantly, although variance in the GNAI2 gene encoding Gαi2 proteins has not 
been investigated in defined salt-resistant versus salt-sensitive populations, two 
single nucleotide polymorphisms in the GNAI2 gene have been linked to 
hypertension risk (Menzaghi et al., 2006; Kohara et al., 2008). Interestingly, one of 
these polymorphisms is a functionally relevant mutation in the GNAI2 promoter 
region, that results in decreased transcription (Menzaghi et al., 2006) – which could 
promote salt sensitivity by preventing dietary sodium-evoked upregulation of Gαi2 
proteins. 
                In the current studies, we hypothesized that GNAI2 genetic variance 
would be associated with the salt sensitivity of blood pressure. To investigate this 
hypothesis, we analyzed genetic and phenotypic data procured from the Genetic 
Epidemiology of Salt Sensitivity (GenSalt) dataset to determine whether GNAI2 
variance correlates with 1) the blood pressure response to increased dietary 
sodium intake as a continuous phenotype, and 2) the salt sensitivity of blood 







In this analysis, salt sensitivity of blood pressure was defined as the change 
in systolic blood pressure observed between a 7-day restricted-sodium feeding 
(51.3 mmol/day) and a 7-day high-sodium feeding (307.8 mmol/day). As per 
GenSalt program design as previously reported (Group, 2007), all blood pressure 
readings were measured in the morning by trained and certified observers using a 
random-zero sphygmomanometer after 5 minutes of rest with the participant in the 
sitting position and the arm placed at the level of the heart. The blood pressure 
levels during the dietary sodium intervention were calculated as the mean of nine 
measurements obtained from three clinical visits on days 5, 6, and 7 of each dietary 
sodium intervention phase (Group, 2007). Salt sensitivity of blood pressure was 
defined by the observation of a greater than a 5mmHg (4.6-4.9mmHg rounded to 
5mmHg) or greater increase in mean systolic blood pressure following the 
transition from a restricted to high-sodium intake (i.e., blood pressure response to 




The GenSalt population cohort study has been extensively defined 
previously. In brief, the GenSalt study was conducted in a Han Chinese population 




Research Oversight committee, and written consent was obtained from each 
participant. This population had a mean systolic blood pressure that ranged from 
130-160mmHg without use of antihypertensive medications. All subjects were 
between 18-60 years, with a mean age of 38.5 ± 6 years (Group, 2007). A total of 
1000 subjects in this study underwent whole genome genotyping using the 
Affymetrix Genome Wide Human SNP Array AFFY_6.0. Of this population, 968 
had complete genotype and phenotype data available for analysis. Among these 
968 subjects, we categorized 369 as “salt-sensitive” (175 females, 194 males) and 
642 as “non-salt-sensitive” (330 females, 269 males). For the salt-sensitive 
subjects, the mean ± SD of blood pressure response to high-sodium diet is 
7.82±3.20. For the non-salt-sensitive subjects, the mean ± SD of blood pressure 
response to high-sodium diet is -0.05 ± 3.16. 
 
Type of Study 
Candidate gene. 
 
Details of the single nucleotide polymorphisms studied 
The candidate gene under investigation was GNAI2. Primary single 
nucleotide polymorphisms (SNPs) investigated were rs10510755, rs9852677, 
rs2282751, rs4547694, and rs2298952 identified from HapMap and 






For the association analysis, the continuous phenotype was the difference 
in mean systolic blood pressure from a low- to a high-salt intake, which represents 
the quantitative trait of the salt sensitivity of blood pressure (i.e., blood pressure 
response to high sodium diet = blood pressure on high-sodium diet minus blood 
pressure on restricted-sodium diet). Linear regression was used to model salt 
sensitivity of blood pressure and an additive genetic model (SNP dosage) adjusted 
for age, sex, and principal components. In addition, we conducted a logistic 
regression analysis, which provides an odds ratio estimate, by treating the binary 
trait (salt-sensitive vs. non-salt-sensitive) as the outcome; SNP as predictor; and 
age, sex, and principal components as covariates. For all analyses, the 
significance threshold was considered at P < 0.05. 
 
Results 
Of the 5 GNAI2 SNPs selected for testing, only SNPs rs1010755, 
rs9852677, and rs2282751 were present in GenSalt after quality control. As such, 
only these 3 SNPs underwent analysis. SNPs rs9852677 and rs2282751 were not 
significantly associated with the salt sensitivity of blood pressure in the GenSalt 
dataset (Table 6.1). However, rs10510755 was associated with salt sensitivity of 
blood pressure (Table 6.1). For SNP rs10510755, the minor allele frequency (MAF) 
was 6.2% in the GenSalt population. The GenSalt dataset contains 369 salt-




subjects. The minor allele at rs10510755 was more frequently observed within the 
salt-sensitive cohort compared to the nonsalt-sensitive cohort (salt-sensitive 
cohort 32% vs. non-salt-sensitive cohort 12%, p < 0.05) even after adjusting for 
age and gender. There was no additive SNP effect observed, however; only one 
subject exhibited two minor alleles in this study. SNP rs10510755 is associated 
with greater odds of the salt sensitivity of blood pressure (case-control phenotype 
odds ratio 3.046; 95% confidence intervals 2.195–4.228, Z-score 6.663, P = 
0.039). This suggests that subjects with GNAI2 SNP rs10510755 are three times 
more likely to be salt-sensitive than subjects that lack SNP rs10510755. 
 
Discussion 
These results suggest a positive association between the GNAI2 SNP 
rs10510755 and salt sensitivity of blood pressure and provide important clinical 
relevance to our prior mechanistic work in animal models regarding the influence 
rsID Locus name Chr Position EA/ALT Trait EAF Effect-size (β) Std. Error Z-score P N
rs10510755 GNAI2 3 50,256,172 T/C
BP response to       
high sodium diet 0.0620 -0.4175 0.2175 -1.9192 4.90E-02 968
rs9852677 GNAI2 3 50,266,621 C/T
BP response to       
high sodium diet 0.4891 -0.1023 0.0955 -1.0716 2.80E-01 968
rs2282751 GNAI2 3 50,266,789 G/A
BP response to       
high sodium diet 0.4332 -0.0438 0.0966 -0.4530 6.50E-01 968
rsID Locus name Chr Position EA/ALT Trait EAF Effect-size (β) Std. Error Z-score P N
rs10510755 GNAI2 3 50,256,172 T/C
Salt Sensitive vs.                                  
non-Salt Sensitive 0.0620 -0.4420 0.2140 -2.0648 3.90E-02
369 (Yes), 
599 (No) 
rs9852677 GNAI2 3 50,266,621 C/T
Salt Sensitive vs.                                  
non-Salt Sensitive 0.4891 -0.0888 0.0950 -0.9353 3.50E-01
369 (Yes), 
599 (No) 
rs2282751 GNAI2 3 50,266,789 G/A
Salt Sensitive vs.                                  
non-Salt Sensitive 0.4332 -0.0381 0.0961 -0.3964 6.92E-01
369 (Yes), 
599 (No) 
rsID Locus name Chr Position EA/ALT EAF Odds Ratio 95% CI Z-score P N
rs10510755 GNAI2 3 50,256,172 T/C Odds Ratio 0.0620 3.046
2.195 -
 4.228 6.663 3.90E-02
369 (Yes), 
599 (No) 
Table 5.1 GNAI2 SNP results Abbreviations and definitions: rsID - dbSNP rsID; locus name, variant annotation; Chr - chromosome; Position - Build 37 
position; EA/ALT - Effect allele and alternative allele; Trait; EAF - Effect allele frequency;  β (SE)/Z-score - effect estimate and standard error for a 
quantitative trait and Z-score for example for a binary trait; CI - Confidence Interval for Odds Ratio; P  - P -value for association; N - number of samples 
analysed. 
Linear-regression model (continuous phenotype)
Logistic-regression model (case-control phenotype)




of Gαi2 proteins on the salt-sensitivity of blood pressure (Wainford et al., 2015). 
Possible limitations of the current analysis are the relatively small sample size, the 
lack of ability to include analysis of body mass index as a covariate, and the low 
minor allele frequency of the indexed SNP. These data suggest GNAI2 
polymorphic variance represents a potential biomarker for salt sensitivity of blood 





CHAPTER SEVEN: Overall Discussion 
 
Summary 
The current studies were designed to investigate the integrated renal and 
neural mechanisms that contribute to sodium homeostasis and blood pressure 
regulation, with the goal of identifying potential mechanisms and therapeutic 
targets in the pathophysiology of salt-sensitive hypertension. We first investigated 
the renal and sympathetic nervous system mechanisms determining salt 
resistance versus salt sensitivity in male young adult Sprague Dawley rats, which 
are classically salt-resistant but become salt-sensitive during norepinephrine 
infusion (Walsh et al., 2016), and extended some of our key findings in Dahl Salt 
Resistant and Dahl Salt Sensitive rats. Based on evidence that human aging is 
associated with increases in the prevalence of both hypertension and salt 
sensitivity as well as elevated sympathetic tone (Luft et al., 1987; Luft et al., 1991; 
Esler et al., 1995; Esler et al., 2002; Muntner et al., 2018; Whelton et al., 2018), 
we then extended our studies using the male Sprague Dawley rat as a model of 
normal aging.  
In Chapter 3, we identified an α1-adrenoceptor-gated WNK1/OxSR1 
signaling pathway that prevents the suppression of NCC-mediated sodium 
reabsorption during high salt intake, promoting the development and maintenance 
of salt-sensitive hypertension in norepinephrine-infused young adult Sprague 
Dawley rats. In Chapter 4, we described a critical role for the mechanosensitive 




maintenance of salt resistance in young adult Sprague Dawley rats and provided 
novel evidence implicating the PVN in the central integration of the afferent and 
efferent arms of the sympathoinhibitory reno-renal reflex. In Chapter 5, we 
extended these findings using the Sprague Dawley rat as a model of normal aging 
and demonstrated that aging animals develop salt-sensitive hypertension driven in 
part by significant and progressive impairment in two mechanisms that contribute 
to salt resistance in young animals – namely, the suppression of sympathetic 
outflow and NCC activity that promotes natriuresis during high salt intake and the 
mechanosensitive afferent renal nerve-mediated sympathoinhibitory reno-renal 
reflex responses that promote natriuresis during acute sodium challenge in young 
rats. In Chapter 6, we demonstrated that a single nucleotide polymorphism in the 
GNAI2 gene encoding Gαi2 proteins is associated with salt sensitivity of blood 
pressure in the GenSalt cohort, providing translational relevance to prior studies 
indicating that Gαi2 proteins in the PVN may be required for salt resistance in 
animal models.  
 
Future Directions 
Interrogation of the α1-Adrenoceptor-Gated WNK1/OxSR1 NCC Regulatory 
Pathway Using Lentiviral Knockdown 
Our studies of the adrenergic regulation of NCC activity in young animals in 
Chapter 3 revealed an α1-adrenoceptor-gated WNK1/OxSR1 signaling pathway 




hypertension. The utility of these targets in reducing NCC activity and attenuating 
blood pressure in norepinephrine-evoked salt-sensitive hypertension and age-
related hypertension and salt sensitivity could be assessed via the targeted 
lentiviral knockdown of each kinase in vivo. These experiments would also provide 
mechanistic insight to strengthen our observational studies. Further, infusion of 
norepinephrine directly into the renal artery would allow for the assessment of the 
specific role of renal adrenergic signaling in the regulation of NCC activity, sodium 
homeostasis, and blood pressure, refining the current studies performed using 
systemic norepinephrine infusion.  
 
Assessment of NCC Post-Translational Modification and Localization 
While our studies in Chapter 3 indicate that the failure to suppress NCC 
activity during high salt intake in young norepinephrine-infused rats could be due 
in part to increased NCC expression and phosphorylation at Thr58, it is possible 
that other alterations known to impact NCC activity, including phosphorylation at 
other sites, ubiquitinylation, or alterations in NCC trafficking to the plasma 
membrane, could also contribute to NCC dysregulation (Moriguchi et al., 2005; 
Sandberg et al., 2006; Richardson et al., 2008; Arroyo et al., 2011). The unbiased 
assessment of post-translational modifications using mass spectrometry, as well 
as the precise cellular localization of the NCC under different dietary conditions 
using electron microscopy, would yield important insight into the regulation of NCC 




increase in physiological NCC activity in the absence of any change in total NCC 
expression and an unexpected decrease in phosphorylation at Thr53.   
 
Investigation of the Relationship between the Renal Nerves and the NCC 
Based on our observations that norepinephrine infusion evokes salt-
sensitive hypertension characterized by failure to suppress NCC activity in young, 
classically salt-resistant rats, we anticipated that removal of the renal sympathetic 
nerves would reduce NCC activity and blood pressure in aged hypertensive 
animals that exhibit increased renal sympathetic tone. However, our studies in 
chapter 5 demonstrated that selective afferent renal nerve ablation and bilateral 
renal denervation, which removes both the afferent renal nerves and the renal 
sympathetic nerves, improved blood pressure but did not attenuate NCC activity 
in hypertensive aged Sprague Dawley rats. It is important to note that these studies 
were performed during normal salt intake, while our studies suggest that 1) 
norepinephrine has no impact on NCC activity during normal salt intake but 
prevents NCC suppression during chronic high salt intake in young adult rats 
(Walsh et al., 2016), and 2) aged animals exhibit a failure to suppress renal 
sympathetic tone and NCC activity during high salt intake. Denervation studies in 
aged animals during high salt intake will therefore provide important insight into 
the potential role of the renal nerves in NCC regulation during acute and chronic 




Further, radiotelemetry studies in which renal denervation is performed 
subsequent to the establishment of chronic NCC antagonism in aged hypertensive 
rats will yield interesting insight into the relationship between the renal nerves and 
the NCC. It is possible that the efficacy of renal denervation is masked by the use 
of thiazide diuretics. Conversely, it is possible that renal denervation during 
thiazide treatment results in a synergistic effect, producing a larger decrease in 
blood pressure than renal denervation or NCC antagonism alone. The findings 
from these studies will be particularly relevant to the interpretation of clinical trials 
in which renal denervation is often performed in subjects in whom existing anti-
hypertensive therapies are maintained.  
 
Investigation of Other Renal Sodium Transporters 
In Chapter 3, we elected to focus on the NCC based on previous studies 
indicating a specific role for impaired regulation of NCC activity in the development 
of norepinephrine-evoked salt-sensitive hypertension (Mu et al., 2011; Uchida et 
al., 2012; Terker et al., 2014; Walsh et al., 2016). Because aging is associated with 
increases in both salt sensitivity and sympathetic tone (Luft et al., 1987; Luft et al., 
1991; Esler et al., 1995; Esler et al., 2002), we maintained our focus on the NCC 
in the renal sodium transporter studies in Chapter 5. Interestingly, while increased 
NKCC2 and ENaC activity have been linked with salt-sensitive hypertension in 
young animal models (Husted et al., 1996; Alvarez-Guerra & Garay, 2002; Aoi et 




decreased NKCC2 and ENaC expression and activity in several animal models 
(Tian et al., 2006; Tiwari et al., 2009). While our studies indicate that increased 
NCC activity promotes age-related hypertension, the role of other transporters in 
age-related hypertension and salt sensitivity of blood pressure has not been fully 
elucidated and warrants further study.  
 
Characterization of Age-Related Impairments in the Afferent Renal Nerves 
Our studies in Chapters 4 and 5 suggest that the mechanosensitive afferent 
renal nerves are required for the responses to acute and chronic sodium challenge 
in young rats, and that age-related hypertension is characterized by impairments 
in the afferent renal nerve-mediated reno-renal reflex. However, the nature of this 
impairment requires further investigation. Together with our acute in vivo sodium 
challenges, our ex vivo studies of afferent renal nerve function suggest that there 
is a primary issue with the afferent renal nerves. While the nature of age-related 
changes in the afferent renal nerves has not been investigated, declines in other 
sensory systems have been attributed to reduced density, atrophy, and impaired 
electrophysiological function of sensory afferent nerve fibers in elderly humans and 
animal models of aging. Future studies will investigate whether the observed 
impairment in afferent renal nerve responsiveness reflects the physical loss of 
afferent renal nerve fibers, impairments in the signaling pathways involved in 
afferent renal nerve activation, or altered electrophysiological afferent renal nerve 




renal pelvis, such as elasticity, could change with age, influencing the degree of 
mechanical stress activating afferent renal nerve mechanoreceptors during a given 
stimulus. Future studies in aged animals replicating those performed in young adult 
Sprague Dawley rats in Chapter 4, in which 1) renal pelvic pressure was measured 
during acute volume expansion in anesthetized animals, and 2) the natriuretic 
responses to direct in vivo manipulation of renal pelvic pressure and sodium 
concentration were assessed, will help to elucidate the mechanistic underpinnings 
of age-related afferent renal nerve dysfunction. 
 
Functional Assessment of the Parvocellular PVN Neurons Activated by Acute 
Volume Expansion 
In Chapter 4, we provided evidence that the afferent renal nerves are 
required for the activation of sympathoinhibitory neurons in the PVN during acute 
volume expansion. It is therefore likely that the reduction in volume expansion-
evoked Fos activation in the PVN of aged rats reflects the observed reduction in 
afferent renal nerve responsiveness. However, it is possible that aging is also 
associated with impairments downstream of afferent renal nerve activation, 
including altered signal transduction within the PVN itself, which could contribute 
to age-related alterations in renal sodium handling and blood pressure regulation. 
Our assessment of neuronal activation in the PVN is based on Fos 
expression. Although our findings are supported by previous studies 




the PVN (Haselton et al., 1994; Patel & Zhang, 1994; Randolph et al., 1998; 
Cunningham et al., 2002; Howe et al., 2004) and results in the suppression of renal 
sympathetic outflow (Haselton et al., 1994; Kapusta et al., 2012), further evidence 
is needed to validate that the parvocellular PVN neurons that exhibit Fos induction 
following volume expansion are 1) functionally activated, 2) sympathoinhibitory in 
nature, and 3) involved in the natriuretic responses to acute sodium challenge. The 
functional nature of the age-related reduction in Fos expression in parvocellular 
PVN neurons should also be confirmed. These remaining questions could be 
addressed in part by studies of the impact of PVN lesion on the natriuretic response 
to acute volume expansion. Further, our findings would be strengthened by renal 
sympathetic nerve recordings that would confirm whether selective afferent renal 
nerve ablation, or PVN lesion, prevents the suppression of renal sympathetic 
outflow during volume expansion, and whether age-related impairments in afferent 
renal nerve function and PVN responses are linked with blunted renal 
sympathoinhibition during acute volume expansion.  
 
Validation of Findings in Other Models of Aging and Human Hypertension 
In Chapter 5, we provided evidence that age-related impairments in the 
afferent renal nerve-mediated sympathoinhibitory reflex and NCC regulation 
promote hypertension and salt sensitivity. While we designed our studies to 
temporally separate the development of salt-sensitive hypertension from the 




intrinsic renal mechanisms driving hypertension, it is important to note that the 
translation of animal age to human age is difficult and varies by the physiological 
system under investigation. Our findings must be validated in other animal models 
of aging and, ideally, investigated in human subjects or perhaps initially in tissue 
obtained from human subjects. Critically, many animal studies that have 
investigated age-related alterations in renal sodium handling have not directly 
assessed blood pressure or salt sensitivity, raising the possibility that seemingly 
conflicting evidence in the literature regarding sodium transport may be easily 
resolved with insight into blood pressure phenotype. For instance, evidence that 
aging Fischer Brown Norway rats exhibit increase baseline NCC expression (Tian 
et al., 2006) seems to conflict with the observation that aging C57Bl6/CBA/129 
mice exhibit decreased baseline NCC activity (Tiwari et al., 2009). However, the 
decrease in baseline NCC activity in aged mice could play a protective role, as the 
same study observed that these animals do not exhibit an age-related increase in 
blood pressure (Tiwari et al., 2009). In contrast, while blood pressure was not 
measured in the study of Fischer Brown Norway rats, other studies have 
demonstrated that these animals develop age-related hypertension (Chugh et al., 
2012; Chugh et al., 2013; Pokkunuri et al., 2015), and it is possible that the 
increase in NCC expression plays a causal role. Together with blood pressure 
data, these apparently conflicting findings support the unified theory that NCC 





Identification and Validation of Biomarkers of Salt Sensitivity 
In Chapter 6, we demonstrated that polymorphic variance in GNAI2, the 
gene encoding Gαi2 proteins that are critical for the maintenance of salt resistance 
in young animals, associates with salt sensitivity of blood pressure in the GenSalt 
dataset. The GenSalt study, which yielded full genotypic and phenotypic data for 
1000 individuals of Han Chinese descent, was relatively limited in both size and 
population diversity (Group, 2007). Thus, our findings must be replicated in a larger 
and more diverse population. It is also important to consider biomarkers that may 
be more broadly relevant in the absence of genetic variation. In Chapter 5, we 
observed that salt-sensitive hypertension in aged animals is associated with 
impaired afferent renal nerve responsiveness, assessed as substance P release, 
even during normal salt intake. These findings raise the possibility that urinary 
substance P, or perhaps other substances involved in afferent renal nerve 
activation including prostaglandin E2 and calcitonin gene-related peptide (Kopp et 
al., 1997; Gontijo et al., 1999; Kopp et al., 2000), could serve as rapid, noninvasive 
biomarkers of salt sensitivity. 
 
Significance and Perspectives 
Hypertension affects one in two adults in the United States and contributes 
to 10% of global deaths. While there is a demonstrated benefit of blood pressure 
reduction on measures of hypertension-related morbidity and mortality, less than 




studies sought to delineate the integrated renal and neural mechanisms that 
modulate sodium homeostasis and blood pressure regulation in the setting of salt 
sensitivity, which promotes hypertension, and aging, which is associated with both 
hypertension and salt sensitivity. The goal of these studies was to identify novel 
therapeutic targets and inform current treatment paradigms for hypertension, 
meeting an urgent public health need. 
Overall, our findings have important implications for the application of 
therapies targeting the sympathetic nervous system and the NCC. The observation 
that NCC antagonism reduces blood pressure in age-related hypertension was not 
unexpected, in light of its use as a first-line anti-hypertensive therapeutic – but is 
informative given a recent report that thiazides are currently under-prescribed, 
particularly in the aging population. Further, although α1-adrenoceptor blockade is 
not a first-line anti-hypertensive therapeutic and poses several risks that are 
magnified in the aging population, including orthostatic hypotension, our findings 
suggest that renal α1-adrenoceptor signaling may be an important therapeutic 
target in salt-sensitive and age-related hypertension. Selective small-molecule 
WNK inhibitors have a beneficial effect on blood pressure in rodent models of 
human WNK overexpression, providing a potential avenue for the downstream 
modulation of renal α1-adrenoceptor signaling pathways that could avoid the 
adverse outcomes associated with systemic α1-adrenoceptor blockade.  
Our findings may be particularly informative to the targeted application of 




a contributing factor to the mixed results of renal denervation trials, and our 
findings raise the possibility that renal nerve ablation could disrupt a protective 
sympathoinhibitory reno-renal reflex in some individuals, blunting the efficacy of 
renal nerve ablation or even exacerbating hypertension. In contrast, individuals in 
whom the sympathoinhibitory reno-renal reflex is impaired may be ideal candidates 
for renal denervation. The development of biomarkers or simple non-invasive 
challenges designed to test the balance of sympathoinhibitory versus 
sympathoexcitatory reno-renal reflexes – for instance, intravenous volume 
expansion, which has been used in human studies of renal physiology for decades 
– and biomarkers of salt sensitivity, including GNAI2 polymorphic variance, could 
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